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Abstract 
Background: Skin cancer, in particular melanoma, is a serious health burden in Queensland, 
Australia where residents have one of the highest rates of skin cancer in the world. Currently 
there is no population-based screening program for melanoma in Australia. The best 
outcomes for patients with melanoma are achieved through early detection. Melanoma is 
often cured when it is detected before it embeds itself deeper into the body, thus early 
detection is thought to improve melanoma survival prospects. Performed on a regular basis, 
skin self-examination may aid in the early detection of melanoma and other skin cancers.  
 
Teledermatology including mobile teledermoscopy: Teledermatology is the broad term used 
to identify all practices that combine the fields of dermatology with telemedicine. 
Telemedicine uses telecommunication technologies to provide clinical health services 
remotely. One application of teledermatology that could aid skin self-examination and is used 
for skin cancer diagnosis is mobile teledermoscopy. Mobile teledermoscopy combines a 
dermatoscope (a skin microscope with a bright light source) and a smartphone. Mobile 
dermatoscopes have specifically been designed to attach to a smartphone to utilise the 
smartphones’ camera and connectivity features. In clinical practice using a dermatoscope can 
increase diagnostic accuracy because of its magnification and lighting features. If a 
suspicious lesion is detected by an individual at home they photograph the lesion with the 
dermatoscope and submit the photo to a dermatologist, along with their medical and lesion 
history. The dermatologist could then provide feedback direct to the patient if the lesion 
requires treatment, a management plan, or no further action is required.  
 
Current research in the field: With the exception of the present studies, no previous research 
has specifically investigated consumer or patient acceptance of mobile teledermoscopy used 
in the home environment for the early detection of melanoma. Previous research has assessed 
satisfaction with physician-initiated and performed teledermatology conducted in a medical 
environment (such as videoconferencing); and only few studies have focused on consumer-
driven teledermatology or mobile teledermoscopy outside of the QUT-led research. 
Furthermore, most studies on patient acceptance and satisfaction did not report whether their 
questionnaires passed rigorous psychometric requirements. 
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Methods:  Firstly, a literature review was conducted on mobile teledermoscopy: including its 
advantages as a screening tool for skin cancer, its history, clinical accuracy compared to face-
to-face consultations and patient perspectives. Secondly, secondary data analysis was 
performed on the ‘The Smartphone Study’ which assessed mobile teledermoscopy use in 
participants 50-64 years of age using a 27-item questionnaire.  The questionnaire was based 
on an adapted Technology Acceptance Model (TAM) and structured around the components: 
perceived usefulness; ease of use; compatibility; attitude and intention; subjective norms; 
facilitators, and trust. Thirdly, based on results from the Smartphone Study, a new cross-
sectional study was developed, conducted and assessed (called The Virtual Skin Check 
Study) which explored the acceptability of mobile teledermoscopy in consumers 18 years of 
age and over. The 27-item mobile teledermoscopy acceptance questionnaire was modified 
based on the results from the Smartphone Study, for use in the Virtual Skin Check Study. 
Participants completed a test-retest questionnaire two weeks later. A small subsample was 
also invited to test the functionality of the dermatoscope and was provided with additional 
satisfaction questions. Facilitators and barriers to using mobile teledermoscopy in both the 
Smartphone Study and Virtual Skin Check Study were described and psychometric testing 
and factor analysis were performed on both acceptability questionnaires.  
 
Results: The literature review identified 18 studies and significant research gaps were found 
with many studies not using valid or reliable questionnaires. A total of 230 adults between 
50-64 years of age completed the Smartphone Study questionnaire, and 228 remained for 
analysis. Acceptance of mobile teledermoscopy by consumers for melanoma early detection 
was high. Almost half (48%) of the items were rated as ‘strongly agree’ or ‘agree’ by 75% or 
more of the participants.  Most (87%) participants agreed mobile teledermoscopy would 
improve their skin self-examination performance and 91% agreed it would be in their best 
interest to use mobile teledermoscopy. Nearly half (45%) of participants were unsure 
however, if they would have complete trust in the dermatologist’s telediagnosis. Based on 
principal components analysis (PCA), consumers’ acceptance for mobile teledermoscopy 
were grouped into four factors: a) technical and skin self-examination facilitators; b) 
similarity to face-to-face encounter and perception of the interaction; c) social indicators and 
practicality; and d) ease of use. Cronbach alpha for the subscales were above acceptable 
levels .90, .79, .85 and .83, respectively. 
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In the Virtual Skin Check Study, 155 participants were available for baseline assessment and 
82 completed the test-retest assessment. Participants were between 21 to 78 years old. Just 
over half the sample was aged 35 years or younger (n=83, 54%). Eleven participants trialled 
the dermatoscope for functionality and perceived usefulness, and survey data are available for 
ten of these participants. All ten participants ‘agreed’ or ‘strongly agreed’ taking photos was 
easy when they trialled the dermatoscope. Despite the older age group in the Smartphone 
Study, the results from the 25-item revised acceptance questionnaire were similar; there was 
high mobile teledermoscopy acceptance among participants at baseline and follow-up.  
Almost half (48%) of the items were rated as ‘strongly agree’ or ‘agree’ by 75% or more of 
the participants. The subscale of ‘technical and skin self-examination facilitators’ (M=4.1, 
IQR= 3.9–4.7), was endorsed most highly by participants and the subscale which included 
trust items, ‘similarity to face-to-face encounters and perception of the interaction’ reported a 
median closer to neutral (M=3.2, IQR=3.0–3.6). Most participants were unsure (57%) 
whether the dermatologist could diagnose a skin cancer by mobile teledermoscopy as well as 
they can face-to-face. All items had moderate to almost perfect agreement in the test-retest 
assessment (Intraclass Correlation Coefficient (ICC)). Cronbach alpha for the subscales were 
0.91, 0.80, 0.84 and 0.73 respectively.  Confirmatory factor analysis (CFA) found 
standardised factor loadings were well above 0.4 (minimum threshold) for all items excluding 
four which were removed. The goodness of fit test indicated some further improvement of 
model fit are required for the questionnaire, as not all model fit indexes met the minimum 
thresholds. 
 
Limitations: The studies did not use a population-based sample and the sample sizes were 
relatively small. This work assessed acceptance when thinking about ‘intention to use’ 
mobile teledermoscopy, and not ‘actual use’ of mobile teledermoscopy, except for the eleven 
participants who trialled the dermatoscope for functionality. 
 
Conclusions: This research adds to the evidence base that consumer acceptance of patient-
initiated and performed mobile teledermoscopy appears high, and warrants further 
assessment for its applicability in remote skin cancer diagnosis. 
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List of Definitions 
Adapted from Encyclopaedia Britannica 2015 
 
Skin cancer: A disease characterised by the uncontrolled growth of cells in the skin. Skin 
cancers are of two distinct types: non-melanoma (NMSC) and melanoma. 
Melanoma: A spreading and frequently recurring cancer of specialised skin cells 
(melanocytes) that produce the protective skin darkening pigment melanin. Melanoma is a 
deadly disease and unlike other skin growths it is always malignant. 
Non-Melanoma Skin Cancer (NMSC): A cancer of surface tissues which can usually be 
cured with minor surgery. There are two forms of NMSC: Squamous cell carcinomas (SCC) 
and Basal cell carcinomas (BCC). 
Nevi: medical term for mole 
Early detection: Conducting tests to detect a precancerous condition or growth in an early 
stage so that it can be removed. 
Screening: The presumptive identification of unrecognised disease or defects by means of 
tests, examinations, or other procedures (modified from WHO, 1968). 
Primary Prevention: Primary prevention is the pre-emptive behaviour that seeks to avert 
disease before it develops. E.g. wearing sun protective clothing to avoid skin cancer. 
Secondary Prevention: The early detection of disease or its precursors before symptoms 
appear with the aim of preventing or curing it. E.g. population based screening 
Tertiary Prevention: An attempt to stop or limit the spread of disease that is already present. 
E.g. chemotherapy. 
Technology acceptance: An individual’s psychological state with regard to his or her 
intended use of a particular technology. 
Technology satisfaction: An individual’s psychological state with regard to his or her actual 
use of a particular technology. 
Dermatology:  The medical specialty dealing with the diagnosis and treatment of diseases of 
the skin. 
Teledermatology: The remote delivery of dermatology services and clinical information 
using telecommunications technology. 
Dermatoscope: A hand-held skin microscope with a bright light source used to magnify the 
skin. 
Dermoscopy:  The examination of skin lesions with a dermatoscope. 
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Teledermoscopy: The transmission of dermoscopic images via telecommunications 
technology (such as e-mail or web applications). 
Mobile teledermoscopy: The process of transferring dermoscopic images captured with 
mobile phones coupled with a dermatoscope. 
Sensitivity: The effectiveness of a test in detecting disease in those that have the disease. 
Specificity: The extent to which a test gives negative results in those that are free of the 
disease. 
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1.1 BACKGROUND 
In Australia, skin cancer is a serious public health issue. Australia has the highest rates of 
skin cancer in the world due in part to: high ambient UV levels; a fair-skinned population and 
an outdoor-focused lifestyle (1). Skin cancer comprises of three main types: Basal Cell 
Carcinoma, Squamous Cell Carcinoma (known collectively as non-melanoma skin cancer 
(NMSC) or keratinocyte cancers), and melanoma (the most deadly form of skin cancer). 
NMSC accounts for about 95% of all skin cancers, while melanoma accounts for the 
remaining 5% (2). Melanoma was the third most commonly diagnosed cancer in Australia in 
2012 in both males (7,440 cases) and females (5,070 cases) (3). Mortality from melanoma 
has changed little since 1991 (4). The most recent mortality statistics indicate that in 2011, 
1,544 deaths from melanoma were recorded, compared with 543 deaths from NMSCs (5).  
New cases of melanoma are forecasted to rise, with 17,570 new cases of melanoma expected 
in 2020 (6).  
 
The average age at diagnosis of melanoma is 60.8 years (3).  However, melanoma is the most 
common cancer for Australians aged 15 to 44 years (7). Besides age, risk factors for 
melanoma include having: a sun sensitive phenotype (fair hair, skin, light eye colour or 
numerous naevi); high sun exposure; history of multiple sunburns; worked outdoors; and a 
genetic disposition or family history of melanoma (8). In addition to the high morbidity and 
mortality rates, melanoma imposes substantial costs on individuals, government and the rest 
of society (9). In Australia the total cost of advanced melanoma was estimated to be $422 
million in 2014 (9). This is mainly associated with productivity loss due to premature 
mortality accounting for 48% (9). Health care cost is the second largest contributor and this 
explains 39% of the expenditure (9). Other costs include informal care and loss of healthy life 
to individuals. NMSC while not as frequently deadly incurs estimated costs of $700 million 
in 2015 (10). 
 
These numbers highlight the public health burden associated with skin cancer in Australia 
and why prevention is important. Skin cancer prevention is divided into primary, secondary 
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and tertiary. Skin cancer primary prevention strategies are designed to improve skin cancer 
risk behaviours which include reducing sun exposure and increasing sun protection. 
Secondary prevention efforts for skin cancer include early detection by skin self-examination 
or examination by a doctor (clinical skin examination). Tertiary prevention includes treating 
and reducing the damage of a diagnosed skin cancer by halting progression and 
complications. This Master’s thesis focuses on the secondary prevention strategy of early 
detection and skin screening for melanoma. Currently, there is no dedicated population-based 
screening program for melanoma in Australia. 
 
Mobile and wireless technologies have enabled new developments in telemedicine. To assist 
with early detection a novel technology called mobile teledermoscopy allows people to take 
clear pictures of their naevi with a specialised camera attachment for their smartphone and 
send them to a dermatologist for remote diagnosis. Mobile teledermoscopy could be used by 
general practitioners (GPs) to get a supportive opinion from a dermatologist. However, this 
research proposes it could be more useful and cost-effective if lay people used it at home 
during skin self-examination and communicated directly with a dermatologist. This 
technology has many benefits: it could benefit rural communities; may improve skin self-
examination outcomes, and may increase peoples’ ability to identify atypical naevi among 
other advantages which will be discussed in the following chapter. Overall, mobile 
teledermoscopy has the potential to greatly improve early detection and therefore reduce 
morbidity and mortality from melanoma in the future. 
 
1.2 SCOPE OF THIS RESEARCH 
This research thesis has three components: (1) a literature review on mobile teledermoscopy: 
including its advantages as a screening tool for skin cancer, its history, clinical accuracy and 
patient perspectives; (2) secondary data analysis evaluating ‘The Smartphone Study’ which 
assessed mobile teledermoscopy use in participants 50-64 years of age; and (3) the 
development, conduct and assessment of a cross-sectional study (called The Virtual Skin 
Check Study) exploring the acceptability of mobile teledermoscopy in consumers 18 years of 
age and over.  
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1.3 OUTLINE OF CHAPTERS 
The thesis begins with a literature review, which describes previous research on mobile 
teledermoscopy, including the topics of clinical accuracy, and patient perspectives.  The 
Technology Acceptance Model (TAM) is discussed as the theoretical foundation of this 
research. Chapter 3 describes the methods used to design and collect the data in ‘The 
Smartphone Study’ and the subsequent ‘Virtual Skin Check Study’. The statistical analysis 
steps are described. The results are presented in Chapter 4 for the Smartphone Study and the 
Virtual Skin Check Study respectively. Finally, Chapter 5 contains a detailed discussion of 
the findings about patient acceptance and satisfaction with mobile teledermoscopy in the 
context of existing literature. 
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This literature review is divided into three parts about mobile teledermoscopy: 
Part One - Early detection of melanoma and mobile teledermoscopy 
Part Two - Diagnostic accuracy of mobile teledermoscopy and agreement with clinical 
diagnosis 
Part Three - Patient perspectives  
 
2.1 PART ONE - EARLY DETECTION OF MELANOMA AND MOBILE 
TELEDERMOSCOPY 
Part one of this literature review discusses the importance of early detection and the strategies 
of population-based screening and skin self-examination. This section then introduces the 
concept, processes, advantages and history of mobile teledermoscopy and discusses 
telemedicine policy and teledermatology applications currently in Australia. 
2.1.1 TYPES OF MELANOMA 
Melanoma occurs when melanocytes (skin cells that produce the pigment called melanin) 
multiply and grow in an uncontrolled way (11). All melanomas do not look the same but are 
often recognised by changed shape (become uneven), size (increasing growth) or colour 
(different shades of black, brown, blue or pink) (11). Melanoma grows and spreads in two 
phases: radial and vertical growth phases (12). Melanoma grows horizontally across the 
surface of the skin in the radial growth phase, thus the risk of spread to other body parts at 
this stage is low (12). The vertical growth phase occurs when the melanoma invades deeper 
into the layers of skin. Melanoma Patients Australia describe the different types of melanoma 
including (12): 
 Superficial spreading melanoma: The most common form of melanoma 
representing 70% of all cases. It usually starts in a pre-existing mole. This type of 
melanoma undergoes a long radial growth phase, prior to invading deeper into the 
skin. 
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 Nodular melanoma: The most aggressive form of melanoma because it enters a 
vertical growth phase immediately. Nodular melanomas are typically a raised, 
nodular lesion with irregular patches of colour and an irregular border. 
 Lentigo maligna melanoma: The least aggressive type of melanoma due to its long 
radial growth phase. This melanoma typically occurs on areas of the body that have 
received lots of sun exposure such as the face, ears, neck and head. 
 Acral lentiginous melanoma: This melanoma has a short radial growth phase thus it 
is considered more aggressive than superficial spreading melanoma and less 
aggressive than nodular melanoma. This melanoma typically occurs on the palms, 
soles of the feet or beneath the nail beds. 
Because the eyes contain melanocytes, melanoma can also be found in the eye (ocular 
melanoma) detectable by an optometrist during an eye examination (13). However, most 
melanomas are located on the skin and thus are thought to be amenable to early detection and 
diagnosis through visual skin examinations (14). If a doctor suspects that a spot on a patients’ 
skin may be a melanoma or NMSC, the patient would receive a biopsy often performed by a 
GP, dermatologist or plastic surgeon depending on the patient’s age and where it is on the 
body.  
2.1.2 IMPORTANCE OF EARLY DETECTION AND TREATMENT FOR MELANOMA 
The best outcomes for patients with melanoma are achieved through early detection (15-17). 
Five-year survival rates from a melanoma improve dramatically if the melanoma is removed 
before it embeds itself deeper into the body and its systems (16). The melanoma survival 
rates are: 
  98% if the melanoma is localised at the epidermis (top layer of skin) (stage 0 (in 
situ), stage I (< 2 mm in thickness) and stage II (> 2 mm in thickness)),  
 62% if it has spread to the regional stage (stage III, spread to lymph nodes), and 
 16% if the melanoma has spread to other organs away from the initial site (distant 
or stage IV) (16).  
Treatment for advanced melanoma stage III and IV (chemotherapy, biological therapy, 
radiotherapy and targeted treatments) is often debilitating with physical and psychosocial 
impacts and there is no guarantee the treatment will be successful. In a study of 404 patients 
with melanoma, one third of the melanomas (nodular melanoma) were estimated to have 
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grown 0.5 mm per month or more (18). It is imperative melanoma is detected early when the 
melanoma is thin and has not penetrated the skin’s basal layer to improve survival rates (19). 
2.1.3 SECONDARY PREVENTION: POPULATION-BASED SCREENING 
Population-based screening refers to an early detection test that is offered to all individuals in 
a target group, usually within a defined age demographic, as part of a systematic program 
(20). The intent of population screening for melanoma is to detect the cancer whilst confined 
to the epidermis which is likely to result in more successful treatment (17). There are 
currently three national population-based screening programs in Australia for cancers 
including breast, cervical and bowel. Due to lack of evidence from randomised controlled 
trials (RCTs), there is currently no dedicated melanoma screening program in Australia. 
Population-based surveillance efforts have been conducted in Germany, with initial results in 
the state of Schleswig-Holstein suggesting a nearly 50% decrease in melanoma mortality 
(21). The Australian criteria by the Australian Health Ministers’ Advisory Council for 
deciding whether or not a new cancer screening program should be introduced in a defined 
target population include (20): 
 
1. Condition: The disease must be an important public health problem with a recognisable 
latent stage.  
2. Test: The screening test needs to be able to detect most people with the disease 
(sensitivity) and be able to exclude most people without the disease (specificity). 
3. Assessment: There should be safe follow-up for diagnostic assessment of individuals with 
a positive screening test. 
4. Treatment: The treatment is effective, safe and early treatment is more effective than 
treatment at a later stage that would occur without screening. 
5. Screening Program: A high level of evidence from RCTs of the benefit of screening for 
the disease is required. The overall benefits of the program should outweigh the harms and be 
cost-effective.  
6. Treatment and ongoing management: Onward referrals will support timely transition 
from screening program diagnosis to treatment. 
 
Despite melanoma meeting many of the above points in the absence of population-based 
clinical screening, the current advice from the Australian Cancer Councils recommend 
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individuals be aware of changes to their skin and conduct skin self-examination every three 
months (22). In contrast, the American Cancer Society recommends that adults perform skin 
self-examination monthly (23). 
2.1.4 SECONDARY PREVENTION: SKIN SELF-EXAMINATION  
Skin self-examination, a patient-initiated behaviour, is a strategy promoted for skin cancer 
early detection. Skin self-examination is defined as ‘the careful and deliberate examination of 
all areas of one’s skin, including those areas rarely exposed to the sun for changes in spots or 
moles’ (24). Skin self-examination is important because patients (or their relatives or friends) 
detect most (61-86%) melanomas during an incidental or planned skin self-examination (25-
27). In a case-control study in the United States individuals who conducted skin self-
examination had a 60% reduced risk of melanoma mortality (28). Studies have demonstrated 
that individuals who had conducted skin self-examination in the past presented to doctors 
with thinner lesions, compared to those who had not conducted skin self-examination (27, 
29). In a Queensland-based study, researchers found that melanomas detected during a 
planned skin examination (skin self-examination or by a doctor) were thinner than those 
detected otherwise (30).  
 
There are emotional, attitudinal, environmental, and social factors that may facilitate or 
impede performance of skin self-examination (31). Skin self-examination prevalence and 
thoroughness is generally low in the Australian population with people failing to view hard-
to-see areas or to document lesions that need to be followed up (17). Further barriers to skin 
self-examination can include lack of: availability of a partner to assist with self-examination, 
availability of a wall mirror, confidence in ability to detect a skin cancer, or self-efficacy, and 
impaired vision or requirements for use of contacts or glasses (32). New mobile technology 
utilising patient-oriented telemedicine applications have become available which may greatly 
aid skin self-examination and skin screening and improve early detection options for 
melanoma by acting as a prompt to action.  
2.1.5 TELEMEDICINE AND DERMATOLOGY 
Telemedicine is an emerging field, allowing for remote exchange of medical information and 
planning of clinical treatments. The World Health Organisation definition of telemedicine is: 
‘The delivery of healthcare services, where distance is a critical factor, by all healthcare 
professionals using information and communication technologies for the exchange of valid 
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information for diagnosis, treatment and prevention of disease and injuries, research and 
evaluation, and for the continuing education of healthcare providers, all in the interests of 
advancing the health of individuals and their communities’ (33). The term telemedicine is 
often interchangeably used with the terms e-health (electronic health), mhealth (mobile 
health), telehealth or online health, however telemedicine generally involves remote clinical 
diagnosis or treatment prescription by a health practitioner. An increasing proportion of 
telemedicine services are becoming mobile based, that is, they rely on portable devices such 
as mobile phones or tablets that have internet connection with built-in cameras (34). 
Telemedicine is commonly used in multiple medical fields including ophthalmology, 
radiology, pathology, psychiatry, and dermatology.  
 
Telemedicine practices in the specialised field of dermatology are also known as 
teledermatology. Modern teledermatology is usually performed in two main ways; store and 
forward systems or live interactive (videoconferencing). Store and forward systems use 
asynchronous, still digital images for communication, similar to e-mail. Using store and 
forward technology, the doctor and patient are separated by space and time, whereas live 
interactive systems use real-time videoconferencing technology requiring both patient and 
doctor to be available at the same time (35).  In early teledermatology research regular digital 
cameras were used to photograph lesions for diagnosis (sometimes called macro imaging – 
macro refers to close up photography of small things). The most recent development in 
teledermatology relevant to skin cancer early detection is mobile teledermoscopy. Mobile 
teledermoscopy is a form of store and forward technology that uses a dermatoscope (hand 
held microscope with polarised light) which is attached to a smartphone to utilise the camera 
feature to capture images of pigmented skin lesions and send them to a dermatologist for 
teleconsultation (36) (Figure 2.1).  
 
 
 
 
 
 
 
 
Figure 2.1 Dermatoscope attachment with iPhone 
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Clinical dermoscopy began in the mid-1980s, rather than relying on naked eye examinations, 
and has been shown to increase the diagnostic accuracy of doctors and reduces the number of 
unnecessary excisions for both melanocytic and nonmelanocytic skin malignancies (37). 
Using dermoscopy removes the reflection from the skins surface and allows a better visual of 
the lesion colour and blood vessel patterns that are important for diagnosis (37). Hence 
mobile teledermoscopy allows better diagnostic accuracy then store and forward 
teledermatology with a regular digital camera. There are two types of dermoscopy 1) contact 
immersion dermoscopy (non-polarised) and 2) polarised light dermoscopy (38). Contact 
immersion dermoscopy has previously been the standard for capturing dermoscopic images 
and requires a liquid interface between the scope and the skin (38). Polarised light 
dermoscopy does not require a liquid interface or direct skin contact (38). The dermatoscope 
attachment for the iPhone is a polarised light source, allowing easier use. 
 
For skin cancer early detection in the home, a participant would notice a suspicious lesion, 
take a photo with their smartphone and dermatoscope attachment, email it via the application 
(app) to the dermatologist with their lesion and medical history, and then receive feedback 
ideally within a short time period (Figure 2.2)  
 
Figure 2.2 The mobile teledermoscopy process initiated by a patient 
At present most companies which are producing mobile dermatoscopes (for example, 
Canfield Scientific Inc and FotoFinder Systems Inc) target health professionals 
(dermatologists and GPs). They currently retail for approximately $AUD 800. The companies 
have also produced apps which manage and store the images captured via a dermatoscope. 
However quite a few e-health companies are interested in developing more affordable, 
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patient-oriented systems. Currently teledermatology consultations are usually physician-
initiated and performed for a second opinion by a specialist, but this research discusses 
patient-initiated and performed teledermatology. Mobile teledermoscopy for the early 
detection of skin cancer is a patient-initiated and performed process, requiring the individual 
to play a more active role in managing their own health status. Outside the QUT-led program 
of consumer-driven research (39-41), there are very limited reports of patients performing 
mobile teledermoscopy for skin self-examination (42), reports of the use of teledermoscopy 
by health professionals other than doctors (e.g. nurses and pharmacists) to triage patients are 
more frequent (43).  
 
There is also an important distinction between apps that use automatic algorithms for skin 
cancer diagnosis without dermatologist input and mobile teledermoscopy performed by 
dermatologists. Mobile teledermoscopy has shown high diagnostic accuracy and agreement 
when conducted by dermatologists (see Section 2.2 Diagnostic accuracy). While mobile 
applications have been developed using computational algorithms for diagnosis of photos 
patients may submit, these do not involve a clinician looking at the photos and some have 
poor sensitivity (0-70%) in assessing melanoma risk (44, 45).  This present research is 
concerned with dermatologists reviewing the photos during the mobile teledermoscopy 
process, and is not researching algorithm-based automatic melanoma diagnosis. 
2.1.6 HISTORICAL BACKGROUND OF TELEDERMATOLOGY 
Teledermatology was coined by Perednia and Brown in 1995 in a publication describing the 
benefits of dermatology in rural areas by a distant provider (46).  Even before the term 
teledermatology was formed, combined telemedicine and dermatology applications date back 
to 1972 when skin lesions of employees at Boston’s Logan Airport were assessed by 
university-based dermatologists via a black and white television screen at the Massachusetts 
Hospital telemedicine centre (47). Teledermatology applications were relatively dormant for 
several years after this until a resurgence in interest in the late 1980s and early 1990s which 
coincided with the development of less expensive, readily available and more efficient 
communications technology (48). Advances such as converting from analogue to digital, 
which allowed compression of video and still images, and increasing transmission bandwidth 
made teledermatology a more practical method (49). In 1997, Zelickson and Homan (50) 
conducted the first study on diagnostic concordance comparing face-to-face diagnoses and 
store and forward teledermatology in a nursing home in the USA. Agreement between 
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diagnoses was up to 88%, with the correct treatment plan identified in up to 90% of cases. In 
1998, Provost and colleagues were the first to trial teledermoscopy accuracy, using store and 
forward technology with dermoscopic images (51). Four dermatologists were provided with 
conventional and dermoscopic images of 31 lesions and they found a high concordance in the 
diagnosis of atypical (dysplastic) melanocytic nevi and early melanoma, compared to 
histopathology. Driven by these rapid technological advancements, dermatology has been 
tested in a telemedicine setting as a screening and diagnosis (39, 52, 53), surveillance (54) 
and triage tool (43, 55) for a range of dermatological conditions. The most common skin 
conditions managed and diagnosed via telemedicine systems include skin cancer, wounds 
follow-up (56), acne (57) and psoriasis (58). 
2.1.7 ADVANTAGES AND CHALLENGES OF MOBILE TELEDERMOSCOPY 
Mobile teledermoscopy performed by a patient aligns with a movement toward ‘the 
quantified self’ whereby people self-track their health information to improve their overall 
wellbeing. Table 2.1 provides an overview of all the potential benefits and challenges of 
mobile teledermoscopy to the patient, health professionals and health system. Mobile 
teledermoscopy may address several health care difficulties in Australia. 
Table 2.1 
Benefits and challenges of mobile teledermoscopy to the patient, health professionals and health system 
Benefits Challenges 
 Equity in health services by providing specialist 
dermatological care to remote or rural areas  
 Convenience and time savings  
 Decrease cost to patients for travel and time off 
work 
 Useful triage tool and reduces unnecessary 
referrals 
 May be faster than traditional referral 
 RCTs report high diagnostic accuracy  
 Dermatologists report higher diagnostic accuracy 
than GPs 
 Large number of images can be reviewed by the 
dermatologist at their convenience 
 Access to international expert opinion 
 Equipment costs decreasing with increasing 
image quality 
 
 Adequate training is required to use the device 
and systems 
 Technical issues: image quality, internet 
availability with high bandwidth required 
 Tendency to focus on presenting lesion instead 
of patient as a whole 
 Technology-centric rather than person-centric 
care. Possible loss of rapport with patient. 
 Dermatologist reimbursements 
 Security, privacy and legal considerations 
 Consults can be conducted between countries 
with different legal frameworks and patient 
rights.  
 
 
There are many benefits to using mobile teledermoscopy (14). It provides access to specialist 
dermatological care to remote or rural areas. Healthcare provision across Australia is not 
uniform resulting in some areas with less access to appropriate health infrastructure and 
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service provision (59, 60). The majority of Australia's health professional specialists (85%) 
and close to 100% of dermatologists work in major cities, resulting in regional and remote 
patients often having to travel great distances to access dermatologists (61, 62). The Medical 
Specialist Outreach Assistance Program (MSOAP) in Australia sends dermatologists in-
person to rural and remote areas, however this service suffers from excessive workloads, and 
is an intermittent service where patients do not have access to a dermatologist between visits 
(62). Mortality and illness levels increase as the distance from metropolitan centres gets 
larger (63). The relatively poor access to health services means people outside metropolitan 
areas are less likely to participate in preventive health care and experience the impact of 
poorer health status even before the onset of disease (59, 64).  Increasing travel time within 
major centres in conjunction with longer working hours and increasing pressure on working 
populations makes it harder for people even within major cities to reach medical services 
(65). People in such circumstances likely also make less than optimal use of preventive 
services (65). 
 
Mobile teledermoscopy may be a useful triage tool and reduce unnecessary referral to 
dermatologists while increasing the speed of appropriate referrals and improve patient 
waiting times (66). In Australia, visiting a dermatologist requires a referral from a GP, and 
there can be long waiting periods. By optimally triaging and expediting patients most in need, 
teledermatology may improve waiting times for an initial dermatology consultation with a 
reduction in mean waiting time in one study of 66% (67). Despite acknowledging that the 
teledermatology may be slightly less accurate than face-to-face care, patients have expressed 
they would rather have their skin problems managed via teledermatology quickly than wait 
weeks to see the dermatologist in-person (68). Teledermatology initiated by a GP has been 
shown to prevent 74% of physical referrals to a dermatologist (n = 19 741 ⁄26 596) (69). The 
same results were found in another study where 136 out of 200 patients could potentially 
have been managed by the GP following remote advice from the dermatologist (43). 
Dermatologists have superior skin cancer diagnostic accuracy when compared to GPs (70). 
Dermatology constitutes up to 16% of all GP consultations, however only a small amount of 
these (8% of all referrals for any health issue by GPs) are being referred to a dermatologist 
(71). An Australian study found of 151 GP referrals to a dermatology clinic (all had 
histological confirmation), GPs agreed with histological diagnosis in 24% of cases, while 
dermatologists agreed in 77% of cases (72).  
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Economic considerations are important for implementation of a telemedicine program. There 
are many variables in telemedicine cost analysis research to consider. The economic 
perspective of an analysis is important to clarify, whether it is the health care system, the 
patient or societal (73).  Analysing a health care system approach the costs incurred directly 
by the system would be of most interest to its decision makers (such as equipment cost, staff, 
training, communication infrastructure and ongoing maintenance costs) (73). Patient 
perspectives include costs incurred only by the patients (service fee, travel costs, and loss of 
productivity costs). The societal perspective considers all the costs and outcomes that affect 
all of society, including the healthcare system, patient, private enterprise and government (all 
the above costs and also including quality-adjusted life years (QALYs)) (73).  
 
In a 2015 systematic literature review on cost-effectiveness of telemedicine studies, including 
teledermatology, the researchers found limited studies available (n=35). Some, but not all, 
studies showed telemedicine systems can reduce costs (74). One study on store and forward 
teledermatology (not using teledermoscopy but a digital camera) found patient savings of up 
to 18% with patients on average paying €192 for an in-person consultation, and €157 for 
telediagnosis receiving results within 4-7 hours (69). In another study, patients were referred 
to a dermatology service by their GP with one or more skin lesions and were triaged to one of 
two groups (teledermatology or in-person) (67).  Total cost savings for the teledermatology 
group were $42.00 per patient or 14% (67). Another study based in rural Mongolia found 
savings of US $76.36 per teledermatology patient, and referrals were reduced by 75% in the 
teledermatology group compared to the usual care group (75). This study also shows a 
significant reduction in travel with the teledermatology group saving a total of 19, 892 km 
and 269 hours of travel when compared with patients in the control group (75). This means 
the cost reduction is even higher in cases where the travelling distance to the dermatologist is 
increased (76). In a systematic review which reported on the reductions in travel associated 
with the use of store and forward teledermatology, across 12 studies there was a mean travel 
reduction of 43% (77).  Due to technology advancing at an accelerating pace without a 
commensurate increase in price, and the time it takes to publish results it is difficult to 
ascertain definitively the current cost-effectiveness of telemedicine (78). 
 
Whilst there are many benefits of using mobile teledermoscopy there are also some 
challenges that would need to be addressed, such as internet capabilities, usability and 
training, security, privacy, patient safety and legal concerns. These challenges can also 
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explain the slow adoption of telemedicine by the Australian health system. These challenges 
are not just for mobile teledermoscopy alone, and would need to be considered using 
telemedicine systems for a variety of health problems. To use mobile teledermoscopy 
adequate training is required to use the device and systems, and appropriate technical 
instructions and customer service systems would need to be in place. Whilst this may not be a 
concern for younger populations who adopt many online practices in their lives, this may be 
more of a hardship in older populations. There are technical issues that could arise using the 
technology such as image quality and high speed internet availability. In the future, the 
Australian Broadband network may allow faster, more efficient transfer and storage of high 
resolution images that would be available in more remote areas than ever before (79). Whilst 
image quality was a limitation in early teledermatology applications, superior technology 
now allows dermoscopic images to be sent with colour and image calibration producing 
higher quality images (14) (Section 2.2 Diagnostic accuracy). 
 
When conducting mobile teledermoscopy, there is a tendency to focus on the presented lesion 
instead of the patient as a whole, and this can also lead to a loss of personal interaction and 
affect the doctor/patient relationship (14). Another challenge is ensuring security and privacy 
is maintained in telemedicine interactions. Users must trust the system is secure for 
transmitting patient details in telecommunications. There are also difficulties that could 
possibly arise using telemedicine when accessing expert knowledge and diagnosis from 
across the world. This can become difficult because legal frameworks and patient rights differ 
across many countries (80). Teledermatologists rarely hold professional licensure or 
insurance outside their own country. In Australia, when teledermatology is used to provide a 
second opinion in Australia or internationally (for example, a GP requires a dermatologist’s 
opinion about a potential skin cancer), the onus of diagnosis remains with the GP. These legal 
hurdles are without precedent and are yet to be fully resolved and relevant changes to medical 
indemnity cover would be required (80).  
 
These challenges to mobile teledermoscopy need to be addressed to overcome any consumer 
resistance to implementing telemedicine and are outside the scope of this research. The 
barriers or challenges to implementing or conducting teledermatology should be seen in the 
context of a wider social phenomenon where there is integration of new technology in all 
areas of medicine and modern life (14). “Computerisation” of interpersonal relationships is 
not restricted to telemedicine but inherent in today’s society (80). It is envisioned mobile 
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teledermoscopy would be an enabling tool to enhance the delivery of overall healthcare, 
rather than a complete replacement tool (48). Overall, mobile teledermoscopy could be a 
valuable tool addressing scarce specialist medical care in remote or rural areas, an increasing 
demand on the health system and rising costs of medical care. 
2.1.8 TELEMEDICINE IN AUSTRALIA 
The Australasian Telehealth Society has developed a telehealth policy ‘Towards a National 
Strategy for Telehealth in Australia 2013-2018 (79). The telehealth strategy includes 
telemedicine. It has three key strategies: 1) Focus on national priority groups (aged care, 
poorly mobile/disabled and outer metropolitan, remote and rural); 2) apply fit for purpose 
models and, 3) optimise the locus for implementation. An objective in key strategy three is 
‘identifying demand, enablers and barriers for uptake by consumers’. The document 
encourages assessment of consumer feedback from telemedicine trials and services. It 
highlights that the current telemedicine environment in Australia is fragmented with many 
drivers. This makes it difficult to know how to embed telemedicine most effectively into such 
a complex mix without knowing what determines use. 
Currently in Australia, store and forward teledermatology is available for rural GPs to access. 
Tele-Derm, established in 2003, is an online resource that allows GPs to submit a digital 
photo of a suspicious lesion and its history, and a dermatologist provides a telediagnosis 
within 48 hours (81). Skin conditions managed through this service include acne, eczema, 
psoriasis, drug reactions, tinea, blistering disorders, and skin cancer among others. Tele-Derm 
is free for rural GPs to access and currently has about 2000 GPs enrolled. It has been 
developed by the Australian College of Rural and Remote Medicine and is funded by the 
Australian Government Department of Health under the Rural Health Outreach Fund (RHOF) 
(81). Using this telemedicine service the GP has to take more responsibility and time for their 
patient’s management then they would with a traditional referral. Since July 2011, when GPs 
or medical specialists conduct live interactive teledermatology with their patients they can 
receive a Medicare rebate in telehealth eligible areas (patient must live outside major cities 
(RA1), or patients in aged care homes or Indigenous services can live anywhere within 
Australia (they do not need to meet the rural requirements) (82). Prior to July 2011, 
reimbursements for live interactive teledermatology were only available for telepsychiatry 
services. There is no previous or current reimbursement for store and forward technology.  
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Recently, the Chemmart pharmacy has started a skin lesion screening service using mobile 
teledermoscopy (83). A pharmacy assistant photographs up to three lesions using a 
dermatoscope for a fee and consumers receive results directly to them within 48 hours. The 
service costs $35 for one spot, $50 for two spots, and $65 for three spots photographed 
(prices correct as of August 2015). If patients have more than three lesions requiring 
assessment, a whole body skin check by a doctor is recommended. There is no information 
available regarding uptake of this service and satisfaction with use. It does not use 
dermatologists for telediagnosis but instead is run by GPs with a special interest in skin 
cancer. An important factor to consider in such applications is the accuracy of telediagnosis. 
 
2.2 PART TWO - DIAGNOSTIC ACCURACY  
Part two of this literature review provides a summary of the diagnostic accuracy and 
agreement of store and forward teledermatology, including mobile teledermoscopy with 
clinical diagnosis. For mobile teledermoscopy to gain acceptance, it should ideally perform as 
well as face-to-face dermatology. A number of clinical trials have assessed the diagnostic 
accuracy of teledermoscopy compared to face-to-face consultations and these have been 
summarised in two literature reviews to date.  
2.2.1 TERMINOLOGY USED IN STUDIES 
Studies on mobile teledermoscopy diagnostic ‘accuracy,’ ‘agreement’ and ‘concordance’ 
commonly report rates of correctly identifying a clinical diagnosis compared with the gold 
standard histopathology (the surgical excision of a lesion and microscopic examination of 
tissue). However in clinical studies histopathology is usually only available for suspicious 
lesions that would require surgical removal in standard clinical practice (e.g. melanoma or 
NMSCs). According to medical diagnostic principles, face-to-face diagnoses by a 
dermatologist are considered adequate to serve as a gold standard for benign and non-
suspicious lesions, where no biopsy procedure is required (53). Interobserver reliability refers 
to agreement measured between two or more different dermatologists. Intraobserver 
reliability refers to the level of agreement a single dermatologist has with their own diagnosis 
when they assess the same lesion on two separate examinations. Investigators commonly 
report their results as simple per cent agreement or with kappa (κ) statistics. A kappa of 0.61 
or higher is a benchmark of high reliability (48).  
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2.2.2 LIMITATIONS OF REVIEWING ACCURACY STUDIES COLLECTIVELY 
Comparisons of diagnostic studies over time may be complicated for a number of reasons, 
including changes in diagnostic criteria, clinical practice guidelines and technological 
advances. Early studies must not be used as fact since more recent technologies have already 
overcome the limitations identified in these studies, such as image quality which was an early 
major limitation. Early studies assessing accuracy in teledermatology are mostly important to 
demonstrate that teledermatology is feasible (the workflow) and useful for remote diagnosis. 
The literature review conducted in this research was therefore restricted to reviews conducted 
in the last ten years for this reason. Other reasons comparisons of studies can be difficult 
include: variations in study populations; dermatological condition assessed; number and level 
of training of dermatologists; and the method of assessing diagnostic agreement (49). Of note 
all but two of the studies reviewed below have taken place in medical settings with medical 
practitioners trained in taking dermoscopic images, i.e. the consumers did not take the photo 
of the lesion themselves.   
2.2.3 SEARCH STRATEGY 
The search strategy followed the 12-step guidelines by Kable, Pich and Maslin-Prothero 
(2012). A search of the online databases MEDLINE, Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), and PsycInfo was made using the terms “teledermatology or 
teledermoscopy” and “review” in April 2015. This search was repeated just prior to 
submission to locate any additional recent publications. In addition, internet searches were 
undertaken to identify any reviews commissioned by government or telemedicine 
associations but not published in journals. Reviews were included if the following criteria 
were met: a focus of the review was teledermoscopy accuracy which must include store and 
forward images, the review was published in the last ten years, and the researchers defined 
their search strategy and search terms. Papers were excluded if they were written in a 
language other than English. To ensure the most up-to date studies are included in this 
literature review on diagnostic accuracy, the above databases were searched a second time, 
removing the search term “review’” and adding “accuracy or concordance or agreement” for 
any studies assessing diagnostic accuracy conducted after the most recent literature review. 
2.2.4 REVIEW OF STUDIES 
The initial search result for reviews revealed 41 manuscripts. The abstracts of 15 manuscripts 
were reviewed against the above criteria and the full text versions of nine potentially suitable 
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reviews were retrieved. Five review manuscripts were excluded as the researchers did not 
specify their search criteria or strategy. A further two reviews did not contain 
teledermatology that involved mobile teledermoscopy (84, 85). This left two reviews that met 
the above criteria in the database search. Internet searches revealed one review titled 
‘Summary of the status of teledermatology research’ published by the American 
Telemedicine Association (86), however this also did not report its search strategy, thus was 
not included. Levin and Warshaw (2009) did not do a formal systematic review, however 
included their search strategy and was thus included in this review. This left two reviews 
from the database search that were critiqued for this current research. An overview of the 
characteristics of these two reviews are presented in Table 2.2. 
 
Table 2.2 
Literature reviews on teledermatology diagnostic accuracy  
 TD and MTD studies 
combined 
MTD studies only 
First Author, 
Year 
Search 
Period 
No. of 
TD 
studies  
No of 
MTD 
studies  
TD and 
MTD 
accuracy to 
HP  
(%) mean 
(range) 
 
F2F to HP 
Accuracy 
 
(%) mean 
(range) 
MTD accuracy 
to HP  
 
(%) mean 
(range) 
Accuracy F2F 
to HP 
 
(%) mean 
(range) 
Levin, 2009 
(49) 
 
Undefined 
- 2008 
16 7 77 (37-95) 72 (30-92) 82 (52-95) 
 
(66-92)  
(data available 
for 5/7 studies 
only) 
Warshaw, 
2011 (35) 
1990-2009 19 4 63 (19-89) 71 (43-92)  Study 1: 52% 
Study 2: k=0.94 
Study 3: 47% 
Study 4: k=0.45 
Study 1: 59%,  
Study 2: NA  
Study 3: 56%  
Study 4: 
k=0.70 
 
*based on primary diagnosis (not including differential diagnosis), TD= teledermatology, MTD=mobile 
teledermoscopy, F2F=face-to-face, HP=histopathology 
 
 
Diagnosis of lesions is not an exact science and misdiagnosis can occur in both face-to face 
examinations and teledermatology. The 2009 literature review had a single-focus on  
teledermatology studies reporting accuracy rates (49). Teledermatology demonstrated good 
accuracy in comparison to face-to-face consultation (mean 77% and 72% respectively). Of 
the 16 studies assessing store and forward teledermatology, seven of these studies assessed 
mobile teledermoscopy and these seven studies reported a mean accuracy rate of 82% (range 
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52-95%).  In one study of store and forward mobile teledermoscopy (the first to use mobile 
phones for melanoma early detection), two teledermatologists obtained accuracy rates of 89% 
and 94% respectively (18 lesions diagnosed in 18 patients were compared to face-to-face 
diagnosis) (36). The 2011 systematic review focussed not only on reporting accuracy rates 
but detailed management, clinical outcomes and costs.  Face-to-face dermatology was 
superior to teledermatology (mean accuracy 71% and 63%, respectively). Of the 19 studies 
that assessed store and forward teledermatology only four of these assessed mobile 
teledermoscopy (35). The accuracy rates for teledermatology improved up to 15% (absolute 
difference) when telediagnosis was conducted with a dermatoscope.  
 
For the purpose of this research, a second systematic review was conducted for clinical trials 
assessing accuracy of mobile teledermoscopy conducted from 2009 onwards, since the most 
recent systematic review (which did not include papers published after 2009). The initial 
search results revealed eight manuscripts. The full texts of all eight manuscripts were 
reviewed. One study was excluded because it was a discussion article on the state of 
teledermatology. Seven studies were found to have assessed diagnostic accuracy and the 
aggregated agreement ranged from 74-94% (41, 43, 52, 53, 55, 87, 88). No further 
manuscripts were found when the search was repeated prior to submission. Seven studies 
were found to assess diagnostic agreement (Table 2.3) 
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Table 2.3 Diagnostic accuracy for store and forward teledermoscopy studies published 2009-August 2015 
First 
Author, 
Year 
Country, Setting Sample 
 
Results  
 
Evidence 
levela 
Tan, 2010 
(43) 
 
New Zealand, 
Hospital skin lesion 
clinic 
200 patients  
 
63% female, 11-
94 years 
 
491 lesions. 
Primary diagnostic concordance 
between face-to-face diagnosis and 
teledermoscopy: 74%  
(Kappa 0.95) 
 
All images allowed a telediagnosis 
III-3 
Kroemer, 
2011 (53) 
Austria, Nurses in a 
general outpatient 
clinic 
88 patients  
 
53% female, 3 -
93 years (mean 
age 69) 
 
113 skin lesions  
Concordance differentiating benign 
from malignant skin 
lesions between face-to-face 
diagnosis and 
teledermoscopy: 90%  
(Kappa 0.84) 
 
Dermoscopic image quality not 
suitable in 9 images  
III-3 
Lamel, 2012 
(52) 
U.S.A, Medical 
trainees at a skin 
screening event 
86 patients  
 
58% female, 
mean age 45 
years 
 
137 skin lesions  
Primary diagnostic concordance 
between face-to-face diagnosis 
and teledermoscopy: 82% 
(Kappa 0.62) 
 
Dermoscopic image quality not 
suitable in 4 images 
III-3 
Massone, 
2013 (55) 
Austria, GPs in a 
preventative health 
care centre for 
second opinion 
690 patients  
 
93% male, 18-
84 years (mean 
age 47) 
 
955 skin lesions 
Primary diagnostic concordance 
between face-to-face diagnosis 
and teledermoscopy: 94% 
 
14 dermoscopic images low image 
quality: 3 cases a telediagnosis 
could not be reached 
III-3 
Manahan, 
2014 (41) 
Australia, RCT,  
Patients conducted 
skin examination at 
home  
49 patients  
 
54% female, 50-
64 years 
 
309 skin lesions 
 
Aggregated diagnostic concordance 
between face-to-face diagnosis and 
teledermoscopy: 89% (Kappa 0.90)  
 
Dermoscopic image quality not 
suitable in 2 images 
II 
Wu et al. 
2015 (88) 
U.S.A, Prospective 
cohort study, 
Patients asked to 
photograph atypical 
naevi that doctors 
identified  during 
face-to-face 
consultation 
34 patients  
 
53% female, 18-
81 years (mean 
age 44) 
 
33 lesions 
The diagnostic concordance 
between face-to-face visits and 
teledermoscopy was 97% (Kappa 
0.87) 
 
Dermoscopic image quality not 
suitable in 2 image pairs 
III-3 
Warshaw et 
al. 2015 (87) 
U.S.A, Cross-
sectional, repeated 
measures study,  
Patients referred to 
a Veterans Affairs 
Medical Center 
Dermatology Clinic 
for evaluation of 
a skin neoplasm 
2152 patients  
 
97% male, 19-
94 years (mean 
age 68)   
 
3021 lesions 
The primary diagnostic 
concordance between face-to-face 
visits and teledermoscopy was 
55.5% (kappa 0.32-0.62). 
 
Aggregated diagnoses was 85.5% 
(Kappa 0.77-0.90) 
 
All images allowed a telediagnosis 
III-3 
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In the study by Tan et al. (2010) concordance between face-to-face diagnosis and 
teledermoscopy was 74% in the IMAGE IT trial (43) which aimed to assess teledermoscopy 
as a triage tool for a hospital skin lesion clinic. Two hundred patients with a total of 491 
lesions were evaluated, and all images were of excellent quality allowing evaluation. 
Seventy-four per cent of all lesions submitted for teledermoscopy were determined to be 
manageable by the GP without the patient needing to be seen face-to-face by a dermatologist. 
This indicates the use of teledermoscopy as a triage tool offers the potential to shorten 
waiting lists and thus improve access and delivery of healthcare (43).  
 
In the Kroemer et al. (2011) study using mobile phones, 113 skin lesions were assessed in 88 
patients; however only 104 of the skin lesions from 80 patients were suitable for evaluation 
owing to poor image quality. The concordance rate was 90% (Kappa 0.84) for both clinical 
and dermoscopic images conducted by one dermatologist (53). In the study by Lamel et al. 
(2012) mobile teledermoscopy was conducted in 86 patients with 137 skin lesions at a skin 
cancer screening event, with primary concordance rate of the telediagnosis 82% (Kappa 0.62) 
between two dermatologists (52). Four lesions were inadequate for telediagnosis. 
 
Massone and colleagues (2013) conducted a study on teledermoscopy where 955 lesions were 
diagnosed by two teledermatologists with an overall diagnostic accuracy rate of 94% (55). 
Almost all lesions (99.7%) would have been successfully diagnosed by telediagnosis, and a 
definitive management decision was established in all these cases. Follow-up was 
recommended for 707 (74%) lesions. All malignant lesions were correctly diagnosed further 
indicating teledermatology is potentially suitable for the triage of skin cancers. 
 
In the study by Manahan et al. (2014), mobile teledermoscopy was used in the home 
environment for the early detection of melanoma (41). This study investigated whether 
patients at high risk of skin cancer could select similar lesions to monitor as their 
dermatologists. Patients used an iPhone 3, 4 or 5 and dermatoscope attachment (Handyscope, 
FotoFinder Systems) to photograph lesions they ‘did not like the look of’. There was 
substantial agreement between telediagnosis and face-to-face examination performed by the 
same dermatologist: 89% (Kappa=0.90) accounting for up to two differential diagnoses. Only 
two dermoscopic images were of poor quality and did not allow telediagnosis (blurry or out 
of focus). The most common lesions imaged were benign naevi (n = 153), seborrhoeic 
keratoses (n = 86) and actinic keratoses (n = 29). Based on images provided by consumers 
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using mobile teledermoscopy, the teledermatologist determined that 68% of participants had 
at least one lesion that required clinical follow-up, and required a face-to-face visit. This 
means a third of patients may have been able to avoid a doctors’ visit through 
teledermoscopy in this study.  
 
Wu et al. (2015) is the second pilot study to assess diagnostic accuracy of images taken by 
lay persons, however it was conducted in a doctors’ office after instruction. In this study the 
dermatologist identified a lesion of concern at the initial visit, and took the anatomical and 
dermatoscopic image whilst also instructing the patient on how to conduct the process. An 
iPhone 4 and dermatoscope attachment (DermScope, Canfield Imaging Systems Inc) was 
used. At the follow-up visit three to four months later, patients were asked to conduct the 
imaging process of the same lesion without guidance from the doctor to simulate the home 
environment. Of the 29 patients who had completed follow-up, 28 participants (29 images) 
took photos that were in focus and able to be evaluated (88). Twenty-five lesions had no 
significant change, and four lesions had significant changes requiring management. 
 
Warshaw et al. (2015) is the most recent and largest teledermoscopy study, and assessed 
diagnostic accuracy of macro imaging (close up photography with a digital camera) and 
dermoscopy for skin neoplasms and found moderate to perfect agreement between clinical 
and telediagnosis in 3021 lesions (87). The research assistants obtained the images, and three 
photos were obtained for all lesions (an anatomical image both distant and close up, and 
dermoscopic). Pigmented lesions only also used contact immersion dermoscopy. Diagnostic 
accuracy rates increased for polarised light dermoscopy, more so using contact immersion 
dermoscopy. The overall primary diagnostic agreement rate was 55.5%, increasing to 85.5% 
for aggregated diagnosis. Forty-one melanomas were confirmed by histopathology. Macro 
and polarised light dermoscopy image quality was rated as low (n=422 images), medium 
(n=1646 images) or high (n=786 images). All lesions allowed a telediagnosis and predictably 
high-quality images resulted in higher diagnostic agreement rates. 
 
In summary, based on the results to date, teledermatology appears to be a reliable and 
accurate technique for remote diagnosis and management of skin cancer compared to face-to-
face diagnosis. All images in the Tan et al. study allowed a diagnosis to be made (clear image 
that was in frame and not out of focus because of user error). All images in the Warshaw et 
al. (2015) clinical trial allowed telediagnosis, however there was a noticeable amount of low 
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quality images. Only a small per cent of lesions were not able to be telediagnosed in the 
remaining studies conducted from 2009 – August 2015 in Table 2.3 (range 0-14 images per 
study). The studies vary in the degree by which they showed potential for management by 
telediagnosis alone, potentially reflecting the skin cancer risk in the studied populations. 
Before further clinical trials are warranted, firstly patient acceptance or demand should be 
established. 
 
2.3 PART THREE - PATIENT PERSPECTIVES  
Part three of this literature review examines patient perspectives on store and forward 
teledermatology, including mobile teledermoscopy. 
2.3.1 TERMINOLOGY USED IN STUDIES 
The current literature examining patient and consumer perspectives in telemedicine varies in 
terms defining their outcomes such as acceptance, satisfaction or preference. However these 
terms can also be commonly interweaved and combined in the one study. For the purpose of 
this review: 
 Acceptance literature examines patients’ intent to use a technology whilst not 
necessarily having used it before,  
 Preference literature provides specific options to evaluate and choose from 
(selecting one method over another),  
 Satisfaction literature involves the patient testing or trialling a product or 
procedure and providing measured feedback. Patient satisfaction research is the 
most common measure of patient perspectives, because patients are increasingly 
viewed as active participants of services in the medical environment (89), 
 Patient perspectives is the broad term used to include all the above. 
2.3.2 SEARCH STRATEGY 
The search strategy was again documented following the 12-step guidelines (90). A search of 
the online databases MEDLINE, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), and PsycInfo was made using the terms “teledermatology or teledermoscopy” 
and “satisfaction” or “acceptance” or “preference” in April 2015. This search was repeated 
just prior to submission to locate any additional recent publications.  Manuscripts were 
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included if the following criteria were met: an objective of the study was patient perspectives 
(primary or secondary), the study includes store and forward teledermatology (conducted 
with standard digital cameras) or mobile teledermoscopy (conducted with dermatoscopes), 
and can include a range of skin conditions, not just skin cancer.  The doctor or the patient 
could be in charge of the imaging process. Papers were excluded if they were written in a 
language other than English. The quality of selected papers was assessed using the McMaster 
Critical Review Form for Quantitative Studies and guidelines (91). The initial search result 
for manuscripts revealed 68 manuscripts available. The abstracts of all manuscripts were 
reviewed against the above criteria and the full text versions of 18 potentially suitable 
manuscripts were retrieved. All 18 manuscripts met the above criteria and critical appraisal 
and were critiqued for this current research. An overview of the studies’ characteristics is 
presented in Table 2.4. 
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Table 2.4 
Patient perspectives studies for store and forward teledermatology, including mobile teledermoscopy 
Reference Country, study, setting, sample 
Methodological 
assessment 
Main findings with 
teledermatology  
Difficulties 
reported with 
teledermatology 
Pak et al. 
1999 (92) 
U.S.A, cohort study 
 
Department of 
Defence. No 
comparison group. 
 
TD baseline: n=77 
patients 
TD 4-6 weeks: n=55 
patients 
 
Survey (items not 
reported) at baseline and 
4-6 weeks 
 
Psychometric testing on 
questionnaire not 
reported 
Satisfaction: 
4-6 weeks 64% satisfied with 
TD 
Preference: 
4-6 weeks: 42% preferred TD 
and 
38% preferred face-to-face 
More than one 
third of patients 
preferred face-to-
face 
Kveder et al. 
1999 (93) 
U.S.A, cohort study 
 
Primary care practice, 
GPs seeking 
dermatologist 
opinion. No 
comparison group. 
 
TD: n=18 patients 
5 statements measuring 
TD patient satisfaction, 
time and comfort. 5 point 
Likert scale (5 strongly 
agree to 1 strongly 
disagree) 
 
Psychometric testing on 
questionnaire not 
reported 
 
Satisfaction: 
Overall satisfaction with TD 
4.56 out of 5 
NR 
Van den 
Akker et al. 
2001 (94) 
 
 
 
 
 
 
 
 
Netherlands, cohort 
study 
 
Primary care practice, 
GPs seeking 
dermatologist 
opinion. No 
comparison group. 
 
TD: n=62 patients 
TD satisfaction was 
collected qualitatively by 
their GPs.  
Only one question was 
reported in the 
manuscript: patients 
were asked to rate their 
TD performance 0 
(worthless) to 10 
(excellent).  
 
Psychometric testing on 
questionnaire not 
reported 
 
Overall satisfaction 7.4 out of 
10 (mean) 
 
Qualitative findings concluded 
that patients were ‘content’ 
with the use of TD. Patients 
felt comfortable sending 
photos and ‘content’ with the 
rapid evaluation via TD. 
Patients were 
concerned about 
incomplete 
information being 
transmitted. 
Williams et 
al. 2001  
(95) 
United Kingdom, 
cohort study 
 
Patients attending a 
teledermatology 
clinic. No 
comparison group. 
 
TD: n=123 patients 
(mean age: 42 years) 
Survey of 15 items 
newly developed for this 
study (5 point Likert 
scale - strongly disagree 
to strongly agree) 
 
Face validity only. No 
other psychometric 
testing performed on 
questionnaire 
 
 
 
 
Satisfaction: 
86% found TD convenient 
85% did not mind being 
photographed 
Preference:  
40% of patients would have 
preferred face-to-face  
68% believed TD as good as 
face-to-face  
 
30% of patients 
were 
uncomfortable 
about not talking 
to dermatologist. 
 
More than one 
third preferred 
face-to-face care. 
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Reference Country, study, setting, sample 
Methodological 
assessment 
Main findings with 
teledermatology 
Difficulties 
reported with 
teledermatology 
Weinstock et 
al. 2002 (96) 
U.S.A, cohort study 
 
Teledermatology 
clinic. No 
comparison group. 
 
TD: n=120 patients 
Telephone survey 
10 satisfaction questions 
(5 point Likert scale – 
excellent to poor) 
 
Psychometric testing on 
questionnaire not 
reported 
 
Satisfaction: 
75% would recommend TD 
42% thought that the program 
overall 
was excellent/good 
Overall 37% of 
patients rated the 
program as 
fair/poor 
Whited et al. 
2004 (97) 
U.S.A, RCT 
 
Patients referred to a 
dermatology consults 
service at a Veteran 
Affairs Medical 
Centre. 
 
TD: n=101 patients 
Face-to-face: n=140 
patients 
 
Telephone survey (5-
point Likert scale, 
excellent to poor) 
 
Face validity only. No 
other psychometric 
testing performed on 
questionnaire 
Satisfaction: 
79% rated TD as excellent or 
very good  
78% rated face-to-face  as 
excellent or very good  
 
Preference: 
42% of patients preferred TD 
37% preferred face-to-face  
care 
22% were neutral 
20% rated the TD 
response time as 
fair or poor 
 
More than one 
third preferred 
face-to-face care. 
Collins et al. 
2004 (68) 
 
 
 
 
 
 
 
 
 
 
 
 
United Kingdom, 
RCT 
 
Patients in the 
general hospital 
dermatology referral 
service. 
 
TD: n=80 
Face-to-face: n=97 
(mean age: 48 years) 
Patient Satisfaction 
Questionnaire III (5-
point Likert scale - 
strongly agree to strongly 
disagree), 
2 additional satisfaction 
questions, 8 further  
items  
included from a 
questionnaire developed 
by Allen and 
Hayes (1995) 
for teleoncology 
 
Adapted previously 
validated questionnaire 
 
Satisfaction: 
Both groups had similar 
satisfaction rates. 87% of face-
to-face patients were satisfied 
84% TD patients were 
satisfied. 
Preference:  
76% of the TD group agreed 
they would rather have their 
skin problems managed via 
TD than wait to see the 
dermatologist face-to-face. 
 
 
38% of TD 
patients agreed 
they would prefer 
to discuss their 
skin problem 
with the 
dermatologist 
face-to-face.  
 
More than one 
third preferred 
face-to-face care. 
McKoy et al. 
2004 (98) 
U.S.A, cohort study 
 
Patients at medical 
clinic for 
dermatology referral. 
No comparison 
group. 
 
TD: n=51 patients 
completed the 
questionnaire 
 
 
 
 
Three statements on a 5-
point Likert scale (5 high 
to 1 low acceptance) 
 
No psychometric testing 
performed on 
questionnaire 
 
 
 
 
 
 
 
 
 
 
Satisfaction: 
82% wanted TD available as 
an alternative to face-to-face 
care  
74% were comfortable with 
remote diagnosis and care 
 
NR 
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Reference Country, study, setting, sample 
Methodological 
assessment 
Main findings with 
teledermatology 
Difficulties 
reported with 
teledermatology 
Moreno-
Ramirez et 
al, 2005 (99) 
Spain, Repeated 
measure design  
 
Triage system 
implemented at a 
pigmented lesion 
clinic 
 
TD: n=219. Of these 
108/219 ‘selected’ for 
additional face-to-
face consultation 
 
One question. ‘Are you 
satisfied with this way of 
being attended by a 
specialist?” Likert scale 
categories not provided. 
 
No psychometric testing 
performed on 
questionnaire 
Satisfaction: 
86% in TD group were very 
satisfied 
98% in face-to-face group 
were very satisfied  (all had 
TD before face-to-face) 
NR 
Eminovic et 
al. 2006 
(100) 
Netherlands, Cohort 
study 
 
GPs referring patients 
to a dermatologist 
 
TD: n=93 pre-
questionnaire 
n=84 post 
questionnaire 
(52% men, mean age 
35) 
 
6 questions, each with a 
5-point response scale (1, 
very negative to 5 very 
positive) 
 
Psychometric testing on 
questionnaire not 
reported 
Acceptance: 
Prior to TD 63% of patients 
expressed positive perceptions 
Satisfaction: 
After TD 75% of patients 
were satisfied 
86% of patients 
indicated that 
they wished to 
see a 
dermatologist 
face-to-face after 
TD, which was 
higher than 
before TD (71%). 
Bowns  et al. 
2006 (101) 
United Kingdom, 
RCT 
  
TD: n=80 (mean age 
43.6) Face-to-face: 
n=67 (mean age 49)   
51 items from Patient 
Satisfaction 
Questionnaire III (5-
point Likert scale - 
strongly agree to strongly 
disagree), plus 9 items 
specific to TD. 
 
Adapted previously 
validated questionnaire 
 
 
Satisfaction: 
84% satisfied overall with TD 
87% satisfied overall with 
face-to-face care  
Preference: 
76% preferred TD over 
waiting for face-to-face care 
38%	agreed	
with	the	
statement	that	
they	would	
prefer	to	discuss	
their	skin	
problem	with	
the	
dermatologist	
face‐to‐face	
	
More than one 
third preferred 
face-to-face care.	
Eminovic et 
al. 2009 
(102) 
Netherlands, RCT  
 
TD n=191 completed 
the survey (mean age 
42, 44% male) 
face-to-face n=159 
completed the survey 
(36% male, mean age 
44) 
 
20/43 Items from Patient 
Satisfaction 
Questionnaire III (5-
point scale, 5 indicates 
greatest satisfaction) 
 
Adapted previously 
validated questionnaire 
 
 
 
 
 
 
 
 
 
Satisfaction: 
No significant differences in 
patient satisfaction were found 
between groups. 
TD patient mean=3.8, 
SD=0.59 
Face-to-face mean=3.8, 
SD=0.59  
NR 
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Reference Country, study, setting, sample 
Methodological 
assessment 
Main findings with 
teledermatology 
Difficulties 
reported with 
teledermatology 
*Lim et al 
2012 (67) 
New Zealand, 
Prospective cohort 
study 
 
Hospital based 
outpatient clinic and 
community-based 
clinic 
 
TD: n=200 (mean age 
52.5, 39% male, 
survey completed by 
54%) 
Face-to-face: n=100 
(mean age 62.7, 36% 
male, survey 
completed by 40%) 
Survey (not provided) 
but assessed waiting 
times, convenience and 
confidence in the TD 
process (5-point Likert 
scale, 1 poor to 5 
excellent).  
 
Psychometric testing on 
questionnaire not 
reported 
Satisfaction: 
82% in the TD group were 
confident in the service 
TD patient group mean=4.5  
Face-to-face group mean=3.8  
Preference: 
In the TD group, 73% 
preferred TD assessment to 
face-to-face assessment. 
In the face-to-face group 33% 
stated they 
would prefer a TD to a face-
to-face appointment 
 
NR 
Hsueh et al. 
2012 (103) 
 
 
USA, Prospective 
cohort study 
 
Veterans receiving 
care in rural clinics 
 
TD: n=501 (mean 
age: 65, 92% male) 
Face-to-face: n=96, 
(mean age: 71 years, 
97% male) 
Newly created telephone 
survey  (5 point Likert 
scale – highly 
dissatisfied to highly 
satisfied) 
 
Face validity only. No 
other psychometric 
testing performed on 
questionnaire 
Satisfaction: 
Patient satisfaction with TD 
was equivalent to face-to-face 
care. 
77% (mean 4.1) were satisfied 
with their TD care. 
78% (mean 4.3) were satisfied 
with their face-to-face care. 
 
Preference: 
66% preferred TD over face-
to-face care. 
NR 
Kaliyadan et 
al 2013 
(104) 
 
Saudi Arabia, clinical 
trial 
 
166 patients in 
dermatology 
outpatient centre. No 
comparison group. 
 
Mean age: 30 years 
(males n=97), 26 
(females n=69) 
 
3 satisfaction statements 
(4 point scale - strongly 
agree to strongly 
disagree) 
 
Psychometric testing on 
questionnaire not 
reported 
Satisfaction: 
76% agreed they were 
satisfied with TD 
23 patients (14%) 
refused to be 
photographed. 
Main reason 
stated: social or 
cultural. 
 
*Wu et al. 
2015 (88) 
USA, Prospective 
cohort study 
 
Home monitoring of 
atypical naevi for 
patients using mobile 
teledermoscopy. No 
comparison group. 
 
TD: Baseline: n=34 
Mean age: 43.6 
(range 18-81) 56% 
women 
Follow-up: n=29 
 
10 items on a 5 point 
Likert scale (1, not at all; 
2, a little; 
3, somewhat; 4, very; 5, 
extremely) 
 
Psychometric testing on 
questionnaire not 
reported 
Satisfaction: 
Baseline: Overall mean 
satisfaction 4.66 out of 5 
Follow-up (3 months): 
Overall mean satisfaction 4.60 
out of 5 
Of the listed 
reasons against 
the use of a 
mobile 
dermatoscope, 
the patients’ 
desire to see a 
dermatologist in 
office ranked 
highest. 
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Reference Country, study, setting, sample 
Methodological 
assessment 
Main findings with 
teledermatology 
Difficulties 
reported with 
teledermatology 
*Ford, 2015 
(105) 
United Kingdom, 
Cohort study 
 
To assess if TD 
reduces secondary 
care referrals to 
dermatology for skin 
lesions  
 
TD: patient survey 
responses  n=28, 
interview n=4 
(mean age: 50 years) 
 
4 survey items reported 
(5-point Likert scale, 1 
not at all to 5 very much) 
and Face-to-face 
interviews 
 
Psychometric testing on 
questionnaire not 
reported 
Satisfaction: 
All participants were 
‘somewhat’ or ‘very much’ 
satisfied with diagnosis and 
speed via TD and would use 
the service again. 
 
NR 
*Marchetti, 
2015 (106) 
USA, cross-sectional 
pilot study. 
 
To determine the 
ability of 12th grade 
high school students 
to capture overview 
clinical and 
dermatoscopic 
images of specific 
skin lesions on 
patient-actors without 
demonstration.  
 
TD: n=19 (mean age: 
18 years, 53% 
female) 
 
27 questions relating to 
patient comfort, 
confidence (5 point 
Likert scale) study 
materials, and ease of 
use. 
 
Survey provided pre- and 
post- using the 
dermatoscope. 
 
Psychometric testing on 
questionnaire not 
reported 
Acceptance and satisfaction: 
The percentage of “very 
comfortable” students 
increased from 42% before 
using the dermatoscope to 
68% after using the 
dermatoscope (p= 0.06). 
 
 
116 of 175 (66%) 
images were in 
focus. Out of 
focus images 
were because the 
dermatoscope 
was not 
contacting the 
skin. 
*used teledermoscopy 
 
2.3.3 REVIEW OF STUDIES 
Of the 18 total manuscripts reviewed in Table 2.4, acceptance or satisfaction percentages 
ranged from 42-98% in favour of teledermatology. Eight studies were conducted in the 
United States, four in the United Kingdom, three in the Netherlands, one in New Zealand, 
one in Spain and one in Saudi Arabia, but none in Australia. Studies were published between 
the years 1999 - 2015. Only four studies assessed mobile teledermoscopy (67, 88, 105, 106), 
all others assessed store and forward teledermatology conducted with digital cameras. All 
studies, excluding two (88, 106), assessed satisfaction with the technology where the health 
professionals take the photos. In the study by Marchetti et al. (2015) the high school students 
were not photographing their own skin and using patient-actors, thus not receiving a personal 
telediagnosis. In the study by Wu et al. (2015) patients were shown how to photograph the 
lesions by the health professional, and then conducted the imaging process themselves at the 
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follow-up office-based consultation.  No study assessed patient-initiated teledermatology for 
screening of melanoma. In the studies which assessed preference a common theme emerged 
that just over one-third of participants preferred face-to-face consultations. Satisfaction 
assessments were mainly a secondary objective of the studies (the primary objective was 
diagnostic accuracy). With regards to psychometric indices, of the 18 manuscripts reviewed 
15 of these either stated their surveys were not formally validated (three studies stated face 
validity was conducted only) or neglected to mention it. Three studies had questionnaires 
based on previous validated survey instruments (68, 100, 101) and performed psychometric 
testing. These three surveys used the Patient Satisfaction Questionnaire III (PSQ-III) that can 
be adapted for many health services. Three studies conducted telephone interviews (96, 97, 
103), one study conducted face-to-face interviews in a sub-sample (105), and the remaining 
studies conducted quantitative written surveys (mostly 4 or 5-point Likert scales). 
Measurement tools in the studies ranged from a single satisfaction item (99) to a 51-item 
satisfaction questionnaire (101). 
 
In the literature, patient perspectives in store and forward teledermatology have been assessed 
in three literature reviews (35, 85, 107). All studies included in the reviews are also listed in 
Table 2.4. The first review by Demiris et al. (2004) (107) included five store and forward 
studies and found there was little to no reliability and validity testing of measurement 
instruments, and heterogeneity in study methodology (study design, study population, skin 
conditions, type of teledermatology and outcomes). In one study reviewed, 17% of patients 
reported they could not ‘say all they wanted to’ using teledermatology. Demiris and 
colleagues commented the term ‘satisfaction’ to be multi-dimensional, and subject to context, 
thus an exact definition for patient satisfaction can be challenging. Broadly, satisfaction 
referred to concepts such as utilisation and future adoption, perception of risks and benefits, 
effectiveness and efficiency. Overall, Demiris et al. concluded that the published studies 
about teledermatology did not reveal clear patient satisfaction with this service (107).  
 
The second review by Whited (2006) identified five store and forward studies that assessed 
patient ‘satisfaction’ in store and forward teledermatology after they used the service. 
Overall, positive satisfaction with teledermatology ranged from 42-75% for store and forward 
methods. Whited concluded the majority of patients were largely satisfied with 
teledermatology. Similar to the review by Demiris and colleagues, Whited highlighted that in 
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some cases, patients expressed dissatisfaction in not having a personal interaction with a 
dermatologist.  
 
In the third systematic review, Warshaw et al. (2011) reviewed patient ‘preference’ and 
‘satisfaction’ towards teledermatology (35). Firstly, patient ‘preference’ of teledermatology 
was assessed in four store and forward studies (approximately 37-42%, or just over one-third 
of patients prefer teledermatology over in-person consults) with the exception of one study 
that reported higher patient preference for teledermatology (76%) (101). Secondly, in the 
Warshaw et al. review patient ‘satisfaction’ was assessed in seven store and forward studies. 
Overall satisfaction with store and forward teledermatology varied widely from 42-93%. Four 
out of the seven studies in the Warshaw et al. review included both teledermatology and 
clinic-based dermatology groups for comparison, one study had a mean satisfaction rating of 
3.8 of 5 for teledermatology (102), and the remaining three reported satisfaction levels 
greater than 75% for teledermatology (97, 99, 101). In the studies with no comparison group, 
one study reported that 42% of the patients rated teledermatology as “excellent” or “good”; 
(96) and in a UK study 93% reported they were “happy” with teledermatology (95). 
 
Six of the manuscripts in Table 2.4 were not included in the three previously published 
reviews because they were conducted after publication (67, 103-106, 108). In the study by 
Lim et al. (2012) 108 patients who completed the teledermatology survey reported higher 
satisfaction rates than the 40 patients completing face-to-face examinations (67). Half the 
respondents in the face-to-face group would confidently participate in teledermatology, and 
33% of these patients stated they would prefer teledermatology compared to a face-to-face 
consultation (67). In the teledermatology group 82% of patients were confident in the service 
and 73% stated they would prefer it over face-to-face assessment (67). Eminovic et al. (2009) 
compared satisfaction between teledermatology and face-to-face examination groups using 
the validated PSQ III questionnaire adapted to teledermatology. The mean scores for general 
satisfaction were the same for both teledermatology and face-to-face examination groups 
M=3.8, SD=0.59 and there were no significant differences between the two groups. 
 
Hsueh et al. (2012) compared satisfaction among 504 veterans, with 77% of patients satisfied 
with store and forward teledermatology provided in a medical environment (103). There was 
no formal survey validation, apart from face validity. Survey items were adapted from 
previously published studies of patient satisfaction with teledermatology (35, 85, 96). 
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Kaliyadan et al. (2013) conducted a study in Saudi Arabia, where patient satisfaction was 
assessed for mobile teledermoscopy used in a medical clinic for expert second opinion (104). 
One hundred and sixty-six patients were asked to rate their agreement with three statements 
created for the study to assess patient satisfaction: 1) You are comfortable with having your 
skin lesion photographed to obtain a consultant opinion; 2) This method eliminates the need 
for seeing a consultant directly for your dermatological problem; and 3) You are satisfied 
with the medical care you have received in this consultation. Most of the participants agreed 
(scale of 1-4 strongly agree to strongly disagree) with the three statements indicating that they 
were highly satisfied with teledermatology. Of note, however 14% of participants refused to 
be photographed in this study for religious or cultural reasons (mainly female). The gender 
difference in refusal to be photographed was significant (P<0.001). Almost half of the males 
were satisfied with teledermatology compared to only 28% of females (104). 
 
Marchetti and colleagues (2015) assessed mobile teledermoscopy acceptance and satisfaction 
in a small pilot study of 19 high schools students. They assessed acceptance prior to use 
finding 42% would be ‘very comfortable’ completing mobile teledermoscopy (106). This 
increased to 68% after use. Wu et al. (2015) assessed patient receptivity of teledermoscopy 
for short-term monitoring of pigmented lesions (88). Among the twenty-nine participants 
none reported barriers to use of the dermatoscope. The participants thought the mobile 
dermatoscope was easy to use, reduced wait time of appointments, would save a trip to the 
doctor’s office and provide added comfort and privacy. There were concerns reported by 
some patients including reliability of diagnosis from the teledermatologist. The study 
mentions this could potentially be alleviated if the patients had an established relationship 
with or had direct access to the remote teledermatologist. 
 
Summary of main findings 
The majority of research on patient views is satisfaction research and the literature reports 
mixed results for teledermatology perspectives and none of the studies were conducted in 
Australia. Satisfaction and acceptance definitions are varied. Most studies reported in Table 
2.4 found at least a third of patients prefer face-to-face examinations instead of 
teledermoscopy, but did not ask participants to explain why. One aspect less well studied is 
models of teledermoscopy where the patient and dermatologist directly communicate. The 
majority of studies reported did not conduct validity or reliability testing on their 
measurement instruments nor used a theoretical foundation. 
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2.4 THEORETICAL MODEL USED TO ASSESS MOBILE TELEDERMOSCOPY 
ACCEPTANCE 
The technology acceptance model (TAM) was the theoretical model used for the Smartphone 
Study (secondary data analysis). This section describes the model and its constructs. 
2.4.1 TECHNOLOGY ACCEPTANCE MODEL (TAM) 
Perhaps the most common theoretical model used in the health care context to explain an 
end-user adoption of new health technology is the Technology Acceptance Model (TAM) 
(109) (Figure 2.3). The TAM is based on the Theory of Reasoned Action (TRA), and 
has been used to explain an individual’s acceptance behaviour since it was 
first proposed by Davis (1989) in his Doctoral thesis. The TAM is composed of five 
constructs, perceived usefulness, perceived ease of use, attitude, behavioural intention to use, 
and actual use. The definitions are: 
 Perceived usefulness is the degree to which a consumer believes that the use of a 
system will increase their performance.  
 Perceived ease of use refers to the degree to which a consumer believes that no effort 
(both physical and mental) will be required to use the system, and how easy it is to 
learn to use the system.  
 Attitude refers to an individual’s evaluative judgment of the target behaviour on some 
dimension (e.g., good/bad, harmful/beneficial, pleasant/unpleasant) 
 Behavioural intention to use refers to an individual’s motivation or willingness to 
exert effort to perform the target behaviour 
 Actual use refers to present or past use of the technology 
As depicted in figure 2.3 Davis et al. (110) identified the two constructs perceived usefulness 
and perceived ease of use as the basic determining factors in technology acceptance. 
Perceived usefulness and perceived ease of use have a significant impact on a user's attitude 
(Attitude is a general construct not tied to any specific beliefs about the technology). 
Perceived ease of use determines perceived usefulness. Behavioural intention to use the 
system is modelled as a function of attitude and perceived usefulness. Behavioural intention 
to use then determines actual use.  
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Figure 2.3. Technology Acceptance Model (TAM) (Source: Holden and Karsh 2010) 
 
Researchers are able to use either the intention to use the technology, or actual usage rates, as 
the outcome measure for usage behaviour. This gives the model flexibility when actual usage 
of new technologies is not yet available. The TAM has been applied in a variety of areas 
including the acceptance and usage of office technology, the internet, telemedicine and home 
telehealth, among others (111). The TAM has proved to be suitable for both genders, various 
age groups, most cultures and for individuals of all levels of information technology 
competency (112). The TAM has been used with populations such as patients, informal 
carers, organisational staff, physicians, health professionals and frail older people in a health 
care context (112). The TAM has also been shown to predict technology acceptance in 
obligatory and voluntary usage settings, with the majority of studies conducted in voluntary 
settings (112). In addition, the reliability of the TAM as well as the validity of the model’s 
constructs has been demonstrated (113). For these reasons outlined and because of its 
technology focus, the TAM was selected as the appropriate theoretical foundation for the 
Smartphone Study. However it was extended to fit the process of mobile teledermoscopy due 
to its original generality and parsimony (114).  
 
Modifications to the Technology Acceptance Model  
The original TAM has been well known for testing user acceptance of new technologies, 
however researchers have emphasised the necessity to extend the original model. A known 
limitation of the TAM is its incapability to consider the influence of external variables and 
barriers to technology acceptance (113). Taylor and Todd (1995) proposed an integrated 
model of the TAM and the Theory of Planned Behaviour (TPB) (115). Lin et al. (2007) 
proposed integrating the Technology Readiness and the TAM to devise the TRAM 
(Technology Readiness and Acceptance Model) (116). Chang (2008) proposed a combined 
model for assessing online auction use of Task-technology fit and the TAM (117). Shin et al. 
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(2011) integrated the TAM and expectation–confirmation model to analyse the intention to 
continuously use the smartphone as a tool for ubiquitous learning (118). 
 
Researchers have also added new constructs, rather than a model, to the TAM. Agarwal and 
Karahanna (2000) added cognitive absorption, playfulness and self-efficacy (119). Chau and 
Hu (2002) integrated peer influence, compatibility and perceived technology control with the 
TAM for assessing telemedicine use in health professionals (114). Joo, Lee and Ham (2014) 
added personal innovativeness, user interface and satisfaction to the TAM for mobile learning 
in university students (120).  Similarly, Cho et al. (2009) expanded the TAM by adding user 
interface, functionality, system resources, and user satisfaction. Liu et al. (2010) applied the 
TAM to examine the effects of personal innovativeness on the intention to use mobile 
learning of Chinese university students (121). Gefen et al. (2003) added the construct trust 
with the TAM in a consumer study about online shopping acceptance (122). Wu and Chen 
(2005) also added the dimension of trust to the TAM for assessing consumers use of online 
tax systems (108). Venkatesh and Davis in 2000 (123)  devised and tested the TAM2 and 
identified the inclusion of general determinants of perceived usefulness, which are, subjective 
norm, image, job relevance, output quality, and result demonstrability. Yarborough  and 
Smith (2007) added the construct barriers to the TAM in assessing physician use of 
information technology (113). Recently, Orruno et al. (2011) added habits, compatibility, 
facilitators and subjective norm to the TAM for mobile teledermoscopy acceptance in GPs 
(112). 
 
2.4.2 MOBILE TELEDERMOSCOPY AND THE TECHNOLOGY ACCEPTANCE MODEL 
Orruno et al. (2011) adopted the TAM to measure GPs intention to use a store and forward 
teledermatology system (112). Orruno et al. then modified the TAM by combining it with 
Chau and Hu’s model of telemedicine acceptance which comprised of three dimensions: the 
individual context, the technological context and the organisational context (Figure 2.4). The 
individual context comprised of TAM’s attitude and newly included construct compatibility. 
Compatibility refers to the degree of correspondence between an innovation and existing 
values, past experiences and needs of potential adopters. The technological context 
comprised of TAM’s perceived use and perceived ease of use, and newly added habits. The 
construct habit refers to behaviour that has become automatic. In the organisational context, 
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the variables subjective norm and facilitators were added. Subjective norm originates from 
the TRA and assesses the extent to which individuals believe that people who are important 
to them will approve of their adopting a particular behaviour. The construct facilitator refers 
to the degree to which an individual believes that an organisational and technical 
infrastructure exists to support the use of the system. 
 
 
Figure 2.4. Modified TAM for mobile teledermoscopy acceptance in GPs (Source: Orruno et al. 2011) 
 
The Smartphone Study used this revised TAM and adapted it to consumer skin self-
examination. The TAM by Orruno et al. underwent the following changes for the Smartphone 
Study. Firstly, habit was removed from the technological context, as participants were 
expected to have never used teledermatology before. Secondly, two new items measuring 
trust were included, similar to the studies by Gefen et al. (2003) and Wu and Chen (2005). 
The new items refer to “the willingness of a party to be vulnerable to the actions of another 
party based on the expectation that other will perform a particular action important to the 
trust, irrespective of the ability to monitor or control that other party” (124). In 
teledermatology, the consumer would need to trust the diagnosis of the teledermatologist, 
who the consumer may or may not see as a healthcare provider. Thirdly, a fourth context, 
‘acceptance’ was added to the existing original construct intention to use. The final revised 
TAM used in the Smartphone Study is shown below (Figure 2.5). 
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Figure 2.5 TAM modified for the Smartphone Study  
 
2.5 SUMMARY, RESEARCH GAP AND IMPLICATIONS 
Recent studies have successfully shown store and forward teledermatology to have high 
diagnostic accuracy and agreement. A number of studies have assessed patient perspectives 
in store and forward teledermatology, although findings vary across different populations. 
Overall, a quick response from the teledermatologist compared to slow clinical services was 
considered an important advantage and a disadvantage was the remote character of the 
service with a lack of personal interaction with the health professional (100). Much of the 
research reported to date has methodological limitations including:  
 Small sample sizes, 
 Did not use valid or reliable questionnaires (each researcher develops their own 
without adding psychometric testing or do not report it),  
 Limited ability to compare use of different questionnaires between studies,  
 High use of Likert scale items,  
 Did not use theories or models to guide questionnaire development and, 
 Poor definitions of patient satisfaction and acceptance, 
 Assessed general satisfaction, and do not detail specific facilitators or barriers. 
Therefore the high levels of satisfaction reported by many authors may be an overestimation 
due to methodological limitations or reporting bias (125). This consistent finding that at least 
one third of participants clearly favour face-to-face care is a further indication that more 
research is needed to understand which circumstances teledermatology is acceptable to users. 
Thorough evidence is lacking for consumer-initiated mobile teledermoscopy acceptance for 
skin cancer diagnosis. There are a multitude of facilitators and barriers taken into account by 
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individuals when they decide to use a technology in a health care context. The factors that 
contribute to use of mobile teledermoscopy can potentially apply to many other forms of 
telemedicine. Thus, this consumer acceptance research can be relevant more broadly to the 
burgeoning fields of telemedicine. 
 
In terms of health behaviour theory and the theoretical foundation, the TAM has been shown 
to be an effective model to predict acceptability of technology use for a variety of 
technologies in health, however there is no research for mobile teledermoscopy acceptability 
in consumers specifically. The TAM is widely used as a predictive model in health and as a 
model to guide the development of methodological assessment tools. The added gains of the 
modified TAM by Orruno et al. (2011) including subjective norm, compatibility, and 
facilitators mean that it may present a useful framework to studying consumer acceptability 
in telemedicine. The research reported in the next two chapters therefore built its acceptance 
measure on the modified TAM and applied it in the field of mobile teledermoscopy. 
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Chapter 3: Research Design 
This section details the methods used to address the aims and objectives of this quantitative 
research and outlines the data collection and statistical analysis procedures. 
3.1 ETHICS 
Ethics approval for both the secondary data analysis and new data collection was granted by 
the ethics committee of Queensland University of Technology (QUT) (ethical approval 
number 1200000553). The Virtual Skin Check Study was submitted as a variation of the 
Smartphone Study. The studies were considered low risk as there was low foreseeable risk or 
discomfort to participants.  
3.2 OBJECTIVES AND RESEARCH QUESTIONS 
The telemedicine industry is continuing to grow with e-health services becoming increasingly 
available to consumers. With the considerations identified in the Background and Literature 
Review the specific objectives of this Masters research program were as follows: 
Objective 1: Review literature 
Conduct a literature review on store and forward teledermatology, in particular mobile 
teledermoscopy. Provide an overview of the history and accuracy of store and forward 
teledermatology and mobile teledermoscopy. Determine what previous research in the 
literature has been conducted on patient satisfaction and acceptance of teledermatology 
(methods and results for objective 1 are previously reported in Chapter 2).  
Objective 2: Secondary data analysis 
Conduct secondary data analysis collected from the 230 participants 50-64 years of age who 
participated in the Smartphone Study. This study assessed mobile teledermoscopy acceptance 
via a 27-item questionnaire based on the TAM. Determine what are the facilitators and 
barriers to using mobile teledermoscopy among adults 50-64 years of age. 
Investigate the psychometric properties of the 27-item mobile teledermoscopy acceptance 
questionnaire (reliability and validity tests, principal components analysis (PCA)).  
Objective 3:   New data collection  
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Based on the findings of objective 2 investigations, refine and expand the mobile 
teledermoscopy acceptance questionnaire using the TAM. Once a revised questionnaire has 
been prepared based on psychometric testing, new data collection will be completed to test 
the revised questionnaire in a new sample. This sample will be expanded to include younger 
consumers because melanoma is one of the most common cancers in younger adults and their 
acceptance of mobile teledermoscopy has not been assessed previously in Australia. Validity 
and reliability tests will again be undertaken in this new sample (internal consistency, test-
retest, confirmatory factor analysis (CFA)) of the newly revised questionnaire. Invite 
interested participants to trial the functionality of the dermatoscope after completing the 
questionnaire and include additional satisfaction questions for this group. Assess if 
acceptance increases after use. This new data collection will be called the Virtual Skin Check 
Study. 
Objective 4: Discuss findings in the context of the current literature 
Finally, compare the findings of objectives 2 and 3 to previous findings and contributions to 
the literature.  
Three research questions guided the analysis: 
1) What are the facilitators and barriers to patient-initiated and performed 
teledermoscopy that determine acceptance in consumers? 
2) Do consumer perceptions of patient-initiated and performed mobile teledermoscopy 
acceptance change after use? 
3) What are the psychometric properties of the mobile teledermoscopy acceptance 
questionnaire used in the Smartphone Study and the Virtual Skin Check Study?  
 
3.3 THE SMARTPHONE STUDY    
Section 3.2 outlines the methods used in the Smartphone Study conducted at QUT in 
2013.  
3.3.1 PARTICIPANTS 
See Figure 3.1 for flow chart of study recruitment. Participants in the Smartphone Study were 
approached through one of two strategies: 1) a random sample of the QSkin Sun and Health 
Study (QSkin) (n=500) and, 2) a community call via QUT media and television news. The 
QSkin cohort study was conducted by the QIMR Berghofer Medical Research Institute and 
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included 43,794 participants who were asked to complete a survey about their demographic 
characteristics, self-reported skin cancer risk, sun exposure and health. In addition to the 500 
QSkin participants, 59 participants contacted the Smartphone Study researchers to request 
participation information after media interest in the local television news and university 
websites affiliated with the researchers. Eligibility criteria for the Smartphone Study 
included; age 50-64 years; reside in the Brisbane metropolitan area, and English proficiency.  
Participants had to meet one or more criterion for high risk of skin cancer: fair skin; light eye 
colour; numerous dysplastic naevi, or history of skin cancer excisions. The 500 QSkin 
participants were mailed an expression of interest letter, information sheet and reply form 
with a reply-paid envelope.  Of the 500 QSkin participants initially contacted, 261 (52%) 
indicated interest in participating. The 261 QSkin participants and 59 participants interested 
via media channels (n=320 in total) were mailed a consent form and the baseline survey 
including the 27-item mobile teledermoscopy acceptance questionnaire. This process was 
completed between March and November 2013. Overall, 228/320 participants (response rate 
71%) completed the survey and were eligible for analysis.  
 
. 
 
Figure 3.1 The Smartphone Study: Flow chart of study recruitment 
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3.3.2 MEASUREMENT INSTRUMENTS 
There were two surveys included in this study: 
a) QSkin demographics survey 
b) Mobile teledermoscopy acceptance survey 
QSkin demographics survey  
QSkin participants had already completed this survey (126, 127) prior to starting the 
Smartphone Study. Participants who were not part of the QSkin study were asked to fill in the 
QSkin demographics survey when they joined the Smartphone Study. Briefly, demographic 
questions included age, marital status, education, employment and general health. The survey 
questions designed to assess phenotype included a question each on skin colour, skin type 
(burning and tanning risk), eye colour, hair colour,  freckling density on the face at the age of 
21 years, and number of nevi (whole body) at the age of 21 years. The QSkin survey 
instrument originally demonstrated fair to good test-retest reliability (127).  
 
Mobile teledermoscopy acceptance survey 
Mobile teledermoscopy acceptance was assessed using 27 items adapted from a survey by 
Orruno and colleagues who used a modified TAM as the theoretical foundation of their 
questionnaire for GPs (112). The survey by Orruno and colleagues originally had 33 items. 
The mobile teledermoscopy acceptance questionnaire for the Smartphone Study was reduced 
to 27 items to evaluate consumer acceptance. Items relating to GP practices and procedures 
were excluded as these were not suitable for consumers. From the original Orruno et al. 
questionnaire, items that involved teledermoscopy as a working tool for GPs were changed to 
mobile teledermoscopy as a tool for assisting consumer skin self-examination. For example, 
‘teledermatology could help me to diagnose my patients more rapidly’ was changed to 
‘mobile teledermoscopy will help me to examine my skin more rapidly.’ Response categories 
were offered as a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly 
agree). The instrument was designed to measure the following modified TAM domains:  
perceived usefulness (5 items), perceived ease of use (4 items), attitude (2 items), 
compatibility (4 items), facilitators (3 items), subjective norm (4 items), and intention (4 
items) and trust (2 items). The model used in the Smartphone Study excluded the construct 
‘habit’ but extended the model to include the new dimension of ‘trust’. The two items to 
measure ‘trust’ were adapted from a study of consumers’ water use in Europe (128) and a 
study of consumers’ ‘trust’ of website information (124). Table 3.1 details the original 
 Chapter 3: Research Design 45 
questionnaire items by Orruno et al. and the modified items for the Smartphone Study and 
their associated TAM constructs. 
 
Along with mobile teledermatology acceptance, participants were asked questions related to 
skin self-examination attitudes and beliefs (16 items) adapted from the Queensland 
Melanoma Screening Trial, sun protection behaviours (7 items), and average time spent in the 
sun (3 items). These questions were from a previous QUT teledermoscopy consumer study 
(40). Smartphone use was assessed by estimating smartphone skill level, hours per week and 
confidence using a Smartphone (20 items), adapted from a questionnaire designed to assess 
use of technology to educate melanoma patients (129).  
Table 3.1 
Mobile teledermoscopy acceptance questionnaire modifications 
Orruno et al. GP questionnaire items Smartphone Study items  
 
Smartphone Study 
dimensions and 
abbreviations according to 
TAM 
Teledermatology could help me to 
diagnose my patients more rapidly 
Mobile teledermoscopy will 
help me to examine my skin 
more rapidly (a) 
Perceived Usefulness  (7 
items)  
PU_1 
Teledermatology can improve my 
performance in patients care 
Mobile teledermoscopy will 
improve my skin self-
examination performance 
(m) 
Perceived Usefulness  
PU_2 
The use of teledermatology may 
improve the diagnosis of my 
patients 
The use of mobile 
teledermoscopy will improve 
the diagnosis of  spots and 
moles on my skin that look 
suspicious (e) 
Perceived Usefulness  
PU_3 
Teledermatology could help me get 
the most out of my time 
Mobile teledermoscopy will 
help me save time (h) 
Perceived Usefulness  
PU_4 
In my opinion, the use of 
teledermatology will have a 
positive impact 
 
Mobile teledermoscopy will 
help to diagnose skin cancer 
quicker (p) 
Perceived Usefulness  
PU_5 
In general, teledermatology may be 
useful to improve the diagnosis of 
my patients 
In general, mobile 
teledermoscopy will be 
useful to improve diagnosis 
of skin cancer (u) 
Perceived Usefulness  
PU_6 
The use of teledermatology is 
beneficial for the diagnosis of my 
patients 
Participating in mobile 
teledermoscopy will be in 
my best interests (i) 
Perceived Usefulness 
PU_7 
Teledermatology can improve my 
performance in patients care 
It will be easy to perform 
mobile teledermoscopy (f) 
Perceived Ease of Use (4 
items) 
PEU_1 
I think that I could easily lean how 
to use the teledermatology software 
I will easily learn how to use 
mobile teledermoscopy (b) 
Perceived Ease of Use  
PEU_2 
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Orruno et al. GP questionnaire items Smartphone Study items  
 
Smartphone Study 
dimensions and 
abbreviations according to 
TAM 
I think that the diagnosis made 
through teledermatology will be 
clear and easily understandable 
Diagnosis of a suspicious 
mole or spot made through 
mobile teledermoscopy 
would be clear and easily 
understandable (j) 
 
Perceived Ease of Use  
PEU_3 
I think it would be easy to perform 
the tasks necessary for the 
diagnosis and management of my 
patients using teledermatology 
I will find it easy to acquire 
the necessary skills to use 
mobile teledermoscopy (q) 
Perceived Ease of Use  
PEU_4 
Teledermatology can help to 
diagnose my patients 
Mobile teledermoscopy will 
help me to examine my skin 
more thoroughly (n) 
Compatibility (4 items) 
COM_1 
The use of teledermatology may 
involve major changes in my 
clinical practice 
The use of mobile 
teledermoscopy will involve 
major changes in my skin 
self-examination practice (d)
Compatibility 
COM_2 
The use of teledermatology is 
compatible with my work habits 
The use of mobile 
teledermoscopy fits with my 
current skin self-examination 
habits (k) 
 
 
Compatibility 
COM_3 
The use of teledermatology may 
interfere with the usual follow-up 
of my patients 
The use of mobile 
teledermoscopy may 
interfere with my usual skin 
self-examination (w) 
(recoded this item) 
 
Compatibility 
COM_4 
I have the intention to use 
teledermatology when it will be 
available in my centre 
I will use mobile 
teledermoscopy when it is 
offered to me (c) 
Intention (4 items) 
INT_1 
I have the intention to use 
teledermatology routinely with my 
patients 
I will use mobile 
teledermoscopy routinely 
when I do skin self-
examination in the future (v) 
Intention 
INT_2 
NA – Newly created item based on 
QUT pilot study (40) 
I will use mobile 
teledermoscopy if it will 
save me time (z)
Intention 
INT_3 
NA – Newly created item based on 
QUT pilot study (40) 
I will use mobile 
teledermoscopy if it will 
save me money (aa) 
Intention 
INT_4 
Other health professionals (nurses, 
other specialists etc…) would 
welcome the fact that I use 
teledermatology 
Other health professionals 
(physicians, nurses, other 
specialists etc.) will welcome 
the fact that I use mobile 
teledermoscopy (t) 
Subjective Norm (3 
items) 
SN_1 
Most of my patients will welcome 
that I use teledermatology 
Most of my friends or family 
will welcome the fact that I 
use mobile teledermoscopy 
(l) 
 
Subjective Norm 
SN_2 
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Orruno et al. GP questionnaire items Smartphone Study items  
 
Smartphone Study 
dimensions and 
abbreviations according to 
TAM 
Health managers would welcome 
the fact that I use teledermatology 
My doctor will welcome the 
fact that I use mobile 
teledermoscopy  (o) 
 
 
Subjective Norm 
SN_3 
NA I will have complete trust in 
the dermatologist’s diagnosis 
based on a photo I emailed 
as part of mobile 
teledermoscopy. (r) 
Trust (2 items) 
TRU_1 
NA I will rely on the 
teledermatology process to 
supply accurate information 
about a mole or spot. (y) 
Trust 
TRU_2 
I would use teledermatology if I 
receive adequate training 
I will use mobile 
teledermoscopy if I receive 
adequate training (s)
Facilitator (3 items) 
FAC_1 
I would use teledermatology if I 
receive technical assistance when I 
need it 
I will use mobile 
teledermoscopy if I receive 
technical assistance when I 
need it (x) 
Facilitator 
FAC_2 
I think that my centre has the 
necessary infrastructure to support 
my use of teledermatology 
There are health 
professionals available who 
will help me with mobile 
teledermoscopy (g) 
 
Facilitator 
FAC_3 
 
3.3.3 DATA ANALYSIS 
Participants’ characteristics, mobile teledermoscopy acceptance, smartphone use and the skin 
awareness scale were summarised using descriptive statistics such as counts and percentages. 
Normality of the mobile teledermoscopy acceptance data was tested using the Shapiro-Wilk 
Test. To meet the assumption of normality the Shaprio-Wilk's test should not be significant. 
Non-normally distributed data  was summarised using non-parametric statistics, such as 
median and interquartile range to report the central tendency and measure of dispersion (130). 
The interquartile range is the difference between the values at the 25th and 75th percentile, 
however in common usage the values themselves are usually reported (130). This research 
reported the latter. Floor and ceiling effects were reported to assess reliability and normality 
of the data. Floor or ceiling effects are considered to be present if more than 15% of 
respondents selected the lowest or highest possible category, respectively, in a sample size of 
at least 50 participants (131). As a consequence, people who score in that range cannot be 
distinguished from each other, thus if a large proportion of participants score in this range, 
reliability of the questionnaire can be reduced. Furthermore, the responsiveness is limited 
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because further improvements or detriments cannot be measured in these participants. Ceiling 
effects may be expected in the Smartphone Study because the sample consisted of interested 
and motivated volunteers. A high number of participants also had skin cancer previously thus 
may be interested in devices used for skin cancer early detection. This means ceiling effects 
may need to be interpreted with caution and would be thought to be less pronounced in a 
population-based study. Bivariate linear regression analyses were used to assess associations 
between participant demographics, phenotype and skin cancer risk factors with mobile 
teledermoscopy acceptance subscales. Statistical tests to ensure the questionnaire was reliable 
and valid were conducted and the methods are described in sections 3.7.2 (Repeatability) and 
3.7.3 (Validity).  A PCA was conducted and the methods are described in section 3.8.1. 
When the items were combined to provide an overall score for each factor found in the PCA, 
the subscale variable was treated as continuous. 
 
3.4 THE VIRTUAL SKIN CHECK STUDY  
Based on the results from the Smartphone Study, a new cross-sectional study was designed 
and implemented called the Virtual Skin Check Study. The Virtual Skin Check Study was 
designed to assess mobile teledermoscopy acceptance in a wider age demographic (18 years 
of age and older) and to conduct further psychometric testing on the revised mobile 
teledermoscopy acceptance questionnaire. Participation involved completion of two surveys 
(baseline and test-retest).  
3.4.1 PARTICIPANTS 
Two recruitment strategies were used for the Virtual Skin Check Study. See Figure 3.2 for 
study recruitment. 
 
Recruitment strategy 1: 
Two outreach skin check days were conducted (14th and 17th of October 2014) as a 
collaboration initiative between Energex, QUT, University of Queensland (UQ), the 
Translational Research Institute (TRI), and the Princess Alexandra (PA) Research 
Foundation. A third outreach skin check day was also conducted with Network Ten (21st 
November 2014) and the above university and research institutes. 
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The outreach days invited employees from Energex and Network Ten to have a whole body 
skin examination by a doctor from the UQ School of Medicine, and to invite people to the 
QUT study ‘Enhanced skin self-examination: Can smartphones detect dangerous skin spots?’  
The primary aim of this separate study was to investigate whether the dermatoscope can be 
used to monitor lesions selected by the doctor over a period of time (up to 4 weeks or 3 
months). To be eligible to participate in this study, individuals needed to be Brisbane 
residents between 18 and 64 years of age, and have access to an iPhone 4 or 5. After the skin 
check, participants completed the mobile teledermoscopy acceptance survey. Participants did 
not use the mobile dermatoscope prior to completing the survey. Data from this survey was 
used in this Master’s research.  
 
Recruitment strategy 2: 
An invitation to participate in the Virtual Skin Check Study and complete the survey online 
along with the participant information sheet (Appendix A) was distributed via QUT email in 
September and October 2014. The new questionnaire (Appendix B) was provided to potential 
participants online using QUT Key Survey software. Email lists included staff and students at 
the Institute of Health and Biomedical Innovation (IHBI) and research higher degree students 
in the Health, Business and Education Faculties. Due to the timeline and available resources, 
an online survey was determined the most efficient survey distribution method to reach 
potential participants. In addition, the return rate for online surveys has been found to be 
higher than for traditional mail (132). Consent was provided by ticking a box prior to 
completing the survey that potential participants had read and understood the participant 
information sheet and consented to the research.  
 
Trialling the dermatoscope between surveys 
Some participants in the second recruitment strategy used the dermatoscope to take an image 
of a lesion following written instructions (Appendix C) in between the baseline and follow-up 
surveys. This was so we could add some additional satisfaction questions to examine ease of 
use, confidence using the device and perceived usefulness (Appendix D). Using the 
dermatoscope between surveys was optional and no medical diagnosis was provided. A 
convenience sample of participants who completed the baseline survey was selected to test 
the dermatoscope if they met the following: a) answered ‘yes’ to the question about trialling 
the dermatoscope in the baseline survey and b) were available at QUT, Kelvin Grove at a 
mutually convenient time with the researcher. Participants were asked to provide an email 
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address if they answered ‘yes’. The participants were provided with written instructions on 
how to take a photo with the dermatoscope using the Handyscope Fotofinder app, and send 
the images via email to themselves. The researcher did not provide any assistance with the 
instructions. Due to being outside of the scope of this Masters, the participants who trialled 
the dermatoscope were not able to send an image of their lesion using the dermatoscope for 
medical diagnosis by a dermatologist. This would have required Clinical Trial Network 
(CTN) registration and a dermatologist trained in teledermoscopy, which was not feasible 
with the resource constraints and research timeline.  
 
 
Figure 3.2 The Virtual Skin Check Study: flow chart of study recruitment 
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Missing data 
In recruitment strategy 1 participants completed the survey on paper and skipped some items, 
however not more than 33%. In recruitment strategy 2 the survey was completed online. 
Thus, all participants had to respond to the questionnaire items before they could continue to 
the next page of the survey. Three participants did not provide email addresses or answer the 
question on private health insurance (last page of survey) and exited the survey at this point, 
and their data was still used. 
 
3.4.2 MEASUREMENT INSTRUMENTS  
There were two surveys included in this study: 
a) baseline survey (recruitment strategy 1 and 2) 
b) test-retest survey (recruitment strategy 2 only) 
All participants were asked to complete a baseline survey (Appendix B) which included:  
 the revised mobile teledermoscopy acceptance questionnaire (25 items), 
 skin awareness questionnaire (12 items), 
 melanoma attitudes (5 items), 
 sun protection (7 items), 
 smartphone use (20 items), 
 skin cancer risk factors (skin type, sunburn history), 
 skin self-examination history (6 items), and 
 socio-demographics (10 items). 
 
Recruitment strategy 2 follow-up 
In the recruitment strategy two, participants were invited to also participate in an 
investigation of the test-retest reliability of the revised teledermoscopy acceptance 
questionnaire. Consent for sending participants the test-retest survey was provided by 
participants when they provided an email at the end of the baseline survey. Consenting 
participants were sent another email with a link to the questionnaire two weeks after 
completing the first survey. The first item in both questionnaires asked respondents to choose 
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an identifier based on the first three letters of their mother’s maiden name and day of birth 
that they would be asked to provide again in the second survey to assist in matching their 
test-retest surveys without providing their name. They were advised the link would be 
available for one week and to complete the survey within this time. The length of time 
between the two test administrations of surveys in previous studies of test-retest reliability 
has ranged from ten minutes to one month (133). Most range from two days to two weeks. 
This time frame is generally believed to be a reasonable compromise between recollection 
bias and change in peoples beliefs or behaviours (133). A very short time interval makes the 
carryover effects due to memory more likely and a longer interval increases the chances that 
a true change in acceptance could occur (133). 
 
3.4.3 DATA ANALYSIS 
The same descriptive data analysis steps described for the Smartphone Study (section 3.3.3) 
were used in the Virtual Skin Check Study. This included describing mobile teledermoscopy 
acceptance, skin awareness, and smartphone use with counts, percentages, medians, and 
interquartile range. The Shapiro-Wilk test for normality was conducted. Bivariate linear 
regression analyses were used to assess associations between participant demographics, 
phenotype and skin cancer risk factors with mobile teledermoscopy acceptance subscales. 
Statistical tests to ensure the questionnaire was reliable and valid are also described in section 
3.7.2 (Repeatability) and 3.7.3 (Validity). Instead of PCA, which was conducted in the 
Smartphone Study, a CFA was conducted (see section 3.8.2). 
 
3.5 DATA MANAGEMENT AND CLEANING 
In both the Smartphone Study and Virtual Skin Check Study, SPSS v 22 was used to store the 
data and conduct the analysis. Frequencies were run for all variables and checked against the 
coding manual to identify any invalid or out of range values or inconsistent data. Range 
constraints were checked as typically numbers should fall within a certain range. They have a 
minimum or maximum permissible value (e.g., all Likert scale answers were from 1 to 5). On 
completion of data entry, 10% of the dataset was re-entered (23 participants) for data 
verification where data was collected on a paper-pencil questionnaire (the Smartphone Study 
only). There were no discrepancies so the original data entry was accepted. 
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3.6 QUESTIONNAIRE DESIGN FOR THE VIRTUAL SKIN CHECK STUDY 
No previously developed tools specifically for assessment of patient-initiated and performed 
mobile teledermoscopy were identified in the literature. Based on the results from the 
Smartphone Study, the mobile teledermoscopy acceptance questionnaire was refined and 
adapted for use in the Virtual Skin Check Study. The questionnaire was developed in 
consultation with senior researchers. To ensure complete description of the web-based 
surveys the CHERRIES checklist was used (134). This checklist works in the same way as 
the CONSORT statement (for RCTs), or the QUORUM statement (for systematic reviews). 
Figure 3.3 is an example of the process a researcher would use to design their questionnaire, 
and was used in this research. 
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Figure 3.3 Example process of questionnaire design  
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In this research firstly, the most important aspects of patient/consumer acceptance with 
mobile teledermoscopy were identified using the TAM and a review of the literature. Failure 
to conceptualise all the possible “whys” that may explain mobile teledermoscopy use will 
result in the probable exclusion of important questions in the final questionnaire (135). Figure 
3.4 is the conceptual summary of this process and displays the factors of the TAM and 
aspects that will potentially influence acceptance.  
 
 
Abbreviations: SSE: skin self-examination, MTD: mobile teledermoscopy 
Figure 3.4 Factors in the early conceptualisation process 
 
These factors were compared to the items included in the 27-item questionnaire in the 
Smartphone Study to ensure all themes were included. A PCA was used on the 27-item 
questionnaire for scale refinement. After conducting PCA to refine the questionnaire (see 
Chapter 4 Results – Section 4.1.3 Principal components analysis), five new items were 
included, including four ‘trust’ and one ‘perceived usefulness’ items.  Four additional items 
were included for the construct ‘trust’ because in the Smartphone Study, only two items were 
in this domain and this was perceived as a main barrier to use in the literature. These items 
were adapted from the Telemedicine Perception Questionnaire by Demiris et al. who 
analysed patient acceptance of home telecare in the elderly (136). The Telemedicine 
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Perception Questionnaire proved to be of acceptable reliability (Cronbach's alpha of 0.8, test 
retest 0.98 which indicates high reliability) and validity (face and content) (136).  
 
The four items that originated from the Telemedicine Perception Questionnaire and adjusted 
for the Virtual Skin Check Study included the following items on ‘trust’:  
 ‘A nurse cannot examine me over the television as well as in person’ was changed 
to ‘A dermatologist cannot diagnose a skin cancer by mobile teledermoscopy as 
well as they can in person.’ 
 ‘I can be as satisfied talking to the nurse over the television as talking in person’ 
was changed to ‘I can be satisfied with the diagnosis by mobile teledermoscopy 
without talking to the dermatologist in person’. 
 ‘The use of this technology does not threaten my privacy or the confidentiality of 
my medical data’ remained the same. 
 ‘I don’t like that there is no physical contact during a home telecare visit’ was 
changed to ‘I don’t like that there is no physical contact with the dermatologist 
using mobile teledermoscopy’. 
One item was added to assess if participants envisioned a future for this service:  
 ‘eHomeCare will be a standard way of health-care delivery in the future’ was 
changed to ‘Mobile teledermoscopy will be a standard way of health-care delivery 
in the future’. 
The five-point Likert scale remained as the response categories, from strongly agree to 
strongly disagree and an ‘unsure’ response.  
 
3.7 METHODOLOGICAL CONSISIDERATIONS ASSOCIATED WITH 
QUESTIONNAIRE DESIGN 
The act of measurement is an essential component of scientific research (133). 
Questionnaires are one of many ways to gather information. Researchers who design their 
own questionnaires need to take steps to ensure that they are correctly measuring their topic. 
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3.7.1 QUESTIONNAIRE OBJECTIVITY 
Questionnaire wording, form and order can affect participants’ responses (135). The 
following points were followed to avoid lack of objectivity or question bias according to 
Brown (2014) (137):  
 Subjective language, slang or acronyms were avoided.  
 Leading questions that guide a respondent in a certain direction were avoided.  
 Double-barrelled questions (two questions in one) were avoided. 
 Long questions were avoided. 
 Likert scale answers were spaced evenly so they are not misinterpreted.  
 To engage participants in the questionnaire from the start, demographic data was 
collected at the end. 
 The items in each factor were mixed together. For example, this is so the 
participants did not answer all the questions about ‘subjective norm’ one after 
another. 
3.7.2 REPEATABILITY  
The issue of repeatability is important in selecting and developing the most appropriate 
measurement instrument because a questionnaire is reliable if it produces consistent results 
on repetition. Determining which methods of reliability should be considered when 
developing a questionnaire depends on the measure of interest, the type of measurement tool 
being developed and the context of the research. There are several forms of repeatability or 
reliability as described in the Encyclopedia of Psychology including (138): 
 Reliability within a questionnaire (internal consistency): that all the questions 
designed to measure a particular trait are actually measuring the same trait (statistical 
tests include Cronbach alpha, item-total correlation, Cronbach alpha if item deleted). 
 Test-retest reliability: whether repeating the same questionnaire under the same 
conditions produce the same results. 
 Alternate form reliability: Two questionnaires administered apart to the same group 
and the survey questions are only slightly different (minor word changes or reverse 
order). If the two questionnaire responses are not too different then alternate-forms 
reliability is established. 
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Reliability testing was conducted in this research in the following ways:  
 calculating Cronbach alpha, Cronbach alpha if item deleted, item-total correlation, 
split-half reliability (both the Smartphone Study and Virtual Skin Check study). 
 test-retest reliability (Virtual Skin Check Study only). 
Acceptable levels of Cronbach alpha are between 0.70 to 0.95 (139), and item-total 
correlation should be above 0.3 (140). Split-half reliability was conducted where a 
questionnaire is split in two and the scores for each half of the test are compared with one 
another. Split-half reliability should be above 0.6 using Spearman Brown. Normally either 
test-retest or alternate form reliability is chosen for one study. In the Virtual Skin Check 
Study, test-retest assessment was conducted using intraclass correlation coefficient (ICC) on 
the 25-item teledermoscopy acceptance questionnaire completed two weeks apart. ICC 
agreement values were classified based on Landis and Koch (141); an ICC of 0–0.2 is poor; 
0.21–0.4 suggests fair agreement; 0.41–0.6 is moderate; 0.61–0.8 is substantial; and 0.81–1.0 
suggests almost perfect agreement. 
3.7.3 VALIDITY 
Validity means the questionnaire is measuring what it is intended to measure.  The types of 
validity include: 
 Face validity: If the questions appear to be measuring the construct at face 
value.  This is known as a "common-sense" assessment.  
 Content validity: The extent to which the items in the questionnaire cover all the 
relevant issues.  
 Criterion-related validity (predictive and concurrent): Predictive validity refers to how 
well the results from one tool predict the results of a future measure of the same topic. 
Concurrent validity is considered when there is a preexisting tool measuring the same 
construct. 
 Construct validity (convergent and discriminant): Assessing convergent and 
discriminant validity involves measures of constructs that theoretically should be 
related to each other are (convergent) as well as different from other measures it 
would be expected to be different from (discriminant). 
Validity was tested in three ways in this research in both the Smartphone Study and Virtual 
Skin Check Study: face validity, content validity, and convergent validity. In the Smartphone 
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Study, the chief investigators on the study: a dermatologist, epidemiologist, behavioural 
psychologist and an oncology nurse who conducts behavioural science research in skin 
cancer assessed face validity. In the Virtual Skin Check Study, face validity was addressed by 
receiving feedback about the questionnaire from two senior researchers. In the Virtual Skin 
Check Study, content validity was addressed in a pilot sample of ten participants who 
completed the questionnaire to assess the time taken to complete the questionnaire, 
appropriateness of the questions, and clarity of the questions. Their responses were reviewed 
to assess how they responded to the answers, and participants were asked by the researcher if 
there are other concepts that affect acceptance not included in the questionnaire. For example, 
in regards to question clarity, statements that needed clarification included ‘close relatives’ as 
participants were unsure what that defined. A statement in brackets listing family members 
this includes was added (parent, child, sibling or grandparents). This data was not entered in 
to SPSS or formally analysed. Convergent validity was assessed in the Smartphone Study and 
the Virtual Skin Check Study by comparing the correlation of the skin awareness 
questionnaire (12 items assessing beliefs and attitudes towards examining your skin) and the 
27-item mobile teledermoscopy acceptance questionnaire. It was assumed individuals who 
agreed that examining their skin was important would also have a greater acceptance of 
mobile teledermoscopy. This was assessed by calculating the Pearson’s correlation 
coefficient of the skin awareness and mobile teledermoscopy acceptance subscale scores. In 
the Smartphone Study and the Virtual Skin Check Study, linear regression was conducted to 
find associations between categorical variables. The dependent variable was continuous. The 
dependent variable was the factor as identified in the PCA of the teledermoscopy acceptance 
questionnaire, and the independent categorical variables were socio-demographic and 
phenotypic characteristics (gender, age, marital status, education, skin cancer history, number 
of moles). Where variables had three or more response categories, these were collapsed to 
make dichotomous variables. 
 
3.8 VALIDATING A THEORETICAL MODEL 
There are a number of statistical methods available to test whether the data collected from the 
questionnaire supports the model, or whether either the questionnaire or the model needs 
revision or development.  PCA and CFA are among the statistical techniques often used to 
assess a model. An exploratory method using PCA was used in the Smartphone Study for 
scale structure, because it is appropriate for reducing the number of factors, examining 
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relationships between categories, and evaluating the construct validity of a measurement 
scale. PCA makes no assumption about an underlying model and assumes the items are 
highly correlated. The overall assumption of PCA is that any item may be associated with any 
one factor. The mobile teledermoscopy acceptance questionnaire was adapted from Orruno et 
al. but because the items were re-written for consumers instead of GP’s it was hypothesised 
the TAM subscales may change. PCA is a variable reduction procedure that typically results 
in a relatively small number of components that account for most of the variance in a set of 
observed variables (142).  
3.8.1 PRINCIPAL COMPONENTS ANALYSIS (PCA) 
The following assumptions for PCA were tested: 
 Psychometric analysis tests to determine if the data was adequate for PCA 
including Kaiser-Meyer-Olkin measure of sampling adequacy (over 0.6), Bartlett’s 
test of sphericity, anti-image correlation matrix (over 0.5), and the communalities 
(over 0.3). 
 An appropriate number of factors to extract using oblique rotation were 
determined. In some situations, oblique solutions are superior to orthogonal 
solutions because they produce cleaner, more easily-interpreted results (142).  
 The number of components retained were determined by: 
a) Kaiser’s (1960) criteria: Eigenvalue > 1 criterion  
b) Scree test 
c) Proportion of variance for each component (5-10%) 
d) Cumulative proportion of variance explained (70-80%). 
 Interpretability was assessed. It is desirable to have at least three or more variables 
loading on each retained component when the PCA is complete (142). 
 If the principal components did not exhibit a conceptual meaning, the PCA was 
repeated with different numbers of factors, different extraction techniques, and 
both orthogonal and oblique rotations. 
 Finally, the solution with the greatest scientific meaning was determined and these 
results were interpreted. 
 Results were summarised in a table. 
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3.8.2 CONFIRMATORY FACTOR ANALYSIS (CFA) 
Exploratory factor analysis or PCA is generally a theory-generating procedure as opposed to 
a theory-testing procedure in CFA. CFA is used to verify the factor structure of a set of 
observed variables (items in a scale). CFA allows the researcher to test the hypothesis that a 
relationship between observed variables and their underlying latent variable (or factors as in 
PCA) exists. Using knowledge of previous research and theory, researchers can propose the 
relationship pattern a priori and then test the hypothesis statistically (143). CFA has the 
ability to formally quantify model fit, conduct statistical tests of parameter estimates, and 
calculate standard errors of parameter estimates (143). Parameters (or factor loadings) 
indicate the effect of each variable in its construct. 
 
CFA was used to examine the factorial validity of the Virtual Skin Check Study’s 25-item 
mobile teledermoscopy acceptance questionnaire. The following process was used:  
(1) A model was specified from the PCA previously conducted; 
(2) Model goodness-of-fit was evaluated (absolute and incremental fit indices).  
To validate the structural model, AMOS 22.0 software was used. Several goodness-of-fit 
statistics were used to assess the fit of the proposed model: the ratio of chi-square to the 
degree of freedom (χ2 /df), goodness-of-fit index (GFI), adjusted goodness-of-fit index 
(AGFI), root mean square error of approximation (RMSEA), root mean square residual 
(RMR), normed fit index (NFI), relative fit index (RFI), incremental index of fit (IFI), 
Tucker-Lewis index (TLI), and comparative fit index (CFI). The goodness-of-fit statistics are 
segregated into the following categories: Absolute fit indices (χ²/df, RMSEA, GFI, AGFI, 
RMR) which measure how well the proposed model reproduced the observed data; and 
Incremental fit indices (CFI and TLI) which indicate how much better a model fits the data 
compared to a baseline model where all variables are uncorrelated.  The following indices 
were used as recommended by Hair et al. (144), as the criteria for the model’s evaluation: 
 
 χ2 /df should be less than 3; 
 GFI should be more than 0.9; 
 AGFI should be more than 0.9; 
 A RMSEA of zero suggests that the model fits exactly, a value of .05 or less 
indicates relatively good fit and a value above .08 indicates poor fit; 
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 RMR should be less than 0.05; 
 NFI should be more than 0.9; 
 RFI should be more than 0.9; 
 IFI should be more than 0.9;  
 TLI should be more than 0.9; 
 CFI should be more than 0.9. 
Overall, the closer the observed data is to the theoretical model, the better the fit of the 
proposed model, and the easier it will be to satisfy the requirements of the above indices 
(145). If the recommended thresholds cannot be met this means the model needs to be 
adjusted.  
Further adjustments to increase model fit were undertaken: 
 Assessing standardised factor loadings: Items below 0.4 were removed and the 
model was re-run.  
 Assessing modification indices: Items can be correlated to improve model fit if a 
modification index larger than 20 and a parameter change larger than 0.10 in 
absolute value is found. If any large errors are found they can be correlated when 
they occur within the same factor. The model can then be re-run. 
 If the model is found to have inadequate fit this could indicated either that the 
model is not suitable, but it could also be a reflection of a too small or too 
homogenous sample not allowing for sufficient variation.  
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Chapter 4: Results 
This results chapter presents the findings in two parts:  
 The Smartphone Study (Section 4.1) and,  
 The Virtual Skin Check Study (Section 4.2). 
 
4.1 THE SMARTPHONE STUDY 
This section is a compilation of results from the Smartphone Study, derived by secondary 
data analysis of existing data. Two hundred and thirty participants completed the survey, and 
228 remained for evaluation after excluding one participant who was outside the age limit 
because their age was incorrectly listed, and one for missing the second page of the 
teledermoscopy acceptance questionnaire (more than recommended 33% of items).  
4.1.1 PARTICIPANTS  
Socio-demographics and phenotypic characteristics of participants in the Smartphone Study 
are described in Table 4.1. Both genders were almost equally represented (n=117, 51% 
female; n=111, 49% male). The age category with the most participants was 50 – 54 years 
(n=108, 47%). The majority of participants were employed full-time (n=134, 59%), and 
living with a partner (n=185, 81%). One hundred fifty-seven (69%) participants had tertiary 
education qualifications, holding a diploma, university degree or higher.  
 
Most participants had sun-sensitive phenotypic characteristics and therefore were at a high 
risk for developing skin cancer. They commonly had blue or grey eye colour (n=110, 48%), a 
fair complexion (n=193, 85%), and burnt moderately or badly when exposed to the summer 
sun unprotected for half an hour (n=140, 61%). Half the sample had one or more skin cancers 
previously removed.  
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Table 4.1 
The Smartphone Study participant characteristics  
Characteristic Total n=228 (%) 
Gender  
     Male  111 (48.7) 
     Female 117 (51.3) 
Age  
     50-54 108 (47.4) 
     55-59 78 (34.2) 
     60-66 42 (18.4) 
Educational Attainment*  
     Primary school or leaving certificate 23 (10.1) 
     High School or trade 44 (19.3) 
     University degree/ diploma 157 (68.9) 
Work  
     Full-time (including self-employed)  134 (58.8) 
     Part-time  33 (14.5) 
     Other/did not specify 61 (26.7) 
Marital Status*  
     Living with partner  185 (81.1) 
     Living without partner 42 (18.4) 
Private Health Insurance  
    Yes 183 (80.3) 
     No 45 (19.7) 
How many skin cancers have you ever had cut off your skin?*  
     11-20+ skin cancers 16 (7.0) 
     2-10 skin cancers 57 (25.0) 
     1 skin cancer 41 (18.0) 
     None 113 (49.6) 
First degree history (close blood relatives had   melanoma)
     Yes 71 (31.1) 
     No 122 (53.5) 
     Don’t know 33 (14.5)
How likely is it that you will get melanoma at some time in the 
future?* 
 
     Highly unlikely 17 (7.5)
     Somewhat unlikely 47 (20.6) 
     About the same as other Queenslanders 96 (42.1) 
     Somewhat more likely 48 (21.1)
     Highly likely 18 (7.9) 
     Don’t know 2 (0.9) 
Natural skin colour  
     Fair 193 (84.6) 
     Medium 32 (14.0) 
     Olive/Dark 3 (1.3) 
Eye colour  
     Blue/Grey 110 (48.2) 
     Green 29 (12.7) 
     Hazel/ Brown 85 (37.3) 
     Other (more than 1 colour) 3 (1.3) 
Have you ever had your skin checked from head to toe by a health 
professional?* 
 
     No 53 (23.2) 
     Yes 173 (75.9) 
*4 missing education;  
*1 missing marital status, how many skin cancers have you ever had cut off your skin?, melanoma 
likelihood, eye colour; 
*2 missing blood relatives melanoma, have you ever had your skin checked.
 Chapter 5: Results 65 
Smartphone use 
Sixty-two (27%) participants had never used a smartphone before; 34 (15%) were unskilled 
while the majority (n=132, 58%) had a median score of one ‘skilled’ with overall use of a 
smartphone (i.e. surfing the internet, sending email, taking photos, downloading applications 
(apps) and others). Skill levels did not differ by gender (p=0.801). Age was associated with 
skill level, with individuals in the 50-54 year age bracket having a higher skill level compared 
to other age ranges (55-59 and 60-64) (p=0.003). Of the 166 participants who had used a 
smartphone before, 125 owned a smartphone. Overall, 136 (60%) participants were skilled at 
surfing the internet on their smartphone with 104 (46%) participants spending two hours or 
less a week on this activity; 140 (61%) participants were skilled in sending email; 120 (53%) 
were confident with downloading apps; and 125 (55%) were skilled in using apps. Only 
seven participants were unskilled in taking photos on their smartphone. Only one participant 
had used mobile teledermoscopy in the past. 
 
Attitudes towards skin cancer 
Table 4.2 details participants’ attitudes towards skin cancer early detection. Most participants 
(91%) agreed it was important to check their skin even if they have no symptoms. If 
participants found a suspicious spot or mole 80% agreed they would go to the doctor right 
away. Participants agreed (97%) if they regularly examine their skin, then they are helping to 
look after their own health. Eighty-two per cent of participants disagreed that checking their 
skin would make them anxious. 
Table 4.2 
Attitudes towards skin cancer (n=228) 
Items Baseline 
n=228 
Median IQR 
It is important to check my skin for skin cancer even if 
I have no symptoms*  
 4.0 5.0-4.0 
     Agree 241 (93.9)   
     Unsure 11 (4.8)   
     Disagree 1 (0.4)   
I think checking my skin would make me anxious+  2.0 2.0-1.0 
     Agree 18 (7.9)   
     Unsure 21 (9.2)  
     Disagree 186 (81.6)   
Checking my skin regularly is a priority for me*  4.0 4.0-2.0 
     Agree 132 (57.9)   
     Unsure 38 (16.7)   
     Disagree 
 
56 (24.6)   
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Items Baseline 
n=228 
Median IQR 
I think I could find a suspicious spot on my skin if it 
was there+ 
 3.0 4.0-3.0 
     Agree 107 (46.9)   
     Unsure 88 (38.6)   
     Disagree 30 (13.2)   
If I saw something suspicious on my skin, I’d go to the 
doctor straight away* 
 4.0 5.0-4.0 
     Agree 183 (80.3)   
     Unsure 25 (11.0)   
     Disagree 17 (7.5)   
I am confident in my doctor’s ability to diagnose skin 
cancer* 
 4.0 5.0-4.0 
     Agree 171 (75.0)   
     Unsure 42 (18.4)   
     Disagree 13 (5.7)   
I have made plans on when to examine my own skin*  2.0 3.0-2.0 
     Agree 33 (14.5)   
     Unsure 50 (21.9)   
     Disagree 143 (62.7)   
I am confident that I can start examining my own skin 
again even if I have not looked at my skin in the past 
few months* 
 4.0 4.0-3.0 
     Agree 168 (73.2)   
     Unsure 37 (16.2)   
     Disagree 21 (9.2)   
I can examine my own skin regularly, even if I have no 
one to help me+ 
 4.0 4.0-3.0 
     Agree 135 (59.2)   
     Unsure 53 (23.2)   
     Disagree 37 (16.2)   
If I regularly examine my skin, then I am helping to 
look after my own health.* 
 4.0 5.0-4.0 
     Agree 222 (97.4)   
     Unsure 4 (1.8)   
     Disagree -   
I am confident that I can detect abnormalities in moles 
or spots I find.* 
 3.0 4.0-3.0 
     Agree 77 (33.8)   
     Unsure 104 (45.6)   
     Disagree 45 (19.7)   
*2 missing participants; + 3 missing participants; IQR= interquartile range; 25th - 75th 
percentile; median and IQR scale 1 strongly disagree to 5 strongly agree. 
 
4.1.2 MOBILE TELEDERMOSCOPY ACCEPTANCE  
Table 4.3 presents the summary statistics for the consumer mobile teledermoscopy 
acceptance questionnaire (n=228). The data was non-normally distributed. Most participants 
agreed it would be in their best interest to use mobile teledermoscopy (n=208, 91%) and 
would improve diagnosis of spots and moles that look suspicious (n=194, 85%). In relation to 
cost and time, 154 (68%) participants agreed they would use mobile teledermoscopy if it 
would save them money and 172 (75%) participants agreed they would use mobile 
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teledermoscopy if it would save them time. Of the 134 (58%) participants who indicated 
checking their skin for skin cancer was a priority for them, 92% agreed it would be in their 
best interest to use mobile teledermoscopy. 
 
In relation to skin self-examination practices, participants agreed mobile teledermoscopy will 
improve skin self-examination performance (n=198, 87%) and allow a more thorough skin 
self-examination (n=203, 89%). Fewer than half of the participants (n=107, 47%) agreed they 
will have complete trust in the dermatologist’s ability to diagnose lesions based on a photo 
while 46% (n=104) of participants were unsure. Forty-seven per cent (n=107) were unsure if 
the diagnosis of a lesion through mobile teledermoscopy would be clear and easily 
understood. Ninety-eight (43%) participants were unsure if their doctor will welcome their 
use of mobile teledermoscopy.  
Table 4.3 
Mobile teledermoscopy questionnaire items 
Item n (%) Median IQR 
Totals 228   
Perceived Usefulness    
PU_1  MTD will help me to examine my skin more 
rapidly* 
 4.0 5.0-4.0 
Strongly agree 61 (26.8)   
Agree 113 (49.6)   
Unsure 44 (19.3)  
Disagree 7 (3.1)   
Strongly disagree 2 (0.9)   
PU_2 MTD will improve my skin self-examination 
performance  
 4.0 5.0-4.0 
Strongly agree 73 (32.0)   
Agree 125 (54.8)   
Unsure 24 (10.5)   
Disagree 6 (2.6)   
Strongly disagree -   
PU_3 The use of MTD will improve the diagnosis of  
spots and moles on my skin that look suspicious  
 4.0 5.0-4.0 
Strongly agree 76 (33.3)   
Agree 118 (51.8)   
Unsure 30 (1.8)   
     Disagree -  
     Strongly disagree -   
PU_ 4 MTD will help me save time   4.0 5.0-3.0 
Strongly agree 34 (14.9)   
Agree 100 (43.9)   
Unsure 79 (34.6)   
Disagree 15 (6.6)   
Strongly disagree 
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Item n (%) Median IQR 
PU_5 MTD will help to diagnose skin cancer quicker   4.0 4.0-3.0 
      Strongly agree 46 (20.2)   
Agree 124 (54.4)   
Unsure 55 (24.1)   
Disagree 3 (1.3)   
Strongly disagree -   
Attitude   
ATT_1 In general, mobile teledermoscopy will be useful 
to improve diagnosis of skin cancer  
 4.0 5.0-4.0 
      Strongly agree 63 (27.6)   
Agree 138 (60.5)   
Unsure 25 (11.0)  
Disagree 2 (0.9)   
Strongly disagree -   
ATT_2 Participating in MTD will be in my best interests  4.0 5.0-4.0 
      Strongly agree 91 (39.9)   
Agree 117 (51.3)   
Unsure 18 (7.9)   
Disagree 2 (0.9)   
Strongly disagree -   
Perceived Ease of Use   
PEU_1 It will be easy to perform MTD  4.0 4.0-3.0 
      Strongly agree 42 (18.4)   
Agree 107 (46.9)   
Unsure 77 (33.8)   
Disagree 2 (0.9)   
Strongly disagree -   
PEU_2 I will easily learn how to use MTD  4.0 5.0-4.0 
      Strongly agree 65 (28.5)   
Agree 132 (57.9)   
Unsure 28 (12.3)   
Disagree 3 (1.3)   
Strongly disagree -   
PEU_3 Diagnosis of a suspicious mole or spot made 
through MTD would be clear and easily understandable  
 4.0 4.0-3.0 
      Strongly agree 26 (11.4)   
Agree 89(39.0)  
Unsure 107 (46.9)   
Disagree 6 (26)   
Strongly disagree -  
PEU_4 I will find it easy to acquire the necessary skills 
to use MTD 
 4.0 5.0-4.0 
      Strongly agree 58 (25.4)  
Agree 136 (59.6)   
Unsure 29 (12.7)   
Disagree 5 (2.2)  
Strongly disagree -   
Compatibility    
COM_1 MTD will help me to examine my skin more 
thoroughly 
 4.0 5.0-4.0 
      Strongly agree 75 (32.9)   
Agree 128 (56.1)   
Unsure 20 (8.8)   
Disagree 5 (2.2)   
Strongly disagree 
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Item n (%) Median IQR 
COM_2 The use of MTD will involve major changes in 
my SSE practice 
 4.0 4.0-3.0 
      Strongly agree 51 (22.4)   
Agree 105 (46.1)   
Unsure 50 (21.9)   
Disagree 22 (9.6)   
Strongly disagree -   
COM_3 The use of MTD fits with my current SSE habits 3.0 4.0-2.0 
      Strongly agree 18 (7.9)   
Agree 81 (35.5)   
Unsure 67 (29.4)   
Disagree 58 (25.4)   
Strongly disagree 4 (1.8)   
COM_4 The use of MTD may interfere with my usual 
SSE  
 2.0 2.0-2.0 
      Strongly agree 4 (1.8)   
Agree 2 (0.9)   
Unsure 39 (17.1)   
Disagree 145 (63.9)   
Strongly disagree 38 (16.7)   
Intention     
INT_1 I will use MTD when it is offered to me   4.0 5.0-4.0 
      Strongly agree 78 (34.2)   
Agree 125 (54.8)   
Unsure 19 (8.3)   
Disagree 6 (2.6)   
Strongly disagree -   
INT_2 I will use MTD routinely when I do skin self-
examination in the future  
 4.0 4.0-3.0 
      Strongly agree 55 (24.1)   
Agree 113 (49.6)   
Unsure 52 (22.8)   
Disagree 8 (3.5)   
Strongly disagree -  
INT_3 I will use MTD if it will save me time   4.0 4.0-4.0 
      Strongly agree 37 (16.2)   
Agree 135 (59.2)  
Unsure 30 (13.2)   
Disagree 25 (11.0)   
Strongly disagree 1 (0.4)  
INT_4 I will use MTD if it will save me money   4.0 4.0-3.0 
      Strongly agree 43 (18.9)   
Agree 111 (48.7)  
Unsure 43 (18.9)   
Disagree 28 (12.3)   
Strongly disagree 3 (1.3)  
Subjective Norm    
SN_1 Other health professionals (physicians, nurses, 
other specialists etc.) will welcome the fact that I use 
MTD  
 4.0 4.0-3.0 
      Strongly agree 31 (13.6)   
Agree 89 (39.0)  
Unsure 104 (45.6)   
Disagree 4 (1.8)   
Strongly disagree 
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Item n (%) Median IQR 
SN_2 Most of my friends or family will welcome the fact 
that I use MTD 
 4.0 4.0-3.0 
      Strongly agree 46 (20.2)   
Agree 108 (47.4)   
Unsure 65 (28.5)   
Disagree 9 (3.9)   
Strongly disagree -   
SN_3 My doctor will welcome the fact that I use MTD 4.0 4.0-3.0 
      Strongly agree 37 (16.2)   
Agree 90 (39.5)   
Unsure 98 (43.0)   
Disagree 3 (1.3)   
Strongly disagree -   
Trust    
TRU_1 I will have complete trust in the dermatologist’s 
diagnosis based on a photo I emailed as part of MTD.  
 3.0 4.0-3.0 
      Strongly agree 18 (7.9)   
Agree 89 (39.0)   
Unsure 104 (45.6)   
Disagree 13 (5.7)   
Strongly disagree 4 (1.8)   
TRU_2 I will rely on the teledermatology process to 
supply accurate information about a mole or spot.  
 4.0 4.0-3.0 
      Strongly agree 26 (11.4)   
Agree 101 (44.3)   
Unsure 79 (34.6)   
Disagree 19 (8.3)   
Strongly disagree 3 (1.3)   
Facilitator     
FAC_1 I will use MTD if I receive adequate training   4.0 5.0-4.0 
      Strongly agree 72 (31.6)   
Agree 138 (60.5)   
Unsure 10 (4.4)   
Disagree 8 (3.5)   
Strongly disagree -   
FAC_2 I will use MTD if I receive technical assistance 
when I need it  
 4.0 4.0-4.0 
      Strongly agree 43 (18.9)   
Agree 151 (66.2)   
Unsure 24 (10.5)   
Disagree 10 (4.4)   
Strongly disagree -   
FAC_3 There are health professionals available who 
will help me with MTD  
 4.0 4.0-3.0 
      Strongly agree 30 (13.2)   
Agree 102 (44.7)   
Unsure 95 (41.7)   
Disagree 1 (0.4)   
Strongly disagree -   
*1 participant missing; MTD=mobile teledermoscopy; SSE=skin self-examination; IQR= 
interquartile range; 25th - 75th percentile; median and IQR scale from 1 strongly disagree to 5 
strongly agree. 
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Floor and ceiling effect  
Responses to the Likert scales revealed that 19/27 (70%) questions in the mobile 
teledermoscopy acceptance questionnaire had a ceiling effect (i.e., more than the 
recommended maximum of 15% of participants answered ‘strongly agree’). Only one item 
which was reverse scored, ‘COM_4 The use of mobile teledermoscopy may interfere with my 
usual skin self-examination’ showed a floor effect. The distributions were mostly negatively 
skewed as the scores fell toward the higher side of the scale. Skewness of items ranged from -
1.14 to .95 (SE .16).  Items with ceiling effects were not removed in this study because this 
was not a population-based sample, and participants were volunteers who potentially have an 
interest in skin cancer research, thus it was hypothesised they would be more likely than 
people from the general population to agree with items. 
Reliability analysis 
Split half reliability of the mobile teledermoscopy acceptance questionnaire was 0.99 
(Spearman-Brown Coefficient), well above the recommended 0.6 indicating that participants 
produced similar results on two halves of the test. This adds further evidence that the 
questionnaire could be reliable.  
4.1.3 PRINCIPAL COMPONENTS ANALYSIS (PCA) 
PCA was conducted on the Smartphone Study 27-item mobile teledermoscopy acceptance 
questionnaire in order to assess the underlying structure. Sample size was sufficient for factor 
analysis following recommendations that require between five and ten times the number of 
variables to participants, thus with 27 items we met the criteria that required a minimum of 
135 participants (146). The factorability of the 27 items was examined using several well-
recognised criteria. 
Firstly, 24 of the 27 item-total correlations were above acceptable standards (> 0.3), 
suggesting reasonable factorability.  The subscale ‘compatibility’ had low item-total 
correlation scores below 0.30 for three out of its four items: ‘COM_2 The use of mobile 
teledermoscopy may interfere with my usual skin self-examination’; ‘COM_3 The use of 
mobile teledermoscopy fits with my current skin self-examination habits’’; and, ‘COM_4 The 
use of mobile teledermoscopy will involve major changes in my skin self-examination 
practice’. In the subscale subjective norm, ‘FAC_3 There are health professionals available 
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who will help me with mobile teledermoscopy’, had an item total correlation of .35, only just 
above the recommendation indicating low correlation also. 
Secondly, the Kaiser-Meyer-Olkin measure of sampling adequacy was .89, above the 
required value of .6, and Bartlett’s test of sphericity was sufficiently large (2 (351) = 
2732.07, p < .01) which indicated important correlations between the variables and the 
suitability for the factor analysis. The diagonals of the anti-image correlation matrix were all 
over .5, further confirming all the items were suitable for PCA. The communalities were all 
above .3, indicating that each of the mobile teledermoscopy acceptance items shared some 
common variance with other items.  Cronbach alpha for the 27 item scale was 0.94. With the 
criteria for factorability met, a PCA was conducted with all 27 items.  
 
PCA was used as the data reduction technique. The initial eigenvalues showed that the factors 
explained 60.78% of total variance. The first factor explained 32.32% of the variance, the 
second factor 8.08% of the variance, the third factor 6.00% of the variance, and the fourth 
factor 5.64%. The fifth and sixth factors had eigenvalues of just over one, explaining 4.67% 
and 4.10% of the variance respectively.  Four, five and six factor solutions were inspected, 
using both rotation methods: varimax and oblimin. The four factor solution, which explained 
52.06% of the variance, was preferred over the six or five factor solutions because of the 
inflection point on the scree plot after four factors (Figure 4.1), the insufficient number of 
primary loadings with five and six factors and difficulty interpreting the fifth factor and sixth 
factor which did not form a conceptually similar item set.  
 
Figure 4.1 Scree Plot 
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Low item component loadings were evident in the sixth component in particular, beginning at 
.58. There were only minimal changes between the rotation methods (varimax and oblimin), 
thus after examining both methods, an oblimin rotation for the final four factor solution was 
selected (Table 4.4). 
Table 4.4 
Principal components analysis (PCA) 
 Rotated factor loadings 
 
Technical 
and skin self-
examination 
facilitators  
Similarity to 
face-to-face 
encounter and 
perception of 
the interaction 
Social 
indicators 
and 
Practicality 
Ease of use 
I will use MTD if I receive technical 
assistance when I need it  .754   
 
I will use MTD if I receive adequate 
training .719   
 
Participating in MTD will be in my best 
interests .566   
 
I will use MTD when it is offered to me .565   .416 
MTD will improve my skin self-
examination performance .563   
 
MTD will help me to examine my skin 
more thoroughly .504   
 
I will use MTD routinely when I do skin 
self-examination in the future .477   
.424 
The use of MTD will involve major 
changes in my skin self-examination 
practice .427   
 
MTD will help me to examine my skin 
more rapidly .323   
 
I will use MTD if it will save me money  .738   
I will have complete trust in the 
dermatologist’s diagnosis based on a photo 
I emailed as part of MT.  .680  
 
I will use MTD if it  will save me time  .647   
I will rely on the teledermatology process 
to supply accurate information about a 
mole or spot  .611  
 
MTD will help me save time  .598   
Diagnosis of a suspicious mole or spot 
made through MT would be clear and 
easily understandable   .559  
 
The use of MTD fits with my current 
skin self-examination habits  .432  
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 Rotated factor loadings 
 
Technical 
and skin self-
examination 
facilitators  
Similarity to 
face-to-face 
encounter and 
perception of 
the interaction 
Social 
indicators 
and 
Practicality 
Ease of use 
The use of MTD may interfere with my 
usual skin self-examination  .274  
 
My doctor will welcome the fact that I use 
MTD   .764 
 
Other health professionals (physicians, 
nurses, other specialists etc.) will welcome 
the fact that I use MTD   
.727 
 
MTD will help to diagnose skin cancer 
quicker   .555 
 
In general, MTD will be useful to improve 
diagnosis of skin cancer   .495 
 
The use of MTD will improve the 
diagnosis of  spots and moles on my skin 
that look suspicious .41  .461 
 
There are health professionals available 
who will help me with MTD   .388 
 
Most of my friends or family will 
welcome the fact that I use MTD   .272 
 
I will easily learn how to use MTD    .817 
I will find it easy to acquire the necessary 
skills to use MTD    
.724 
It will be easy to perform MTD    .705 
Eigenvalues 8.73 2.18 1.62 1.52 
% of variance 32.32 8.08 6.01 5.64 
Cronbach alpha .90 .79 .85 .83 
Abbreviation: MTD= mobile teledermoscopy, bold items removed.
 
According to the item composition, the four factor concepts were termed: 1) technical and 
skin self-examination facilitators, factor 2) similarity to face-to-face encounter and perception 
of the interaction, factor 3) social indicators and practicality, and factor 4) ease of use. 
 
Model factors and acceptance with mobile teledermoscopy 
Due to the participants overall high item agreement, acceptance model factors (or called 
subscales) were also in the affirmative range (Table 4.5). This included the factor ‘technical 
and skin self-examination facilitators’ (M=4.0, IQR= 3.8–4.6), ‘social indicators and 
practicality’ (M=3.9, IQR=3.6–4.1), and ‘ease of use’ (M=4.0, IQR=3.7–4.3). The ‘similarity 
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to face-to-face encounter and perception of the interaction’ (M=3.4, IQR=3.0–3.8) subscale 
was closer to neutral. Cronbach alphas were 0.79 or higher for all subscales. 
Table 4.5 
Internal reliability measure of subscales 
  Technical and 
skin self-
examination 
facilitators 
(Factor A) 
Similarity to face-
to-face encounter 
and perception of 
the interaction 
(Factor B) 
Social indicators 
& practicality 
(Factor C) 
Ease of use 
(Factor D) 
Cronbach Alpha .90 .79 .85 .83 
Mean 4.1 3.4 3.9 4.0 
SD .56 .54 .52 .60 
Median 4.0 3.4 3.9 4.0 
Interquartile range 
(25th – 75th percentile) 3.8 - 4.6 3.0 – 3.8 3.6 – 4.1 3.7 – 4.3 
*mean and median scores on a scale of 5 strongly agree to 1 strongly disagree 
Significant socio-demographic associations with mobile teledermoscopy 
Table 4.6 lists the mobile teledermoscopy acceptance factors and associations with socio-
demographic and phenotypic characteristics. There was only one characteristic that showed a 
significant association with a factor. Participants with fair skin were more likely to agree with 
‘ease of use’ (p=0.02). 
Table 4.6 
Associations between socio-demographic characteristics and mobile teledermoscopy acceptance questionnaire 
subscales 
Demographics Factors 
 Technical and skin 
self-examination 
facilitators         
(Factor A) 
Similarity to face-to-
face encounter and 
perception of the 
interaction  
(Factor B) 
Social indicators / 
practicality        
 (Factor C) 
Ease of use  
(Factor D) 
 Mean SE p 
value 
Mean SE p 
value 
Mean SE p 
value 
Mean SE p 
value 
Gender             
1: Male 4.1 .05 0.40 3.4 0.5 0.67 3.9 .05 0.45 4.1 .06 0.39 2: Female 4.1 .05 3.4 0.5 3.9 .05 4.0 .06
Age             
1: 50-59 4.1 .04 0.74 3.4 .04 0.30 3.9 .04 0.23 4.0 .04 0.22 2: 60-64 4.1 .09 3.5 .08 4.0 .09 3.9 .09
Marital Status             
1: married, living 
together 4.1 .04 
0.20 
3.4 .04 
0.29 
3.9 .04 
0.26 
4.1 .04 
0.59 2: single, 
divorced, never 
married 
4.0 .09 3.3 .08 3.8 .08 4.0 .09 
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Demographics Factors
 Technical and skin 
self-examination 
facilitators         
(Factor A) 
Similarity to face-to-
face encounter and 
perception of the 
interaction  
(Factor B) 
Social indicators / 
practicality        
 (Factor C) 
Ease of use  
(Factor D) 
 Mean SE p 
value 
Mean SE p 
value 
Mean SE p 
value 
Mean SE p 
value 
Health status             
1: Excellent, very 
good, good 4.1 .04 0.53 3.4 .04 0.85 3.9 .04 0.63 4.0 .04 0.68 
2: Fair, poor 4.0 .13 3.4 .13 3.9 .12 4.0 .14 
Work             
1: full-time 
 4.1 .05 
0.51 
3.4 .04 
0.06 
3.9 .04 
0.55 
4.1 .05 
0.19 2: part-time, 
student, home 
duties, retired 
4.1 .06 3.3 .05 3.9 .05 4.0 .06 
Close relatives 
with melanoma             
1: yes 4.1 .07 0.24 3.5 .06 0.07 3.9 .06 0.14 4.0 .07 0.89 2: no/don’t know 4.1 .05 3.3 .04 3.8 .04 4.0 .05 
Fair skin             
1: Fair, very fair 4.1 .04 
0.09 
3.4 .04 
0.12 
3.9 .04 
0.21 
4.1 .04 
0.02 2: medium, olive, 
dark 
3.9 .09 3.3 .09 3.8 .09 3.8 .10 
Skin cancer 
removed 
            
1: yes 4.1 .05 0.97 3.4 .05 0.87 3.9 .05 0.55 4.0 .06 0.80 2: no, don’t know 4.1 .05 3.4 .05 3.9 .05 4.0 .06 
Country of birth             
1: Australia 4.1 .04 0.11 3.4 .04 0.43 3.9 .04 0.08 4.0 .05 0.63 2: Overseas 4.0 .08 3.3 .07 3.8 .07 4.0 .08
*mean scale 5 strongly agree to 1 strongly disagree; significant p values in red; close relatives are defined as child, 
mother, father, sibling or grandparents. 
 
4.1.4 QUESTIONNAIRE REFINEMENT 
Once the four factor solution was selected in the PCA, several steps were conducted for 
questionnaire item refinement. Firstly, four items were eliminated because they failed to meet 
a minimum criterion in PCA of having a primary factor loading of .4 or above.  These include 
the items:  
 PU_1 Mobile teledermoscopy will help me to examine my skin more rapidly,  
 FAC_3 There are health professionals available who will help me with mobile 
teledermoscopy, 
 COM_4 The use of mobile teledermoscopy may interfere with my usual skin self-
examination, and  
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 SN_2 Most of my friends or family will welcome the fact that I use mobile 
teledermoscopy.  
The following items also had low communalities just over .326 and .348 respectively, 
reinforcing removal:  
 FAC_3 There are health professionals available who will help me with mobile 
teledermoscopy and,  
 COM_4 The use of mobile teledermoscopy may interfere with my usual skin self-
examination. 
Cronbach’s alpha if item deleted was investigated and reported in Table 4.7. Cronbach alpha 
analysis suggested that internal consistency would increase if two items were deleted. The 
item: ‘SN_2 Most of my friends or family will welcome the fact that I use mobile 
teledermoscopy,’ was deleted because it loaded less than 0.4 in PCA as described above and 
the Cronbach alpha increases if removed. The items: ‘PEU_3 Diagnosis of a suspicious mole 
or spot made through mobile teledermoscopy would be clear and easily understandable,’ and 
‘PU_3 The use of mobile teledermoscopy will improve the diagnosis of spots and moles on 
my skin that look suspicious’ if deleted would increase the Cronbach alpha only minimally, 
that it would not make a significant difference. No other subscales had an increase in 
Cronbach alpha if that item was deleted. Thus no items were removed using the statistical test 
Cronbach’s alpha if item deleted.  
Table 4.7 
Reliability of the Smartphone Study items 
Smartphone Study items  
 
Item-total 
correlation 
Cronbach 
alpha if 
item 
deleted 
PU_1 Mobile teledermoscopy will help me to examine 
my skin more rapidly  
.574 .878 
PU_2Mobile teledermoscopy will improve my skin 
self-examination performance  
.717 .857 
PU_3 The use of mobile teledermoscopy will improve 
the diagnosis of  spots and moles on my skin that look 
suspicious  
.696 .860 
PU_4 Mobile teledermoscopy will help me save time  .585 .875 
PU_5 Mobile teledermoscopy will help to diagnose 
skin cancer quicker  
.728 .856 
PU_6 In general, mobile teledermoscopy will be useful 
to improve diagnosis of skin cancer  
.732 .857 
PU_7 Participating in mobile teledermoscopy will be 
in my best interests  
.689 .861 
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Smartphone Study items  
 
Item-total 
correlation 
Cronbach 
alpha if 
item 
deleted 
PEU_1 It will be easy to perform MTD  .661 .732 
PEU_2 I will easily learn how to use MTD .671 .729 
PEU_3 Diagnosis of a suspicious mole or spot made 
through MTD would be clear and easily 
understandable  
.451 .833 
PEU_4 I will find it easy to acquire the necessary skills 
to use MTD 
.707 .710 
COM_1 MTD will help me to examine my skin more 
thoroughly  
.565 .176 
COM_2 The use of MTD will involve major changes 
in my skin self-examination practice  
.270 .417 
COM_3 The use of MTD fits with my current skin 
self-examination habits 
.212 .490 
COM_4 The use of MTD may interfere with my usual 
skin self-examination (reverse coded this item for 
Cronbach alpha) 
.142 .517 
INT_1 I will use MTD when it is offered to me  .577 .748 
INT_2 I will use MTD routinely when I do skin self-
examination in the future  
.614 .727 
INT_ 3 I will use MTD if it will save me time  .615 .725 
INT_4 I will use MTD if it will save me money  .599 .740 
SN_1 Other health professionals (physicians, nurses, 
other specialists etc.) will welcome the fact that I use 
MTD 
.645 .647 
SN_2 Most of my friends or family will welcome the 
fact that I use MTD 
.519 .788 
SN_3 My doctor will welcome the fact that I use MTD .656 .632 
TRU_1 I will have complete trust in the 
dermatologist’s diagnosis based on a photo I emailed 
as part of MTD 
.638 - 
TRU_2 I will rely on the teledermatology process to 
supply accurate information about a mole or spot. 
.638 - 
FAC_1 I will use MTD if I receive adequate training  .643 .384 
FAC_2 I will use MTD if I receive technical assistance 
when I need it 
.508 .569 
FAC_3 There are health professionals available who 
will help me with MTD 
.353 .762 
Abbreviations: MTD=mobile teledermoscopy 
 
Two further items were removed because they had low loadings of 0.427 and 0.432 
respectively, and the items fell at the bottom of factor one and two which had sufficient 
items. These include: 
 COM_2 The use of mobile teledermoscopy will involve major changes in my skin 
self-examination practice, and  
 COM_3 The use of mobile teledermoscopy fits with my current skin self-
examination habits. 
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Further questionnaire refinement included removing the item ‘PU_4 mobile teledermoscopy 
will help save me time’, because it was too similarly worded with ‘INT_3 I will use mobile 
teledermoscopy if it will save me time’, and did not correlate in a factor as highly as item 
PU_4. Item FAC_1 was reworded to ensure better clarity to ‘I would use mobile 
teledermoscopy routinely when I do skin self-examination in the future if it was available to 
me.’ Table 4.8 displays the revised questionnaire. 
Table 4.8 
The revised mobile teledermoscopy acceptance questionnaire (in questionnaire order) 
Item Factor 
a. I will use mobile teledermoscopy when it is offered to me Factor A: Technical and skin 
self-examination facilitators  
b. The use of mobile teledermoscopy will improve the diagnosis of  
spots and moles on my skin that look suspicious 
Factor C: Social indicators and 
practicality  
c. It will be easy to perform mobile teledermoscopy Factor D: Ease of use 
d. Mobile teledermoscopy will be a standard way of health-care 
delivery in the future 
Factor C: Social indicators and 
practicality 
e. Participating in mobile teledermoscopy will be in my best interests Factor A: Technical and skin 
self-examination facilitators 
f. I don’t like that there is no physical contact with a health 
professional using mobile teledermoscopy 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
g. Diagnosis of a suspicious mole or spot made through mobile 
teledermoscopy would be clear and easily understandable 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
h. The use of this technology does not threaten my privacy or 
confidentiality of my medical data 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
i. Mobile teledermoscopy will improve my skin self-examination 
performance 
Factor A: Technical and skin 
self-examination facilitators 
j. Mobile teledermoscopy will help me to examine my skin more 
thoroughly 
Factor A: Technical and skin 
self-examination facilitators 
k. My doctor will welcome the fact that I use mobile teledermoscopy Factor C: Social indicators and 
practicality 
l. Mobile teledermoscopy will help to diagnose skin cancer quicker Factor C: Social indicators and 
practicality 
m. I will find it easy to acquire the necessary skills to use mobile 
teledermoscopy 
Factor D: Ease of use 
n. I would be satisfied with the diagnosis by mobile teledermatology 
without talking to the dermatologist in person 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
o. I will rely on the teledermatology process to supply accurate 
information about a mole or spot. 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
p. I will use mobile teledermoscopy if I receive adequate training  Factor A: Technical and skin 
self-examination facilitators 
q. Other health professionals (physicians, nurses, other specialists 
etc.) will welcome the fact that I use mobile teledermoscopy  
Factor C: Social indicators and 
practicality 
r. In general, mobile teledermoscopy will be useful to improve 
diagnosis of skin cancer  
Factor C: Social indicators and 
practicality 
s. I would use mobile teledermoscopy routinely when I do skin self-
examination in the future if it was available to me
Factor A: Technical and skin 
self-examination facilitators 
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Item Factor 
t. A dermatologist cannot diagnose a skin cancer by mobile 
teledermoscopy as well as they can in person 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
u. I will use mobile teledermoscopy if I receive technical assistance 
when I need it  
Factor A: Technical and skin 
self-examination facilitators 
v. I would have complete trust in the dermatologist’s diagnosis based 
on a photo I emailed as part of mobile teledermoscopy 
Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
w. I will use mobile teledermoscopy only if it will save me time Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
x. I will use mobile teledermoscopy only if it will save me money Factor B: Similarity to face-to-
face encounter and perception of 
the interaction  
y. I will easily learn how to use mobile teledermoscopy Factor D: Ease of use 
 
The above questionnaire was pilot tested and then used in a new cross-sectional study 
called the Virtual Skin Check Study. The results for this new sample are below in section 4.2, 
the Virtual Skin Check Study.  
 
4.2 THE VIRTUAL SKIN CHECK STUDY 
This section is a compilation of results from the Virtual Skin Check Study that was created, 
conducted and assessed for this Master’s thesis. 
4.2.1 PARTICIPANTS 
Recruitment strategy 1: At three skin outreach days 46 participants completed the mobile 
teledermoscopy acceptance survey. These participants completed baseline assessments only. 
Recruitment strategy 2: The baseline survey was completed by 109 participants, and of these 
the follow-up survey, to be used for the test-retest calculations, was completed by 82 
participants (75%). 78/109 (72%) participants answered ‘yes’, that they would be interested 
in testing the functionality of the dermatoscope between surveys. However of those emailed 
only 20 responded, and only eleven tested the dermatoscope at QUT between surveys. 
Follow-up surveys were completed by ten of these eleven participants. This data from the ten 
participants was used to assess sensitivity to change. 
 
Combined sample from recruitment strategies 1 and 2: A total of 155 participants are 
available for baseline assessment, and 82 for follow-up assessment (n=72 test-retest, n=10 
sensitivity group).  
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Participant characteristics 
Table 4.9 displays participant demographics and phenotypic characteristics at baseline and 
follow-up. At baseline, the majority of participants were women (n=59, 38% men; n=96, 62% 
women), and 21-35 years of age (n=83, 54%). The majority of participants were married 
(n=110, 71%), and had a diploma, university degree or higher (n=119, 79%). In the work 
category, many participants were employed full-time (n=87, 56%), or students (n=33, 21%). 
Participants commonly had blue or grey eye colour (n=69, 45%) and a fair or very fair 
complexion (n=117, 76%). The majority of the sample (n=120, 77%) had no personal history 
of skin cancer. Four participants had previously had a melanoma. At follow-up, there were 16 
men (20%) and 66 women (81%). The largest category of participants were 35 years or 
younger (n=36, 44%).  
Table 4.9 
The Virtual Skin Check Study: participant characteristics 
Characteristic 
Combined 
baseline 
sample 
n (%) 
Sample 2 
follow-up 
n (%) 
Total 
Gender 
155 82 
     Male  59 (38.1) 16 (19.5) 
     Female 96 (61.9) 66 (80.5) 
Age*   
    21-25 21 (13.5) 15 (18.3) 
    26-35 62 (40.0) 36 (43.9) 
    36-49 40 (25.8) 13 (15.9) 
    50-60 22 (14.2) 14 (17.1) 
    61-78 9 (5.8) 4 (4.9) 
Educational Attainment   
     No high school or other qualification 1 (0.6) 1 (1.2) 
     High School or trade 35 (22.5) 8 (9.8) 
     University degree/ diploma 119 (79.3) 73 (89.0) 
Work   
     Full-time  87 (56.1) 31 (37.8) 
     Part-time  25 (16.1) 19 (23.2) 
     Home duties 5 (3.2) 4 (4.9) 
     Student 33 (21.3) 25 (30.5) 
     Retired 5 (3.2) 3 (3.7) 
Marital Status   
     Married/living together 110 (71.0) 56 (68.3) 
     Divorced 4 (2.6) 2 (2.4) 
     Single/never married 39 (25.2) 22 (26.8) 
     Other 2 (1.3) 2 (2.4) 
What country were you born in?   
     Australia 115 (74.2) 65 (79.3) 
     Other 40 (25.8) 17 (20.7) 
Private Health Insurance*   
    Yes 121 (78.1) 64 (78.0) 
     No 
 
29 (18.7) 18 (22.0) 
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Characteristic 
Combined 
baseline 
sample 
n (%) 
Sample 2 
follow-up 
n (%) 
How many skin cancers have you ever had cut 
off your skin? 
  
     None 120 (77.4) 64 (78.0) 
     1 skin cancer 22 (14.2) 11 (13.4) 
     2-9 skin cancers 12 (7.7) 7 (8.5) 
     10-19 skin cancers 1 (0.6) - 
     20+ skin cancers - - 
First degree history (sibling, parent or child)   
     Yes 32 (20.6) 21 (25.6) 
     No 99 (63.9) 48 (58.5) 
     Don’t know 24 (15.5) 13 (15.9) 
How likely is it that you will get melanoma at 
some time in the future? 
  
     Highly unlikely 5 (3.2) 2 (2.4) 
     Somewhat unlikely 30 (19.4) 15 (18.3) 
     About the same as other  Queenslanders 82 (52.9) 45 (54.9) 
     Somewhat more likely 27 (17.4) 14 (17.1) 
     Highly likely 7 (4.5) 4 (4.9) 
     Already been diagnosed 4 (2.6) 2 (2.4) 
Have you made an attempt to get a sun tan in 
the past 12 months? 
  
     No 108 (69.7) 20 (24.4) 
     Yes 44 (28.4) 60 (73.2) 
     Unsure 3 (1.9) 2 (2.4) 
How many times have you been sunburnt in 
the past 12 months? 
  
     Never 30 (19.4) 21 (25.6) 
     Once 58 (37.4) 31 (37.8) 
     2-5 times 54 (34.8) 27 (32.9) 
     6 or more times 10 (6.5) 1 (1.2) 
     Don’t know 3 (1.9) 2 (2.4) 
If you were exposed to strong sun for 30 
minutes at the beginning of summer without a 
tan and without protection, would your skin… 
  
     Not burn 14 (9.0) 5 (6.1) 
     Burn a little 70 (45.2) 37 (45.1) 
     Burn moderately 54 (34.8) 31 (37.8) 
     Burn badly 17 (11.0) 9 (11.0) 
Compared to other people, would you say 
your health is? 
  
     Excellent 20 (12.9) 9 (11.0) 
     Very good 77 (49.7) 40 (48.8) 
     Good 49 (31.6) 25 (30.5) 
     Fair 9 (5.8) 8 (9.8) 
     Poor/Very Poor - - 
Natural skin colour    
     Very Fair 28 (18.1) 18 (22.0) 
     Fair 89 (57.4) 45 (54.9)
     Medium 27 (17.4) 13 (15.9) 
     Olive or brown 11 (7.1) 6 (7.3) 
Eye colour 
     Blue/Grey 69 (44.5) 32 (39.0) 
     Green or Hazel 39 (25.2) 23 (28.0) 
     Brown or Black 47 (30.3) 27 (32.9)
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Characteristic 
Combined 
baseline 
sample 
n (%) 
Sample 2 
follow-up 
n (%) 
Hair colour*   
     Red/auburn 12 (7.7) 5 (6.1) 
     Dark brown 49 (31.6) 25 (30.5) 
     Blonde/fair 24 (15.4) 16 (19.4) 
     Light brown 56 (36.1) 28 (34.1) 
     Black 13 (8.6) 8 (9.8) 
In the past 12 months, has a doctor 
deliberately checked the skin on your whole 
body for skin cancer? 
  
     No 86 (55.5) 47 (57.3) 
     Yes 69 (44.5) 35 (42.7) 
*1 participant missing 
 
Smartphone use 
Only four participants had never used a smartphone before; nine (6%) were unskilled and 142 
(92%) were skilled with overall use of a smartphone (i.e. surfing the internet, sending email, 
taking photos, downloading applications (apps) and others). Skill levels did not differ by 
participant demographics (gender or age (data not shown)). Most participants were skilled or 
very skilled using the functions on their smartphone that would be required for mobile 
teledermoscopy. Ninety-two per cent were skilled at surfing the internet on their smartphone 
with 33% of participants spending six or more hours a week on this activity. Ninety per cent 
of participants were skilled in sending email, 87% were confident with both downloading and 
using apps. Only six participants were unskilled in taking and managing photos on their 
smartphone.  
 
Attitudes towards skin self-examination and skin cancer 
Table 4.10 details participants’ attitudes towards skin self-examination and skin cancer. 
There was a positive association (r=0.3, p=0.01) between the 12-item skin awareness 
questionnaire and the 25-item mobile teledermoscopy acceptance questionnaire. Participants 
who had high mobile teledermoscopy acceptance were also more likely to agree that skin 
self-examination was important. The majority of participants (96%) agreed it was important 
to check their skin even if they have no symptoms. Seventy-six per cent of participants 
agreed if they found a suspicious spot or mole they would go to the doctor right away. Most 
participants (94%) agreed if they regularly examine their skin, then they are helping to look 
after their own health. Participant responses varied with the statement ‘I am confident that I 
can detect abnormalities in moles or spots I find’ (39% agreed, 38% unsure, 23% disagreed). 
In relation to melanoma in particular, 88% of the participants agreed ‘the thought of 
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melanoma scares me’. Most participants (95%) agreed going to the doctor as quickly as 
possible after noticing a symptom of melanoma increases the chances of surviving’.  
Table 4.10 
Attitudes towards skin cancer early detection (n=155) 
Items Baseline 
n=155 
Median IQR 
It is important to check my skin for skin cancer even if 
I have no symptoms  
 5.0 5.0-4.0 
     Agree 149 (96.1)   
     Unsure 4 (2.6)  
     Disagree 2 (1.3)   
I think checking my skin would make me anxious*  2.0 3.0-2.0 
     Agree 25 (16.1)   
     Unsure 16 (10.3)   
     Disagree 113 (72.9)   
Checking my skin regularly is a priority for me.  4.0 4.0-3.0 
     Agree 90 (58.1)  
     Unsure 27 (17.4)   
     Disagree 38 (24.5)  
I think I could find a suspicious spot on my skin if it 
was there* 
 3.0 4.0-3.0 
     Agree 77 (49.7)   
     Unsure 53 (34.2)   
     Disagree 24 (15.5)   
If I saw something suspicious on my skin, I’d go to the 
doctor straight away. 
 4.0 5.0-4.0 
     Agree 118 (76.1)   
     Unsure 28 (18.1)   
     Disagree 9 (5.8)   
I am confident in my doctor’s ability to diagnose skin 
cancer.* 
 4.0 4.0-3.0 
     Agree 109 (70.3)   
     Unsure 36 (23.2)   
     Disagree 9 (5.8)   
I have made plans on when to examine my own skin +  2.0 3.0-2.0 
     Agree 30 (19.4)   
     Unsure 26 (16.8)   
     Disagree 97 (62.6)   
I am confident that I can start examining my own skin 
again even if I have not looked at my skin in the past 
few months.* 
 4.0 4.0-3.0 
     Agree 94 (60.6)   
     Unsure 35 (22.6)   
     Disagree 25 (16.1)   
I can examine my own skin regularly, even if I have no 
one to help me + 
 4.0 4.0-3.0 
     Agree 89 (54.7)   
     Unsure 33 (21.3)   
     Disagree 31 (20.0)   
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Items Baseline 
n=155
Median IQR 
If I regularly examine my skin, then I am helping to 
look after my own health. 
 4.0 5.0-4.0 
     Agree 146 (94.2)   
     Unsure 6 (3.9)   
     Disagree 3 (1.9)   
I am confident that I can detect abnormalities in moles 
or spots I find. 
 3.0 4.0-3.0 
     Agree 60 (38.7)   
     Unsure 59 (38.1)   
     Disagree 36 (23.2)   
The thought of melanoma scares me   4.0 5.0-4.0 
     Agree 137 (88.4)   
     Unsure 8 (5.2)   
     Disagree 10 (6.5)   
Going to the doctor as quickly as possible after 
noticing a symptom of melanoma could increase the 
chances of surviving 
 5.0 5.0-4.0 
     Agree 147 (94.8)   
     Unsure 8 (5.2)   
     Disagree -   
*1 participant missing; + 2 participants missing, median scale 1 strongly disagree to 5 strongly 
agree; IQR=interquartile range 25th - 75th percentile. 
 
4.2.2 MOBILE TELEDERMOSCOPY ACCEPTANCE  
Descriptive results for the Virtual Skin Check Study mobile teledermoscopy acceptance 
questionnaire are reported in Table 4.11. The data was non-normally distributed for all items, 
and non-parametric descriptive statistics are presented. Four participants stated they had used 
mobile teledermoscopy before. There was high mobile teledermoscopy acceptance reported 
in the overall questionnaire among participants at baseline (n=155) and follow-up (n=72). 
This is similar to those reported in the Smartphone Study. The new items in the Virtual Skin 
Check Study performed well eliciting a wider range of responses than in the Smartphone 
Study. Forty-five per cent of participants would be satisfied with the diagnosis by mobile 
teledermoscopy without talking to the dermatologist, and 28% were unsure. In regards to the 
absence of physical contact with the health professional 22% of participants strongly agreed 
or agreed that this would be a barrier to their use, 23% were unsure, 42% disagreed and 13% 
strongly disagreed. Most participants were unsure (57%) that the dermatologist could 
diagnose a skin cancer by mobile teledermoscopy as well as they can in person. Forty-one per 
cent of participants were also unsure if they had complete trust in the dermatologist’s 
diagnosis based on a photo emailed to a dermatologist. Seventy-three per cent of participants 
strongly agreed or agreed that teledermoscopy would not threaten their confidentiality or 
medical data when transmitted online 
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Table 4.11  
The Virtual Skin Check Study mobile teledermoscopy acceptance questionnaire results 
Items Baseline 
n=155 
Baseline 
Median 
IQR Follow-
up    
n=82 
Follow-
up 
Median 
IQR 
a. I will use MTD when it is offered to 
me  
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 62 (40.0)   29 (35.4)   
     Agree 74 (47.7) 41 (50.0)  
     Unsure 15 (9.7)   9 (11.0)   
     Disagree 4 (2.6)   3 (3.7)   
     Strongly disagree -   -   
b. The use of MTD will improve the 
diagnosis of  spots and moles on 
my skin that look suspicious 
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 47 (30.3)   20 (24.4)   
     Agree 83 (53.5)   44 (53.7)   
     Unsure 24 (15.5)   17 (20.7)   
     Disagree 1 (0.6)   1 (1.2)   
     Strongly disagree -   -   
c. It will be easy to perform MTD  4.0 4.0 – 4.0  4 4.0 – 4.0 
     Strongly agree 38 (24.5)   20 (24.4)   
     Agree 84 (54.2)   45 (54.9)   
     Unsure 33 (21.3)   17 (20.7)   
     Disagree -   -   
     Strongly disagree -   -   
d. MTD will be a standard way of 
health-care delivery in the future 
 4.0 4.0 – 3.0  4 4.0 – 3.0 
     Strongly agree 24 (15.5) 17 (20.7)  
     Agree 87 (56.1)   36 (43.9)   
     Unsure 42 (27.1)   26 (31.7)   
     Disagree 2 (1.3) 3 (3.7)  
     Strongly disagree -   -   
e. Participating in MTD will be in my 
best interests 
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 62 (40.0)   28 (34.1)   
     Agree 74 (47.7)   45 (54.9)   
     Unsure 18 (11.6) 8 (9.8)  
     Disagree 1 (0.6)   1 (1.2)   
     Strongly disagree -   -   
f. I don’t like that there is no 
physical contact with a health 
professional using MTD 
 2.0 3.0 - 2.0  3 3.0 - 2.0 
     Strongly agree 4 (2.6)   2 (2.4)   
     Agree 25 (16.1)   27 (32.9)   
     Unsure 45 (29.0)   21 (25.6)   
     Disagree 65 (41.9)   25 (30.5)   
     Strongly disagree 16 (10.3)   7 (8.5)   
g. Diagnosis of a suspicious mole or 
spot made 1through MTD would be 
clear and easily understandable 
 3.0 4.0 – 3.0  3 4.0 – 3.0 
     Strongly agree 10 (6.5) 6 (7.3)  
     Agree 65 (41.9)   36 (43.9)   
     Unsure 75 (48.4)   39 (47.6)   
     Disagree 5 (3.2) 1 (1.2)  
     Strongly disagree 
 
-   -   
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Items Baseline 
n=155 
Baseline 
Median 
IQR Follow-
up    
n=82 
Follow-
up 
Median 
IQR 
h. The use of this technology does 
not threaten my privacy or 
confidentiality of my medical 
data 
 4.0 4.0 – 3.0  4 4.0 – 3.0 
     Strongly agree 25 (16.1)   13 (15.9)   
     Agree 91 (58.7)   50 (61.0)   
     Unsure 35 (22.6)   13 (15.9)   
     Disagree 3 (1.9)   6 (7.3)   
     Strongly disagree 1 (0.6)   -   
i. MTD will improve my skin self-
examination performance 
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 57 (36.8)   29 (35.4)   
     Agree 75 (48.4) 45 (54.9)  
     Unsure 21 (13.5)   6 (7.3)   
     Disagree 2 (1.3)   2 (2..4)   
     Strongly disagree -   -   
j. MTD will help me to examine my 
skin more thoroughly 
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 57 (36.8)   29 (35.4)   
     Agree 79 (51.0)   45 (54.9)   
     Unsure 15 (9.7)   7 (8.5)   
     Disagree 4 (2.6)   1 (1.2)   
     Strongly disagree -   -   
k. My doctor will welcome the fact 
that I use MTD 
 4.0 4.0 – 3.0  4 4.0 – 3.0 
     Strongly agree 24 (15.5)   14 (17.1)   
     Agree 59 (38.1)   33 (40.2)   
     Unsure 69 (44.5)   32 (39.0)   
     Disagree 2 (1.3)   3 (3.7)   
     Strongly disagree 1 (0.6)   -   
l. MTD will help to diagnose skin 
cancer quicker 
 4.0 5.0 - 3.0  4 5.0 - 3.0 
     Strongly agree 40 (25.8) 18 (22.0)  
     Agree 74 (47.7)   49 (59.8)   
     Unsure 39 (25.2)   15 (18.3)   
     Disagree 2 (1.3)   -   
     Strongly disagree -   -   
m. I will find it easy to acquire the 
necessary skills to use mobile 
teledermoscopy 
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 41 (26.5)   25 (30.5)   
     Agree 84 (54.2)   47 (57.3)   
     Unsure 29 (18.7)   10 (12.2)   
     Disagree -   -   
     Strongly disagree 1 (0.6)   -   
n. I would be satisfied with the 
diagnosis by MTD without 
talking to the dermatologist in 
person  
 3.0 4.0 – 3.0  3 4.0 – 3.0 
     Strongly agree 13 (8.4)   5 (6.1)   
     Agree 56 (36.1)   22 (26.8)   
     Unsure 52 (33.5)   27 (32.9)   
     Disagree 26 (16.8)   25 (30.5)   
     Strongly disagree 
 
 
8 (5.2)   3 (3.7)   
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Items Baseline 
n=155 
Baseline 
Median 
IQR Follow-
up n=82 
Follow-
up 
Median 
IQR 
o. I will rely on the MTD process to 
supply accurate information about a 
mole or spot.* 
 4.0 4.0 – 3.0  4 4.0 – 3.0 
      Strongly agree 15 (9.7)   9 (11.0)   
     Agree 67 (43.2)   34 (41.5)   
     Unsure 47 (30.3)   26 (31.7)   
     Disagree 20 (12.9)   11 (13.4)   
     Strongly disagree 5 (3.2)   2 (2.4)   
p. I will use MTD if I receive 
adequate training  
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 50 (32.3)   21 (25.6)   
     Agree 87 (56.1)   53 (64.6)   
     Unsure 13 (8.4) 6 (7.3)  
     Disagree 4 (2.6)   2 (2.4)   
     Strongly disagree 1 (0.6)   -   
q. Other health professionals 
(physicians, nurses, other 
specialists etc.) will welcome the 
fact that I use MTD 
 4.0 4.0 – 3.0  4 4.0 – 3.0 
     Strongly agree 25 (16.1)   13 (15.9)   
     Agree 65 (41.9)   35 (42.7)   
     Unsure 62 (40.0)   30 (36.6)   
     Disagree 2 (1.3)   4 (4.9)   
     Strongly disagree 1 (0.6)   -   
r. In general, MTD will be useful to 
improve diagnosis of skin cancer  
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 46 (29.7)   25 (30.5)   
     Agree 90 (58.1)   46 (56.1)   
     Unsure 19 (12.3)   10 (12.2)   
     Disagree -   1 (1.2)   
     Strongly disagree -   -   
s. I would use MTD routinely when I 
do skin self-examination in the 
future if it was available to me 
 4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 57 (36.8)   30 (36.6)   
     Agree 72 (46.5)   42 (51.2)   
     Unsure 23 (14.8)   9 (11.0)   
     Disagree 2 (1.3)   1 (1.2)   
     Strongly disagree 1 (0.6)   -   
t. A dermatologist cannot diagnose 
a skin cancer by MTD as well as 
they can in person 
 3.0 3.0 - 3.0  3 3.0 - 3.0 
     Strongly agree 7 (4.5)   4 (4.9)   
     Agree 31 (20.0)   20 (24.4)   
     Unsure 91 (58.7)   43 (52.4)   
     Disagree 21 (13.5)   12 (14.6)   
     Strongly disagree 5 (3.2)   3 (3.7)   
u. I will use MTD if I receive 
technical assistance when I need it  
 4.0 4.0 - 4.0  4 4.0 - 4.0 
     Strongly agree 36 (23.2)   14 (17.1)   
     Agree 99 (63.9)   56 (68.3)   
     Unsure 15 (9.7)   10 (12.2)   
     Disagree 3 (1.9)   1 (1.2)   
     Strongly disagree 
 
 
2 (1.3)   1 (1.2)   
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Items Baseline 
n=155 
Baseline 
Median 
IQR Follow-
up   
n=82 
Follow-
up 
Median 
IQR 
v. I would have complete trust in the 
dermatologist’s diagnosis based on 
a photo I emailed as part of MTD 
 3.0 4.0 – 3.0  3 4.0 – 3.0 
     Strongly agree 10 (6.5)   3 (3.7)   
     Agree 58 (37.4)   30 (36.6)   
     Unsure 62 (40.0)   32 (39.0)   
     Disagree 19 (12.3)   17 (20.7)   
     Strongly disagree 6 (3.9)   -   
w. I will use MTD only if it will save 
me time 
 3.0 4.0 – 2.0  3 4.0 – 2.0 
     Strongly agree 16 (10.3)   3 (3.7)   
     Agree 58 (37.4)   22 (26.8)   
     Unsure 26 (16.8) 17 (20.7)  
     Disagree 49 (31.6)   38 (46.3)   
     Strongly disagree 6 (3.9)   2 (2.4)   
x. I will use MTD only if it will save 
me money 
 3.0 4.0 – 2.0  3 4.0 – 2.0 
     Strongly agree 14 (9.0)   3 (3.7)   
     Agree 57 (36.8)   27 (32.9)   
     Unsure 26 (16.8)   15 (18.3)   
     Disagree 50 (32.3)   34 (41.5)   
     Strongly disagree 8 (5.2)   3 (3.7)   
y. I will easily learn how to use MTD  4.0 5.0 - 4.0  4 5.0 - 4.0 
     Strongly agree 48 (31.0)   28 (34.1)   
     Agree 88 (56.8)   40 (48.8)   
     Unsure 19 (12.3)   14 (17.1)   
     Disagree -   -   
     Strongly disagree -   -   
MTD=mobile teledermoscopy; median scale 1 strongly disagree to 5 strongly agree; IQR=interquartile range 25th, 
75th percentile; new items in bold 
 
 
Significant associations between participant characteristics and mobile teledermoscopy 
acceptance 
Table 4.12 lists the mobile teledermoscopy acceptance factors and associations with socio-
demographic and phenotypic characteristics. There were no associations between mobile 
teledermoscopy acceptance and skin type, skin cancer history or mole count and the four 
factors. For the ‘technical and skin self-examination facilitators’ subscale there was an 
association with marital status, work and country of birth: 
 Respondents who were married or living together were more likely to agree with 
items in this domain, in comparison with respondents who did not live with a 
partner (p=0.01). 
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 Respondents who worked full-time were more likely to agree with items in this 
factor, compared to respondents who worked part-time, conducted home duties, 
were retired or a student (p=0.01). 
 Individuals who were born in Australia were more likely to agree with items in this 
factor, compared to individuals born overseas (p=0.03)  
For the ‘similarity to face-to-face encounter and perception of the interaction’ factor there 
was an association with gender, education and work: 
 Females were more likely to disagree with the items relating to time, cost and trust 
in the diagnosis compared to males (p=0.01). 
 Respondents with a university degree were more likely to disagree with items 
about time savings and trust in the diagnosis compared to respondents who had 
completed high school, trade, or a diploma (p=0.02). 
 Respondents who worked full-time were more likely to agree with items in this 
domain on time, cost and trust in the diagnosis, compared to respondents who 
worked part-time, worked home duties, were retired or a student (p=0.01). 
For ‘social indicators and practicality’ there was an association with marital status and work: 
 Respondents who were married or living together were more likely to agree with 
items in this domain, in comparison with respondents who did not live with a 
partner (p=0.01). 
 Respondents who worked full-time were more likely to agree with items in this 
factor, compared to respondents who worked part-time, conducted home duties, 
were retired or a student (p=0.01). 
For ‘ease of use’ there was an association with age: 
 Older adults (51-78 years of age) were more likely to respond ‘unsure’ to ‘ease of 
use’ items, in comparison to adults (21-50 years of age) who were more likely to 
agree (p=0.01). 
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Table 4.12 
Significant associations with each factor 
Demographics Factors 
 Technical and skin 
self-examination 
facilitators         
(Factor A) 
Similarity to face-to-
face encounter and 
perception of the 
interaction (Factor B) 
Social indicators / 
practicality       
  (Factor C) 
Ease of use  
(Factor D) 
 Mean SE p 
value 
Mean SE p 
value 
Mean SE p 
value 
Mean SE p 
value 
Gender      
1: Male 4.2 .08 0.91 3.4 .05 0.01 3.9 .07 0.65 4.0 .07 0.40 2: Female 4.2 .06 3.2 .04 3.9 .06 4.1 .06 
Age      
1: 21- 50 4.2 .05 0.55 3.3 .03 0.25 3.9 .05 0.93 4.2 .05 0.01 2: 51- 78 4.1 .11 3.2 .08 3.9 .10 3.8 .10 
Marital Status      
1: married, living 
together 4.3 .05 
0.01 
3.3 .04 
0.22 
4.0 .05 
0.01 
4.1 .05 
0.83 2: single, 
divorced, never 
married 
4.0 .09 3.2 .06 3.7 .08 4.1 .08 
Education      
1: high school, 
trade, diploma 4.3 .08 0.19 3.4 .06 0.02 4.0 .07 0.40 4.0 .08 0.32 
2: university 4.1 .06 3.2 .04 3.9 .05 4.1 .05
Work             
1: full-time 4.3 .06 
0.01 
3.3 .04 
0.01 
4.0 .06 
0.01 
4.1 .06 
0.63 2: part-time, student, home 
duties, retired 
4.0 .07 3.0 .05 3.8 .06 4.1 .07 
Born in Aust.             
1: Born in 
Australia            4.3 .05 0.03 3.2 .04 0.56 3.9 .05 0.42 4.1 .05 0.65 
2: Born overseas 4.0 .09 3.3 .07 3.9 .09 4.1 .09 
Fair skin             
1: Fair, very fair 4.2 .05 
0.75 
3.3 .04 
0.46 
4.0 .05 
0.09 
4.1 .05 
0.23 2: medium, olive, 
dark 
4.2 .10 3.2 .07 3.8 .09 4.0 .09 
Skin cancer 
removed 
            
1: yes 4.2 .10 0.74 3.2 .07 0.14 3.9 .09 0.49 3.9 .09 0.07 2: no, don’t know 4.2 .05 3.3 .04 3.9 .05 4.1 .05 
Number of 
moles 
            
1: none, few 4.2 0.6 0.28 3.3 .04 0.85 3.9 .06 0.91 4.1 .06 0.65 2: some, many 4.3 0.7 3.3 .05 3.9 .07 4.1 .07 
*mean scale 5 strongly agree to 1 strongly disagree, significant p values in red. 
 
4.2.3 QUESTIONNAIRE RELIABILITY  
Internal consistency 
Cronbach alpha for the newly developed 25-item questionnaire was 0.87 in the baseline 
(n=155), and 0.87 in the retest sample (n=82). Cronbach alpha for each of the four factor 
subscales were all above 0.73, thus reporting high reliability. Participants indicated high 
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agreement with the four factor subscales at baseline (Table 4.13). At baseline, split-half 
reliability was 0.8 (Spearman-Brown Coefficient), above the recommended 0.6 and therefore 
adequate.  
Central tendency 
Due to the participants with high item agreement, acceptance model factor scores were in the 
affirmative range (Table 4.13). This included the factor ‘technical and skin self-examination 
facilitators’ (M=4.1, IQR= 3.9–4.7), ‘social indicators and practicality’ (M=3.8, IQR=3.5– 
4.2), and ‘ease of use’ (M=4.0, IQR=3.7–4.3). The ‘similarity to face-to-face encounter and 
perception of the interaction’ (M=3.2, IQR=3.0–3.6) subscale was closer to neutral.  
Table 4.13 
Four factor model constructs at baseline (n=155) 
  Technical and 
skin self-
examination 
facilitators 
(Factor A) 
Similarity to face-
to-face encounter 
and perception of 
the interaction 
(Factor B)
Social 
indicators and 
practicality 
(Factor C) 
Ease of use 
(Factor D) 
Cronbach Alpha .91 .80 .84 .73 
Mean 4.2 3.3 3.9 4.1 
SD .58 .41 .54 .54 
Median 4.1 3.2 3.8 4.0 
Interquartile range 
(25th – 75th percentile) 
3.9 – 4.7 3.0 – 3.6 3.5 – 4.2 3.7 – 4.3 
*mean and median scores on a scale of 5 strongly agree to 1 strongly disagree 
*Items B7 and B9 were reverse coded for Cronbach alpha only 
 
 
 
Test-retest reliability 
Overall the ICC values of survey time points one and two ranged from 0.41 to 0.83, 
indicating agreement ranged from moderate to almost perfect agreement (Table 4.13). Nine 
items were moderate, 15 items were substantial and one item had almost perfect agreement. 
Table 4.14 
ICC values comparing survey time points one (n=109) and two (n=72) 
Item 
Factor 
ICC 
average ICC 95% CI 
Factor A (Technical and skin self-examination facilitators) 0.745   
A1 I will use MTD if I receive technical assistance when I need it    0.790 (.665-.869) 
A2 I will use MTD if I receive adequate training   0.656 (.449-.785) 
A3 Participating in MTD will be in my best interests   0.757 (.611-.848) 
A4 I will use MTD when it is offered to me  0.840 (.745-.900) 
A5 MTD will improve my skin self-examination performance   0.729 (.567-.830) 
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Item 
Factor 
ICC 
average ICC 95% CI 
A6 MTD will help me to examine my skin more thoroughly   0.663 (.462-.789) 
A7 I would use MTD routinely when I do skin self-examination in the 
future if it was available to me   0.780 (.649-.862) 
Factor B (Similarity to face-to-face encounter and perception of the 
interaction) 0.625   
B1 I will use MTD only if it will save me money   0.500 (.198-.688) 
B2 I will have complete trust in the dermatologist’s diagnosis based on 
a photo I emailed as part of MTD   0.540 (.269-.712) 
B3 I will use MTD only if it  will save me time   0.474 (.156-.672) 
B4 I will rely on the teledermatology process to supply accurate 
information about a mole or spot   0.764 (.622-.852) 
B5 Diagnosis of a suspicious mole or spot made through MTD would 
be clear and easily understandable    0.592 (.348-.744) 
B6 I will be satisfied with the diagnosis by mobile teledermatology 
without talking to the dermatologist in person   0.788 (.662-.867) 
B7 A dermatologist cannot diagnose a skin cancer by mobile 
teledermoscopy as well as they can in person  0.447 (.113-.655) 
B8 The use of this technology does not threaten my privacy or 
confidentiality of my medical data   0.757 (.611-.848) 
B9 I don’t like that there is no physical contact with a health 
professional using mobile teledermoscopy   0.763 (.595-.857) 
Factor C Social indicators and  practicality 0.597   
C1 My doctor will welcome the fact that I use MTD  0.749 (.598-.843) 
C2 Other health professionals (physicians, nurses, other specialists etc.) 
will welcome the fact that I use MTD  0.612 (.378-.758) 
C3 MTD will help to diagnose skin cancer quicker   0.607 (.373-753) 
C4 In general, MTD will be useful to improve diagnosis of skin cancer  0.516 (.223-.698) 
C5 The use of MTD will improve the diagnosis of  spots and moles on 
my skin that look suspicious   0.460 (.135-.663) 
C6 Mobile teledermoscopy will be a standard way of health-care 
delivery in the future   0.635 (.417-.772) 
Factor D Ease of Use 0.543   
D1 I will easily learn how to use MTD  0.746 (.595-.841) 
D2 I will find it easy to acquire the necessary skills to use MTD   0.412 (.056-.633) 
D3 It will be easy to perform MTD  0.471 (.151-670) 
*MTD=mobile teledermoscopy    
 
Ceiling effects 
 
Similar to what was observed in the Smartphone Study, 17/25 (68%) teledermoscopy 
acceptance questionnaire items had ceiling effects. There were better psychometric outcomes 
in the new trust items which were specifically included to be more ‘difficult’ to agree with. 
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Only one of the new items, ‘the use of this technology does not threaten my privacy or the 
confidentiality of my medical data’ showed ceiling effects. 
4.2.4 SATISFACTION WITH USE OF DERMATOSCOPE 
Table 4.15 reports satisfaction with the use of the dermatoscope. Follow-up results were 
available for ten out of eleven participants who trialled the dermatoscope (sensitivity to 
change group). Demographic data of these ten participants were similar to the overall sample. 
Five participants indicated they would be highly confident in taking photos using dermoscopy 
with a top rating of 10 (range 6-10) (scale: 1 not at all confident to 10 highly confident). All 
participants said they would ask for someone to assist them take photos. Potential barriers to 
teledermoscopy included: six participants thought it would be hard to photograph images in 
hard to see locations on the body, and one participant expected difficulties taking a clear and 
close up photo. However, all participants agreed or strongly agreed taking photos was easy 
when they trialled the dermatoscope. They also found the instructions provided on using the 
dermatoscope (using the Handyscope app, taking images and emailing them) to be clear. 
Three participants would find themselves anxious or distressed by taking photos of lesions or 
waiting for the telediagnosis. Nine participants strongly agreed or agreed having the 
dermatoscope would encourage them to examine their skin more regularly. Three participants 
intend to purchase a dermatoscope in the future, six participants were unsure and only one 
person disagreed that they would ever buy a dermatoscope in the future. Participants were not 
provided with a current price range for the dermatoscope. 
Table 4.15 
Satisfaction with dermatoscope after use (n=10) 
Items n (%) 
Taking photos with the dermatoscope 
attachment was easy 
 
     Strongly agree 7 (70) 
     Agree 3 (30) 
     Unsure - 
     Disagree - 
     Strongly disagree - 
The procedures for taking photos were 
clearly explained 
 
     Strongly agree 7 (70) 
     Agree 3 (30) 
     Unsure - 
     Disagree - 
     Strongly disagree 
 
 
 
- 
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Items n (%) 
Using the dermatoscope has motivated me to 
do skin examinations on myself more 
regularly 
 
     Strongly agree 3 (30) 
     Agree 6 (60) 
     Unsure 1 (10) 
     Disagree - 
     Strongly disagree - 
By taking pictures of my spots or moles, I 
would feel distressed, anxious or worried 
about these spots or moles 
 
     Strongly agree 1 (10)
     Agree 2 (20) 
     Unsure 3 (30) 
     Disagree 3 (30)
     Strongly disagree 1 (10) 
I intend to purchase a dermatoscope for 
myself in the future 
 
     Strongly agree 1 (10) 
     Agree 2 (20) 
     Unsure 6 (60)
     Disagree 1 (10) 
     Strongly disagree - 
Conducting a whole body skin examination 
with the dermatoscope would be easy 
 
     Strongly agree 3 (30) 
     Agree 3 (30) 
     Unsure 3 (30) 
     Disagree 1 (10) 
     Strongly disagree - 
I will continue examining my skin in the 
future 
 
     Strongly agree 6 (60) 
     Agree 3 (30) 
     Unsure 1 (10) 
     Disagree - 
     Strongly disagree - 
I will continue examining my skin in the 
future using a dermatoscope 
 
     Strongly agree 2 (20) 
     Agree 4 (40) 
     Unsure 4 (40) 
     Disagree - 
     Strongly disagree - 
 
Sensitivity to change  
Acceptability stayed the same for three factors; technical and skin self-examination 
facilitators, similarity to face-to-face encounter and perception of the interaction, social 
indicators and practicality (Table 4.15). The mean for ‘ease of use’ increased slightly, 
indicating higher agreement after use. 
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Table 4.16 
Acceptability before and after use of dermatoscope (n=10) 
  Technical and 
skin self-
examination 
facilitators  
(Factor A) 
Similarity to 
face-to-face 
encounter and 
perception of 
the interaction 
(Factor B) 
Social 
indicators and 
practicality 
(Factor C) 
Ease of use. 
(Factor D) 
Baseline mean 4.2 3.3 4.2 4.2 
Baseline SD .31 .76 .45 .42 
Follow-up mean 4.2 3.3 4.2 4.3 
Follow-up SD .47 .86 .46 .25 
*1 strongly disagree to 5 strongly agree, reverse coded items t and f. 
 
4.2.5 CONFIRMATORY FACTOR ANALYSIS (CFA): STRUCTURAL MODEL RESULTS 
The hypothesised model 
The hypothesised model is in Figure 4.2. CFA was conducted to test the factor structure of 
the new questionnaire using the four factors identified in the PCA: technical and skin self-
examination (abbreviated SSE in Figure 4.2) facilitators; similarity to face-to-face encounter 
and perception of the interaction; social indicators and practicality; and, ease of use. Factors 
are called ‘latent variables’ in CFA. The four latent variables were assumed to be correlated 
as indicated via the lines in the path diagram in Figure 4.2. Absence of a line connecting 
variables would imply a lack of a hypothesised direct effect. 
  
 
Figure 4.2 Hypothesised model 
 
Technology 
acceptance 
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Assumptions 
The dataset contained responses from 155 respondents in the baseline teledermoscopy 
acceptance questionnaire. There were complete data for 154 participants. One participant was 
missing data for one teledermoscopy acceptance item. This analysis used complete cases only 
(n=154).  
Model Estimation 
As shown in Table 4.17, the results of CFA obtained for the proposed conceptual model in 
the first attempt revealed that χ2/df = 2.6 (p < 0.001), GFI = 0.75, AGFI = 0.70, RMSEA = 
0.10, RMR = 0.07, NFI = 0.69, IFI = .79, TLI = 0.76, and CFI = 0.78. These results indicated 
that some improvement of model fit is required and that the current model did not meet all 
the minimum thresholds for acceptable model’s fit (only χ²/df, met minimum requirements).  
However, the small sample size (n=154) was limiting good model fit. Lei and Wu 2007, state 
the minimum sample size should be no less than n=200 as a general rule (147). In addition, 
the latent variable ease of use, only had three items, and it is optimal to have at least five 
items per factor.  
Table 4.17 
Statistical summary of model fit 
Model goodness of fit indexes Recommended 
value (144) 
Attempt 1  Attempt 2 
Removing items 0.4 or 
less, correlating errors.  
Chi-squared/degree of freedom (χ²/df) ≤ 3 2.6* 1.6* 
Goodness of fit (GFI) ≥  0.90 .75 .86 
Comparative Fit Index (CFI) ≥  0.90 .78 .94* 
Adjusted Goodness of fit Index (AGFI) ≥  0.90 .70 .82 
Normalised Fit Index (NFI) ≥  0.90 .69 .85 
Root Mean Squared Error of Approximation 
(RMSEA) 
≤  0.05 .10 .06 
Tucker-Lewis index (TLI) ≥  0.90 .76 .93* 
Incremental index of fit (IFI) ≥  0.90 .79 .94* 
Root mean square residual (RMR) ≤  0.05 .07 .04* 
*met minimum requirement    
 
Model modifications were performed in an attempt to develop a better fitting model (148). 
Standardised factor loadings in measurement models should fall between 0 and 1 with higher 
values suggesting better indications of the observed variables (teledermoscopy acceptance 
items) for the latent variable (factor). To improve model fit, observed variables that 
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correlated r=0.4 or less with their latent variable were removed. Three out of the four latent 
variables all had their observed variables correlating above 0.4: 
 technical and skin self-examination facilitators,  
 social indicators and practicality and,  
 ease of use.  
The latent variable ‘similarity to face-to-face encounter and perception of the interaction’ had 
four observed variables with a correlation of 0.4 or below including:  
 B1 ‘I will use mobile teledermoscopy if it will save me money,’  
 B3 ‘I will use mobile teledermoscopy if it will save me time,’  
 B7 ‘a dermatologist cannot diagnose a skin cancer by mobile teledermoscopy as 
well as they can in person’ and,  
 B9 ‘I don’t like that there is no physical contact with a health professional using 
mobile teledermoscopy.’ 
The next step involved analysing modification indices. Modification indices suggested 
freeing the covariance between two error terms (Error 3 and Error 2, and Error 15 and error 
14 had large errors) (Table 4.18). 
 
Table 4.18 
Modification Indices 
   
Modification 
Indices 
Parameter 
Change 
e25 <--> ease of use 4.308 .033 
e20 <--> e23 6.467 -.075 
e19 <--> technical and skin self-examination facilitators 4.301 -.053 
e19 <--> e23 4.129 .072 
e17 <--> technical and skin self-examination facilitators 15.062 .087 
e17 <--> similarity to face-to-face encounter and perception of the interaction 7.654 -.090 
e17 <--> e20 6.028 .068 
e17 <--> e19 4.963 -.075 
e15 <--> ease of use 5.013 -.039 
e15 <--> e12 7.174 -.058 
e14 <--> ease of use 7.083 -.046 
e14 <--> e15 54.784 .224 
e11 <--> technical and skin self-examination facilitators 4.403 .040 
e10 <--> e23 5.630 .058 
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Modification 
Indices 
Parameter 
Change 
e10 <--> e14 4.898 -.051 
e8 <--> e25 14.042 .100 
e8 <--> e20 13.355 .097 
e7 <--> e23 8.695 .092 
e6 <--> social indicators and practicality 4.849 -.030 
e6 <--> e7 13.291 .089 
e4 <--> e11 4.302 .043 
e3 <--> e12 5.453 .042 
e3 <--> e7 5.345 -.055 
e3 <--> e5 4.553 -.039 
e3 <--> e4 8.915 -.058 
e2 <--> e7 7.542 -.063 
e2 <--> e5 4.842 -.039 
e2 <--> e4 7.143 -.050 
e2 <--> e3 76.654 .166 
e1 <--> e15 4.739 .051 
e1 <--> e4 8.141 .052 
e1 <--> e3 6.413 -.047 
*large errors in bold. 
 
Once these two errors were correlated and the four above items were removed model fit 
increased (Attempt 2 in Table 4.17 previously). The incremental fit indices CFI, TLI, IFI, 
RMR and χ²/df exceeded the minimum criteria. CFI may be a more reliable indicator for this 
sample as it performs well when sample size is small (148). For example, NFI is very 
sensitive to sample sizes under 200, thus may not be reliable in this sample. The NFI along 
with GFI, AGFI, and RMSEA improved after the model was adjusted (all the absolute 
indices) but were still below the recommended minimum criteria.  
 
The final results for the structural model with the estimated standardised path coefficients 
among the latent and observed variables are presented in Figure 4.3. In the diagram circles 
represent latent variables and rectangles represent observed variables. The abbreviations for 
the observed variables are displayed in Table 4.19. The latent variable ‘technical and skin 
self-examination facilitators’ and ‘social indicators and practicality’ had the highest 
correlation (r=0.76), followed by ‘social indicators and practicality’ and ‘ease of use’ 
(r=0.75). The standardised loadings for the factor correlations ranged from 0.55 to 0.76, with 
higher values indicating better correlations. 
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Figure 4.3 Confirmatory factor analysis path diagram 
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Table 4.19 
The Virtual Skin Check Study mobile teledermoscopy acceptance questionnaire 
Item Abbreviation 
A Technical and skin self-examination facilitators 
I will use mobile teledermoscopy if I receive technical 
assistance when I need it  
A1 
I will use mobile teledermoscopy if I receive adequate training  A2 
Participating in mobile teledermoscopy will be in my best 
interests 
A3 
I will use mobile teledermoscopy when it is offered to me A4 
Mobile teledermoscopy will improve my skin self-examination 
performance 
A5 
Mobile teledermoscopy will help me to examine my skin more 
thoroughly 
A6 
I would use mobile teledermoscopy routinely when I do skin 
self-examination in the future if it was available to me 
A7 
B Similarity of face-to-face encounter and perception of the interaction
I will use mobile teledermoscopy only if it will save me money B1 
I will have complete trust in the dermatologist’s diagnosis 
based on a photo I emailed as part of mobile teledermoscopy 
B2 
I will use mobile teledermoscopy only if it will save me time B3 
I will rely on the teledermatology process to supply accurate 
information about a mole or spot. 
B4 
Diagnosis of a suspicious mole or spot made through mobile 
teledermoscopy would be clear and easily understandable 
B5 
I will be satisfied with the diagnosis by mobile teledermatology 
without talking to the dermatologist in person 
B6 
A dermatologist cannot diagnose a skin cancer by mobile 
teledermoscopy as well as they can in person 
B7 
The use of this technology does not threaten my privacy or 
confidentiality of my medical data 
B8 
I don’t like that there is no physical contact with a health 
professional using mobile teledermoscopy 
B9 
C Social indicators and practicality
My doctor will welcome the fact that I use mobile 
teledermoscopy 
C1 
Other health professionals (physicians, nurses, other specialists 
etc.) will welcome the fact that I use mobile teledermoscopy 
C2 
Mobile teledermoscopy will help to diagnose skin cancer 
quicker 
C3 
In general, mobile teledermoscopy will be useful to improve 
diagnosis of skin cancer  
C4 
The use of mobile teledermoscopy will improve the diagnosis 
of  spots and moles on my skin that look suspicious 
C5 
Mobile teledermoscopy will be a standard way of health-care 
delivery in the future 
C6 
D Ease of use 
I will easily learn how to use mobile teledermoscopy D1 
I will find it easy to acquire the necessary skills to use mobile 
teledermoscopy 
D2 
It will be easy to perform mobile teledermoscopy D3 
 
.
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Chapter 5: Discussion 
5.1 RESEARCH OVERVIEW 
Skin cancer is a major public health issue in Australia. Most melanomas and other skin 
cancers occur on the skin where they can be seen, thus individuals themselves are often the 
first to detect their melanoma (149). Diagnosis of melanoma at an early stage is crucial 
because when melanoma is caught early the patient can often be cured with relatively minor 
surgery (150). Skin self-examination is therefore recommended and it is thought that the 
more regular and thorough an individual conducts skin self-examination, the greater the 
chance of detecting a potentially pre-cancerous skin spot (22). The patient then needs to 
present rapidly for a clinical skin examination by a doctor for treatment. Mobile 
teledermoscopy combines skin self-examination and teledermatology and may therefore 
contribute to the early detection of melanomas by potentially allowing people to quickly 
obtain dermatology advice. This Masters research makes a contribution to existing early 
detection methods for melanoma by assessing acceptance of patient-initiated and performed 
mobile teledermoscopy. Previous research has described the use of mobile teledermoscopy 
mainly conducted in a medical environment whereby nurses or general practitioners take the 
photo for the patient and send the images to a dermatologist for telediagnosis (35, 85, 107); 
little research has investigated acceptability of patient-performed mobile teledermoscopy in 
everyday consumers (41, 88).  
 
A review of the literature revealed mobile teledermoscopy commonly has a good diagnostic 
accuracy when compared to face-to-face clinical consultation (Section 2.2). The rates of 
patient acceptance and satisfaction with store and forward teledermatology, including mobile 
teledermoscopy, varied in the literature; however most studies reported the majority of 
patients were satisfied with use. About a third of participants however commonly preferred 
face-to-face visits with the dermatologist (Section 2.3). The review undertaken on patient 
preferences revealed a greater research focus on patient satisfaction research, compared to 
acceptance. The findings in the literature commonly reveal the extent of satisfaction. 
However there is little research to identify which aspects of telemedicine were satisfactory or  
patients’ general perceptions of the system (136). Acceptance with the broader concept of 
teledermatology has been reported to increase after use, with one study in 2006 finding 63% 
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were comfortable with teledermatology before their experience, compared to 75% afterward 
(100).  
 
Secondary data analysis from the Smartphone Study, investigating consumer acceptance of 
patient-initiated and performed mobile teledermoscopy for melanoma early detection in 
individuals 50-64 years old enabled the first description of consumer acceptance in this 
thesis. This research found that there was high agreement in relation to almost all consumer 
mobile teledermoscopy acceptance items; people thought it likely that it will improve skin 
self-examination, save time and be in their best interests to use it (detailed scores in Section 
4.1.2). The PCA showed that the structure of the Smartphone Study data differed from the 
TAM concepts. Results suggested that participants did not discriminate between all TAM 
elements of acceptance but made judgements based on four broad constructs: technical and 
skin self-examination facilitators; similarity to face-to-face encounter and perception of the 
interaction; social indicators and practicality; and ease of use. Similarity to face-to-face 
encounter was the only factor which consumers rated lower (greater number of respondents 
selecting the unsure category) compared to other factors, indicating that participants were 
uncertain of how well mobile teledermoscopy would replace face-to-face encounters (full 
body skin examination by a doctor). There were some participants in both studies that had not 
had a face-to-face encounter recently. In the Smartphone Study, 23% of participants (n=53) 
had never had a full body skin examination by a doctor. In the Virtual Skin Check Study, 
participants were asked if they had a full body skin examination by a doctor in the last 12 
months, and 56% (n=86) of participants answered ‘no’.  
 
After the initial assessment of reliability of a modified TAM questionnaire in the Smartphone 
Study, a review and critique of patient studies assessing satisfaction and acceptance for 
mobile teledermoscopy was undertaken. During this review, it became evident there was a 
lack of validated and reliable measurement tools in this area of research. To further progress 
the research in this area, a cross-sectional study, the Virtual Skin Check Study, was designed 
and conducted as the final component in this Masters research. It assessed acceptability of 
mobile teledermoscopy in adults 18 years of age and older after creating a revised mobile 
teledermoscopy acceptance questionnaire based on psychometric analysis from the 
Smartphone Study. This second study reported similar high acceptance to the Smartphone 
Study, using the revised 25-item acceptance questionnaire.  
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The continuation of this chapter discusses the enablers and barriers to use of mobile 
teledermoscopy in consumers found in the Smartphone Study and the Virtual Skin Check 
Study compared to existing literature. The use of reliable and valid questionnaires in the 
context of mobile teledermoscopy research is discussed. Finally, the strengths and limitations 
of the study are addressed and recommendations are made for future research directions. 
 
5.2 FACILITATORS AND BARRIERS TO USE 
The first research question sought to find the facilitators and barriers to patient-initiated and 
performed mobile teledermoscopy that determines acceptance in consumers. This following 
section details the facilitators and barriers to use. 
 
Facilitators to use 
Rural Australians, those with mobility limitations, or under time pressure have the most to 
gain from mobile teledermoscopy. In a study comparing patient satisfaction with 
teledermatology in rural versus urban areas, teledermatology conducted in rural areas found 
patients rated the level of service, accessibility and overall satisfaction higher than did urban 
patients (151). This present research was completed in an urban population who by necessity 
can also benefit from time-savings, and the potential for a quick response and diagnosis, as 
the technology allows instant retrieval once sent. In the Virtual Skin Check Study participants 
who worked full-time were significantly more likely to agree with the items relating to time 
savings and convenience (Section 4.2.2). In one pilot study on store and forward 
teledermatology using mobile phones, the teledermatologist could have diagnosed 53% to 
59% of cases without the need for in-person visits, saving at least half of the patients time and 
travel and allowing the practitioner more time to deal with those cases requiring further 
review, diagnosis and treatment (152).  
 
Potential for cost savings was a further motivator to teledermoscopy use in this research, 
(68% of participants agreed they would use mobile teledermoscopy if it saved them money in 
the Smartphone Study, and 46% in the Virtual Skin Check Study). The higher acceptance in 
the Smartphone Study likely reflects the importance this high risk population of 50-64 year 
olds place on skin cancer prevention. Mobile phones are already well integrated into most 
people’s lives, with many people owning a Smartphone with a built-in camera, and therefore 
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they already have available part of the equipment needed to conduct mobile teledermoscopy. 
They would only be required to purchase or borrow a dermatoscope. In 2012, the World 
Bank estimated that 75% of the world’s population had access to a mobile phone, up from 
60% just three years earlier and transmission networks are doubling their bandwidth every 
1.5 years (153). Mobile phone access is also higher in populations with a low socioeconomic 
status compared to computer technology (154). Cost and technical support were found to 
contribute highly to user acceptance of telemedicine in a qualitative European study about 
home telemedicine adoption in adults 55-75 years of age (155). Similarly, the Smartphone 
Study also assessed an older age demographic, and a main facilitating motivator was 
technical support. Younger patients may have fewer technological issues, and may be more 
inclined to accept a mobile diagnosis, given their greater likelihood to also conduct other 
aspects of their daily life online. A pilot study asked 19 high school students (mean age 18 
years) to take dermoscopic and anatomical images of skin lesions on patient-actors in a 
supervised setting but without instruction or demonstration (106). The majority of students 
(79%) reported the imaging process as “very easy” or “easy” (106). Sixty-six per cent of 
images were in focus. Some participants did not place the dermatoscope directly on the skin 
resulting in out of focus images and future studies may benefit from instructions that 
emphasise the dermatoscope lens must touch the skin (106). Research however shows that the 
younger demographic (16-30 years of age) are less likely to perform skin self-examination 
alone compared to older populations (156) and it needs to be ascertained in a larger 
population-based study whether adding the possibility of getting teledermoscopy feedback 
from dermatologists would increase their skin self-examination performance. Demographics 
more likely to conduct skin self-examination include patients who are more prone to worry, 
at high risk of developing melanoma (31), and those who practice regular sun protection 
(156). The roll out of mobile teledermoscopy for melanoma screening would likely target 
these groups. 
 
Barriers to use 
Despite the advantages of mobile teledermoscopy it still has not become widely available. 
Some of the concerns raised in the literature around teledermatology which also apply to 
teledermoscopy include patient privacy, loss of physician-patient relationship, and patient 
ability to select medically concerning lesions for imaging (14). Putting this technology in the 
hands of the consumer raises the concern over an individual's ability to detect atypical moles 
and that it may provide a false sense of security. Most participants were satisfied with the AC 
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rule to detect a melanoma in this research however no randomised clinical trial in the home 
environment has been performed to demonstrate that using the AC criteria or the earlier 
ABCDE criteria (Asymmetry, Border, Colour, Diameter, and Evolving) improves the ability 
of laypersons to detect melanoma (157). Evidence for the value of the AC rule comes from an 
image-based study which found that laypersons, educated with the AC rule, were able to 
improve their sensitivity for spotting melanomas on dermoscopic images, compared to 
clinical photographs or naked eye examinations alone (158). These results indicate that 
teledermoscopy may improve skin self-examination. A wide scale rollout of this technology 
would need to be accompanied by improved ‘how to spot a melanoma’ awareness campaigns 
among the general population. There were mixed responses in the Smartphone Study when 
participants were asked to rate their agreement with the statement ‘I am confident that I can 
detect abnormalities in moles or spots I find’ (34% agreed, 46% were unsure and 20% 
disagreed). In the Virtual Skin Check Study, participant responses were again mixed with the 
same statement (39% agreed, 38% unsure, 23% disagree). In a previous study, women felt 
they “definitely” knew or “had some idea” of what skin changes to look for compared to men 
(p = 0.0002) (156). This is consistent with women being more likely to find their own, and 
the melanomas of their partners (149). More research is needed to evaluate the impact of 
educating laypersons about how to conduct skin self-examination and identify a potential 
melanoma. Daniel and colleagues (2015) described the study protocol of a RCT designed to 
educate survivors of childhood cancer about the importance of skin self-examination and how 
to detect a skin cancer (159). Individuals that undergo radiation treatment for cancer are at an 
increased risk of skin cancer (159). Patient recruitment has yet to be commenced at time of 
publication (159). The intervention arms will include a combination of: educational print 
materials; a website with a unique log-in including instructional skin self-examination videos 
and images of abnormal lesions; and texts messages designed to prompt use of the website 
and target skin self-examination behaviours. In addition to the educational materials some 
participants will be provided with a dermatoscope and encouraged to image suspect lesions to 
send to a dermatologist. If these educational trials are successful they could be expanded to 
the general population. 
 
Our study was consistent with the study by Wu et al. which summarised patient receptivity of 
teledermoscopy for short-term monitoring of pigmented lesions (88). Wu et al. found there 
were concerns reported by some patients regarding the reliability of telediagnosis from the 
teledermatologist. In this Masters research in both studies, trust items that assessed the 
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similarity to the face-to-face encounter were the only items that had a lower agreement level 
compared to other items, with participants mainly reporting neutral viewpoints. The need for 
a face-to-face consultation may always remain for some patients, for example those at very 
high risk with many moles who require regular dermatologist check-ups. Part of this concern 
about trust could be alleviated if the patient had an established relationship or had direct 
access to the dermatologist, for example through an electronic conversation. Participants in 
this research were not provided with information on the accuracy of mobile teledermoscopy 
or made aware of any previous diagnostic accuracy clinical trials conducted. Providing this 
information, along with a description of the dermatologist detailing their accreditations and 
experience, could improve consumer trust in the diagnosis. Patients may prefer that they are 
conducting mobile teledermoscopy not to reach a clear-cut, definitive diagnosis but for the 
dermatologist to make a decision if the patient needs to be seen face-to-face (160). Lower 
trust in the diagnosis of store and forward teledermatology compared to in-person 
consultations is a trend similarly reported in the literature, with 38-40% of patients agreeing 
they would prefer to visit a dermatologist in person (68, 95), particularly patients with poor 
quality of life (95). In this research, most patients rated their current health status as either 
excellent, very good or good (Smartphone Study: 92%, Virtual Skin Check Study: 94%) 
which may have contributed to the high acceptance observed. In one previous study, 
teledermatology patients reported dissatisfaction with wait time of the results of their 
teledermatology consult; with 20% rating the response time as only fair or poor (97). 
Previous research found participants would prefer to receive their results after conducting 
mobile teledermoscopy “up to 1 day” later (161).  Provision of results would need to be 
streamlined to provide a prompt service with quick follow-up.  
 
Perception of facilitators and barriers after use 
The ten participants in this research who were shown the dermatoscope reported high self-
confidence in their ability to use the mobile dermatoscope. The second research question in 
this Masters work asked ‘Do perceptions of mobile teledermoscopy change after use?’ 
Acceptability increased after use for the subscale ‘ease of use’ only. All ten participants 
‘agreed’ or ‘strongly agreed’ taking photos was easy when they trialled the dermatoscope and 
instructions were clear. Potential barriers to dermoscopy after use included: 60% of 
participants thought it would be hard to photograph images in some locations on the body 
such as the back of the legs, and one participant expected difficulties taking a clear and close 
up photo themselves. There may be some instances that are not appropriate for mobile 
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teledermoscopy such as full body skin self-examinations where a person has numerous 
dysplastic naevi, or lesions in hair-bearing areas, and no access to another person who could 
assist with photo taking. Patients may also be unwilling to send photos of lesions in sensitive 
areas, although anecdotal evidence from teledermatologists suggests otherwise. In the Virtual 
Skin Check Study people who were married or living together were more likely to agree with 
items relating to mobile teledermoscopy improving skin self-examination performance, 
compared to people who did not live with a partner (p=0.01). This could be because people 
may need assistance with taking photos in hard to see areas. Further barriers not ascertained 
in this research may exist and subsequent studies should aim to incorporate a qualitative 
component to elucidate these. The present study did not include such a component, which is 
one of its limitations, and instead relied on participants’ response to questionnaires. It did 
however contribute to the evidence by focussing on the psychometric properties of the 
questionnaire, which has rarely been done in this field of research in the past.   
 
5.3 VALID AND RELIABLE QUESTIONNAIRES 
The third research question in this Master’s work asked “What are the psychometric 
properties of the mobile teledermoscopy acceptance questionnaire used in the Smartphone 
Study and the Virtual Skin Check Study?” The most common way to measure satisfaction 
with healthcare more broadly is by self-administered surveys. Recent literature reviews have 
found that firm conclusions about patient satisfaction or acceptance with store and forward 
teledermatology are difficult to reach because of methodological difficulties and poor 
research designs (35, 107). This is also the case in other telemedicine studies as noted in a 
previous review. Most reports of telemedicine satisfaction do not include information on the 
reliability and validity of the questionnaire used to measure satisfaction (162). Many 
manuscripts are being published in journals without reporting their questionnaire design 
processes, and researchers are acknowledging the lack of a validated or reliable instrument as 
a limitation of the study, despite there being a wealth of guidance in the health literature 
about how to design a valid and reliable questionnaire (133, 137, 163). When developing an 
instrument researchers need to reduce the measurement error (random or systematic) by 
testing and refining the instrument using preplanned methods. Reducing the measurement 
error and increasing the reliability of an instrument will increase the repeatability of the 
questionnaire and enable the detection of existing patterns and relationships between items 
(136). Failure to do so may lead to difficulty interpreting results. This thesis presented an 
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introduction to the evaluation of a questionnaire and the questionnaire development process. 
Both the Smartphone Study and the Virtual Skin Check study indicated they could be a 
reliable and valid instrument (high Cronbach alpha, split-half reliability, and tested for face, 
content and convergent validity). The Virtual Skin Check study indicated it had moderate to 
perfect agreement in the test-retest. 
 
In this review of patient preferences for mobile teledermoscopy (Section 2.3) of the 18 
manuscripts found, only three had used a validated or reliable measurement instrument, and 
measurement items ranged from one single response item to a scale of 51 items. Multi-item 
scales are generally used in preference to single-item scales to avoid bias, misinterpretation 
and reduce measurement error (137). A questionnaire that relies upon a single-item response 
is unlikely to accurately measure all aspects of a person’s acceptance. Among the studies 
reviewed in Section 2.3, a variation of the PSQ-III was the most common validated 
questionnaire used in three studies. The PSQ-III is a 50-item survey that uses a 5-point 
agreement Likert scale that assesses satisfaction with six aspects of traditional medical care: 
technical quality, interpersonal manner, communication, financial aspects of care, time spent 
with doctor, and accessibility of care. However, the PSQ-III was created in 1987 prior to 
telemedicine technology introduction, thus the items may not adequately address all factors 
of acceptance for use of modern telemedicine technology. ‘Time spent with doctor’ and 
‘interpersonal manner’ are subscales that would need to be changed to assess the remote 
characteristics of telemedicine. The authors who used the PSQ-III in telemedicine studies had 
to add additional questions from elsewhere to cover the unique concepts of telemedicine (68), 
and do not always establish the measurement properties of these new items.    
 
A small number of telemedicine studies (not store and forward teledermatology) have 
assessed psychometric qualities of their questionnaires. Demiris and colleagues provided 
evidence for the internal consistency and test-retest reliability and validity (face, content, and 
construct) of the 20-item Telemedicine Perception Questionnaire (136) for videoconferencing 
technology. For the Virtual Skin Check Study, five items from this questionnaire (four items 
on similarity to face-to-face encounter and one item on usefulness that were not covered in 
the Smartphone Study) were adapted for the Virtual Skin Check Study.  The Telemedicine 
Perception Questionnaire was not adapted in full for this research because the other items did 
not cover store and forward technology components or were already addressed in the 
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Smartphone Study questionnaire. Yip et al. developed the ten-item Telemedicine Satisfaction 
Survey and explored its construct validity through factor analysis (164). The items in the Yip 
et al. questionnaire were tailored for videoconferencing more specifically, and the items were 
less relevant to the store and forward process than the items by Demiris et al. Another study, 
the IDEATel study compared telemedicine with face-to-face care in older patients with 
diabetes mellitus using the Telemedicine Satisfaction and Usefulness Questionnaire and 
conducted reliability (factor analysis, internal consistency, Cronbach alpha) and validity (face 
and content) testing. This questionnaire was based on the Telemedicine Perception 
Questionnaire by Demiris et al, thus the original items created by Demiris and colleagues 
were adapted for use in this research. The methodology and findings of the psychometric 
analysis reported in this research adds to the range of questionnaires with known 
psychometric properties that can be used in future teledermatology research.  
 
5.4 STRENGTHS 
To the researcher’s knowledge, the Smartphone Study and the Virtual Skin Check Study are 
the first studies to assess the enablers and barriers involved in this patient-oriented process 
where patients take the initiative to select and photograph skin lesions themselves. This study 
is unique in that it a) uses mobile teledermoscopy which involves a more intricate image 
acquisition  process than in teledermatology allowing higher image quality, and b) most 
previous research has been conducted in health professional settings.  Patient-initiated and 
performed teledermoscopy allows the patient to communicate directly with the dermatologist, 
removing the GP as the intermediary. This study could be a useful foundation for exploring 
the implementation of patient-initiated and performed telemedicine systems and why patients 
would or would not use it in Australia more widely and what needs to be considered to make 
a digital health care system successful. Studies that develop and validate acceptance or 
satisfaction instruments will be important in advancing the current status of telemedicine 
research, and are an important prerequisite to validate results of RCTs. It would not be useful 
or cost-efficient to conduct clinical trials or RCTs on telemedicine services if acceptability by 
the target population is not first established. Research such as this may be useful as a starting 
point for the development of questionnaires and acknowledging the importance of formal 
instrument development and validation based on a well-designed process. 
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5.5 LIMITATIONS 
Several limitations of this study must be noted. This study measured intention to use instead 
of actual usage of mobile teledermoscopy. Bagozzi (2007) questioned the intention to use and 
actual usage construct link and observed that the time period between intention and actual use 
could be full of uncertainties that might influence a person’s decision to adapt a technology 
(165). Intention to use mobile teledermoscopy rather than actual adoption of mobile 
teledermoscopy was assessed for the following reasons: Firstly, owing to the strong causal 
link between behavioural intention and actual behaviour in most previous research, use of 
behavioural intention as the dependent variable is not a serious limitation. It is part of the 
theoretical framework of many psychological behavioural theories, and has been shown to be 
strongly linked in previous studies (166, 167). Secondly, it has been argued that actual use 
can be replaced by intention to use when the technology is still undergoing development, 
currently has very few users, and when the research aims are stated to predict intention to use 
(109). Mobile teledermoscopy use in Australia to date has been limited to health 
professionals taking the photos, and it is not currently set up for consumers to use outside of 
experimental studies. Further limitations in this research include generalisability of the results 
and measurement quality, which are discussed below. 
 
5.5.1 GENERALISABILITY 
The Smartphone Study sample was recruited from the QSkin study (126), and participants 
were specifically selected to have at least one major risk factor for melanoma including 
previous skin cancer excisions, a family history or susceptible phenotype. This population 
was at high-risk for skin cancer thus may be more motivated in skin cancer early detection 
via mobile teledermoscopy than the general population, limiting generalisability. This 
population is likely more interested in incorporating new technologies into their care for 
conditions that directly affect them. However, implementation of teledermoscopy would also 
likely focus on high-risk groups once it is rolled out and it therefore appeared to be an 
appropriate population for the research questions. Both samples were very highly educated 
(University degree or diploma: the Smartphone Study 69%, the Virtual Skin Check Study: 
89%), compared to the general population. OECD data shows that in Australia in 2012, 41% 
of 25-64 year olds had attained this level of tertiary education (168). The present study was 
furthermore biased towards consumers who were willing and able to complete the survey. 
Self-selection bias affects all research that allows respondents to decide if they want to 
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participate. The Virtual Skin Check Study used convenience sampling in the university and at 
two workplaces, which may mean that data collected is likely not representative of the 
general population, thus placing limitations on the generalisability of results. Further research 
should use a probability sampling technique and assess non-response bias to make findings 
more generalisable to the general population. 
 
5.5.2 MEASUREMENT QUALITY 
Items in the mobile teledermoscopy acceptance questionnaire were measured using a five-
point Likert scale. A seven-point Likert scale may have been more successful in preventing 
respondents' reluctance towards selecting neutral values and leading to the high ceiling 
effects. Demiris recommends the use of a five-point Likert scale with agree and disagree 
labels for response scale design (169).  However, the five-point Likert scale may not be most 
appropriate for measuring improvements in acceptance in patients who are already well 
accepting, as was demonstrated in this sample. Masino and Lam (2014) found loading the 
rating scale with more positive ratings appears to be a useful strategy for reducing ceiling 
effects (170). Most items, excluding one, were phrased positively in the Smartphone Study. 
Phrasing the items both negatively and positively will also prevent a ‘halo’ effect, where 
respondents have an overall attitude towards the statements and do not read the statements 
carefully. Questions that are phrased negatively can also prevent response acquiescence, 
defined as the tendency to agree rather than disagree or to just keep ticking the same number.  
 
5.6 FUTURE RESEARCH DIRECTIONS 
There is no stringent rule to determine acceptable levels of reliability and validity. A 
questionnaire can be continuously tested according to the stage of its development and the 
questionnaires intended use (136). Final questionnaire testing procedures are based on the 
compromise of having a reasonable small number of items and keeping reliability and 
validity at acceptable levels (136). This work is the preliminary stage in assessment of patient 
acceptability of mobile teledermoscopy. This work is the initial development and pilot testing 
of an acceptability questionnaire to assess consumer views and future work is needed to 
further revise it. 
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In this research, the CFA suggested the model was not a good fit in its current form. A good 
fit means that the hypothesised model provides a good account for the actual relationships in 
the dataset, however good fit does not mean that the model is “correct”, only that it is 
plausible. Further adaptation to the model is required. The next steps are to make further 
changes by refining items that had low standardised factor loadings or adding further factors 
in the CFA, and then use the questionnaire in a larger, more generalised population. The 
items to be added would be to factors that had below the recommended number of well 
performing items. These additional items could be adapted from existing questionnaires, or 
could be designed through qualitative research with end users. Further research to improve 
construct validity would include interviewing clinicians and patients to ensure all aspects of 
acceptability are included and adding any items as needed based on the literature.  More work 
is also needed to show the responsiveness of the questionnaire to change (testing the 
questionnaire before use of mobile teledermoscopy and after use to assess if the score 
changes). When conducting the survey in a new sample, it would be beneficial to include a 
statement about the accuracy of mobile teledermoscopy at the beginning, to make it clear that 
clinical trials have been conducted previously with good results, and this may increase patient 
trust.  
 
This present research was conducted in an urban population in a developed country.  It would 
be beneficial to assess acceptance of mobile teledermoscopy in a rural or remote Australian 
population, where the distance to travel to see a specialist is far. There may also be numerous 
benefits to using teledermatology systems in developing countries (171). Teledermatology 
could assist in bridging the gap in these resource poor areas that lack available specialists, not 
only for skin cancer which is potentially less common in these areas, but for a variety of skin 
conditions. The International Foundation for Dermatology estimates that three billion people 
living in 345 developing countries lack basic care for skin diseases (172).  Acceptability in 
developing or semi-developed countries may vary due to cultural differences, as was reported 
in a pilot study of ten participants where some females refused to be photographed (104). The 
acceptance questionnaire would need to be adapted to include this added ‘cultural’ 
dimension, and would likely be targeted towards their health professionals. Assessing 
acceptance of Australian GP’s or dermatologists views of mobile teledermoscopy is also 
important. Health professionals would have different motivations towards acceptance such as 
workload, use as an educational tool and financial reimbursements. Health systems are 
financially driven and further cost-effectiveness studies on mobile teledermoscopy for 
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melanoma screening are required before it is implemented as a population-based screening 
tool. 
 
5.7 CONCLUSIONS 
The delivery of health care is being transformed by advances in telemedicine and by a 
technology-literate consumer population. However, telemedicine systems developed for 
consumers to initiate and perform, not the health professional, remain at the early stages of 
development. It is not yet known whether telemedicine will fill only a unique function in the 
health system, such as allowing medical access for populations living in rural or remote areas 
(78). Or, alternatively, whether telemedicine can be integrated with in-person services and 
accepted as a necessary component of the mainstream healthcare system for both those in the 
general population and those who are isolated due to distance (78). As technology continues 
to advance, an inevitable growth in telemedicine systems is expected to occur. Patient-
initiated and performed mobile teledermoscopy systems would allow more personal 
investments in health care for screening and self-monitoring of lesions for melanoma (173). 
Aside from the Smartphone Study and Virtual Skin Check Study no previous research has 
investigated the acceptability of mobile teledermoscopy initiated and performed by the 
consumer. Most of the participants in this research have not used mobile teledermoscopy 
before, yet are accepting of the new technology. The current research added to the evidence 
base for guiding implementation of the technology. A conclusion regarding the health 
behavior theory and model fit is preliminary only due to limitations found in the factor 
analysis. There were some challenges found in this research to bring mobile teledermoscopy 
to successful implementation, such as patient trust. However, mobile teledermoscopy for skin 
cancer screening could provide a reliable and time efficient solution for remote diagnosis of 
skin cancer.  
 References 115 
References 
1. Sinclair C, Foley P. Skin cancer prevention in Australia. Br J Dermatol. 
2009;161(s3):116-23. 
2. Eide M, Weinstock M. Epidemiology of skin cancer, In Cancer in the skin. Rigel D, 
Friedman R, Dzubow L, Reintgen D, Bystryn J, Marks R, Editors. 2011, Elseveir 
Saunders: Philadelphia, PA. p. 44-55. 
3. Australian Institute of Health and Welfare (AIHW), Australasian Association of 
Cancer Registries. Cancer in Australia: an overview 2012. 2013  [cited 2014 April 
24]. Available from: http://www.aihw.gov.au/publication-detail/?id=60129542359 
4. Australian Institute of Health and Welfare. Cancer in Australia 2012: an overview. 
Cancer series no. 74. Cat. no. CAN 70. 2012.  
5. Australian Institute of Health and Welfare (AIHW). Australian Cancer Incidence and 
Mortality (ACIM) 2014 [cited 2014 April 24]. Available from: 
http://www.aihw.gov.au/acim-books 
6. Australian Institute of Health and Welfare (AIHW). Submission into the House of 
Representative inquiry into skin cancer in Australia, Canberra. 2014.  
7. Parliament of Australia. House health committee to inquire into skin cancer. 2014  
[cited 2015 May 4]. Available from: http://www.aph.gov.au/Parliamentary_Business/ 
Committees/House/Health/Skin_Cancer/Media_Releases 
8. SunSmart Victoria. Risk Factors: People at higher risk of skin cancer. 2015  [cited 
2014 April 24]. Available from: http://www.sunsmart.com.au/skin-cancer/risk-factors 
9. KPMG, Melanoma Patients Australia. Advanced Melanoma – The real cost of 
Australia’s national cancer 2014  [cited 2015 May 13]. Available from: 
http://www.melanomapatients.org.au/wp-content/uploads/MPA_the_real_cost.pdf 
10. Fransen M, Karahalios A, Sharma N, et al. Non-melanoma skin cancer in Australia. 
Med J Aust. 2012;197(10):565-8. 
11. Kaufman HL. The Melanoma Book: A Complete Guide to Prevention and Treatment, 
Including the Early Detection Self-Exam Body Map. 2005, New York, USA: Gotham 
Books. 
12. Melanoma Patients Australia. A guide to understanding melanoma: a starting point for 
people in their journey of melanoma. 2015  [cited 2015 June 29]. Available from: 
http://www.melanomapatients.org.au/wpcontent/uploads/pdf/MPA%20A%20Guide%
20to%20Melanoma_proof%2023072012%20FINAL.pdf 
13. Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, et al. Ocular melanoma: an overview 
of the current status. Int J Clin Exp Pathol. 2013;6(7):1230-44. 
14. Wurm EMT, Soyer HP, Smith AC. Introduction to Teledermatology, In Telemedicine 
in Dermatology. Soyer HP, Wurm EMT, Binder M, Smith AC, Editors. 2011, 
Springer-Verlag Berlin Heidelberg: Dordrecht. p. 1-7. 
 116 References 
15. King AJ, Gehl RW, Grossman D, et al. Skin self-examinations and visual 
identification of atypical nevi: comparing individual and crowdsourcing approaches. 
Cancer Epidemiol. 2013;37(6):979-84. 
16. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9-
29. 
17. Yagerman S, Marghoob A. Melanoma patient self-detection: A review of efficacy of 
the skin self-examination and patient-directed educational efforts. Expert Rev 
Anticancer Ther. 2013;13(12):1423-31. 
18. Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics 
and associations of rapidly growing melanomas. Arch Dermatol. 2006;142(12):1551-
8. 
19. Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and 
treatment in the 21st century. CA Cancer J Clin. 2000;50(4):215-36; quiz 37-40. 
20. Australian Government Department of Health. Population based screening 
framework. 2015  [cited 2015 May 13]. Available from: 
http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/populati
on-based-screening-framework 
21. Katalinic A, Waldmann A, Weinstock MA, et al. Does skin cancer screening save 
lives? Cancer. 2012;118(21):5395-402. 
22. Cancer Council Australia. National Cancer Prevention Policy. 2013  [cited 2015 
January 5]. Available from: http://www.cancer.org.au/policy-andadvocacy/prevention 
-policy/national-cancer-prevention-policy.html 
23. American Cancer Society. Skin cancer prevention and early detection. 2013 [cited 
2014 March 23]. Available from: http://www.cancer.org/cancer/cancercauses/ 
sunanduvexposure/skincancerpreventionandearlydetection/skin-cancer-prevention-
and-early-detection-toc.  
24. Kasparian NA, McLoone JK, Meiser B, et al. Skin cancer screening behaviours 
among individuals with a strong family history of malignant melanoma. Br J Cancer. 
2010;103(10):1502-9. 
25. Robinson JK, Stapleton J, Turrisi R. Relationship and partner moderator variables 
increase self-efficacy of performing skin self-examination. J Am Acad Dermatol. 
2008;58(5):755-62. 
26. Hamidi R, Cockburn MG, Peng DH. Prevalence and predictors of skin self‐
examination: prospects for melanoma prevention and early detection. Int J Dermatol. 
2008;47(10):993-1003. 
27. Carli P, De Giorgi V, Nardini P, et al. Melanoma detection rate and concordance 
between self-skin examination and clinical evaluation in patients attending a 
pigmented lesion clinic in Italy. Br J Dermatol. 2002;146(2):261-6. 
28. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from 
melanoma. J Natl Cancer Inst. 2005;97(3):195-9. 
29. Pollitt RA, Geller AC, Brooks DR, et al. Efficacy of skin self-examination practices 
for early melanoma detection. Cancer Epidemiol Biomarkers Prev. 2009;18(11):3018-
23. 
 References 117 
30. Baade PD, Youl PH, English DR, et al. Clinical pathways to diagnose melanoma: a 
population-based study. Melanoma Res. 2007;17(4):243-9. 
31. Kasparian NA, Bränström R, Chang Y, et al. Skin examination behavior: The role of 
melanoma history, skin type, psychosocial factors, and region of residence in 
determining clinical and self-conducted skin examination. Arch Dermatol. 
2012;148(10):1142-51. 
32. Martin RA, Weinstock MA, Risica PM, et al. Factors associated with thorough skin 
self-examination for the early detection of melanoma. J Eur Acad Dermatol Venereol. 
2007;21(8):1074-81. 
33. World Health Organisation (WHO). Telemedicine: opportunities and developments in 
Member States: report on the second global survey on eHealth 2009. 2010  [cited 
2015 April 5]. Available from: http://www.who.int/goe/publications/goe_telemedicine 
_2010.pdf 
34. Wurm EMT, Soyer HP. Mobile teledermatology, In Telemedicine in Dermatology. 
Soyer HP, Wurm EMT, Binder M, Smith AC, Editors. 2011, Springer-Verlag Berlin 
Heidelberg: Dordrecht. p. 79-85. 
35. Warshaw EM, Hillman YJ, Greer NL, et al. Teledermatology for diagnosis and 
management of skin conditions: a systematic review. J Am Acad Dermatol. 
2011;64(4):759-72. 
36. Massone C, Hofmann-Wellenhof R, Ahlgrimm-Siess V, et al. Melanoma screening 
with cellular phones. Plos One. 2007;2(5):e483-e. 
37. Rosendahl C, Cameron A, McColl I, et al. Dermatoscopy in routine practice - 'chaos 
and clues'. Aust Fam Physician. 2012;41(7):482-7. 
38. Benvenuto-Andrade C, Dusza SW, Agero AL, et al. Differences between polarized 
light dermoscopy and immersion contact dermoscopy for the evaluation of skin 
lesions. Arch Dermatol. 2007;143(3):329-38. 
39. Janda M, Loescher LJ, Banan P, et al. Lesion Selection by Melanoma High-Risk 
Consumers During Skin Self-examination Using Mobile Teledermoscopy. JAMA 
Dermatol. 2014;150(6):658-8. 
40. Janda M, Loescher LJ, Soyer HP. Enhanced skin self-examination: A novel approach 
to skin cancer monitoring and follow-up. JAMA Dermatol. 2013;149(2):231-6. 
41. Manahan MN, Soyer HP, Loescher LJ, et al. A pilot trial of mobile, patient-performed 
teledermoscopy. Brit J Dermatol. 2015;172(4):1072-80. 
42. Goulart JM, Malvehy J, Puig S, et al. Dermoscopy in skin self-examination: A useful 
tool for select patients. Arch Dermatol. 2011;147(1):53-8. 
43. Tan E, Yung A, Jameson M, et al. Successful triage of patients referred to a skin 
lesion clinic using teledermoscopy (IMAGE IT trial). Brit J Dermatol. 
2010;162(4):803-11. 
44. Chadwick X, Loescher LJ, Janda M, et al. Mobile Medical Applications for 
Melanoma Risk Assessment: False Assurance or Valuable Tool? System Sciences 
(HICSS). Proceedings for the 47th Hawaii International Conference. 2014. p. 2675-84. 
45. Wolf JA, Moreau JF, Akilov O, et al. Diagnostic inaccuracy of smartphone 
applications for melanoma detection. JAMA Dermatol. 2013;149(4):422-6. 
 118 References 
46. Perednia DA, Brown NA. Teledermatology: one application of telemedicine. Bull 
Med Libr Assoc. 1995;83(1):42-7. 
47. Murphy RL Jr, Fitzpatrick TB, Haynes HA, et al. Accuracy of dermatologic diagnosis 
by television. Arch Dermatol. 1972;105(6):833-5. 
48. Pak HS, Edison KE, Whited JD, Teledermatology: A Practical Manual. 2008 
Cambridge, UK: Cambridge University Press. 
49. Levin YS, Warshaw EM. Teledermatology: a review of reliability and accuracy of 
diagnosis and management. Dermatol Clin. 2009;27(2):163-76. 
50. Zelickson BD, Homan L. Teledermatology in the nursing home. Arch Dermatol. 
1997;133(2):171-4. 
51. Provost N, Kopf AW, Rabinovitz HS, et al. Comparison of conventional photographs 
and telephonically transmitted compressed digitized images of melanomas and 
dysplastic nevi. Dermatology (Basel, Switzerland). 1998;196(3):299-304. 
52. Lamel SA, Haldeman KM, Ely H, et al. Application of mobile teledermatology for 
skin cancer screening. J Am Acad Dermatol. 2012;67(4):576-81. 
53. Kroemer S, Frühauf J, Campbell TM, et al. Mobile teledermatology for skin tumour 
screening: diagnostic accuracy of clinical and dermoscopic image tele-evaluation 
using cellular phones. Brit J Dermatol. 2011;164(5):973-9. 
54. Frühauf J, Schwantzer G, Ambros-Rudolph CM, et al. Pilot study using 
teledermatology to manage high-need patients with psoriasis. Arch Dermatol. 
2010;146(2):200-1. 
55. Massone C, Maak D, Hofmann-Wellenhof R, et al. Teledermatology for skin cancer 
prevention: an experience on 690 Austrian patients. J Eur Acad Dermatol Venereol. 
2013;28(8):1103-8. 
56. Zarchi K, Haugaard VB, Dufour DN, et al. Expert advice provided through 
telemedicine improves healing of chronic wounds: prospective cluster controlled 
study. J Invest Dermatol. 2015;135(3):895-900. 
57. Frühauf J, Kröck S, Quehenberger F, et al. Mobile teledermatology helping patients 
control high-need acne: a randomized controlled trial. J Eur Acad Dermatol Venereol. 
2015;29(5):919-24. 
58. Frühauf J, Schwantzer G, Ambros‐Rudolph CM, et al. Pilot study on the acceptance 
of mobile teledermatology for the home monitoring of high‐need patients with 
psoriasis. Australas J Dermatol. 2012;53(1):41-6. 
59. Sabesan S, Piliouras P. Disparity in cancer survival between urban and rural patients--
how can clinicians help reduce it? Rural Remote Health 2009;9(3):1146. 
60. Jong KE, Vale PJ, Armstrong BK. Rural inequalities in cancer care and outcome. 
Med J Aust. 2005;182(1):13. 
61. Australian Bureau of Statistics (ABS). 4102.0 - Australian Social Trends, April 2013, 
Doctors and Nurses. 2013  [cited 2014 April 13]. Available from: 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Main+Features20April+
2013#p6 
62. Muir J, Lucas L. Telederm Australia, In Telemedicine in Dermatology. Soyer HP, 
Wurm EMT, Binder M, Smith AC, Editors. 2011, Springer-Verlag Berlin Heidelberg: 
Dordrecht. p. 23-31. 
 References 119 
63. Australian Institute of Health and Welfare (AIHW). Cancer Survival and Prevalence 
in Australia: Cancers Diagnosed from 1982 to 2004. Cat. no. CAN38, Canberra 2008.  
64. Datta SK, Buchanan AH, Hollowell GP, et al. Telemedicine vs in-person cancer 
genetic counseling: measuring satisfaction and conducting economic analysis. J Comp 
Eff Res. 2011;2011:43-50. 
65. Sabesan S, Larkins S, Evans R, et al. Telemedicine for rural cancer care in North 
Queensland: Bringing cancer care home. Aust J Rural Health. 2012;20(5):259-64. 
66. Muir J, Xu C, Soyer HP. Skin Emergency Telemedicine, In Telemedicine in 
Dermatology. Soyer HP, Wurm E, Binder M, Smith A, Editors. 2011, Springer-
Verlag Berlin Heidelberg: Dordrecht. 
67. Lim D, Oakley AMM, Rademaker M. Better, sooner, more convenient: A successful 
teledermoscopy service. Australas J Dermatol. 2012;53(1):22-5. 
68. Collins K, Walters S, Bowns I. Patient satisfaction with teledermatology: quantitative 
and qualitative results from a randomized controlled trial. J Telemed Telecare. 
2004;10(1):29-33. 
69. van der Heijden JP, de Keizer NF, Bos JD, et al. Teledermatology applied following 
patient selection by general practitioners in daily practice improves efficiency and 
quality of care at lower cost. Br J Dermatol. 2011;165(5):1058-65. 
70. Chen SC, Pennie ML, Kolm P, et al. Diagnosing and managing cutaneous pigmented 
lesions: primary care physicians versus dermatologists. J Gen Intern Med. 
2006;21(7):678-82. 
71. Britt H, Miller GC, Henderson J, et al. General practice activity in Australia 2013-14. 
General Practice Series No.36, The University of Sydney, 2014. [cited 2014 
November 2]. Available from: http://ses.library.usyd.edu.au/bitstream/2123/11882/ 
4/9781743324226_ ONLINE.pdf 
72. Tran H, Chen K, Lim AC, et al. Assessing diagnostic skill in dermatology: a 
comparison between general practitioners and dermatologists. Australas J Dermatol. 
2005;46(4):230-4. 
73. Whited JD. Economic analysis of telemedicine and the teledermatology paradigm. 
Telemed J E Health. 2010;16(2):223-8. 
74. de la Torre-Díez I, López-Coronado M, Vaca C, et al. Cost-utility and cost-
effectiveness studies of telemedicine, electronic, and mobile health systems in the 
literature: A systematic review. Telemed J E Health. 2015;21(2):81-5. 
75. Byamba K, Syed-Abdul S, García-Romero M, et al. Mobile teledermatology for a 
prompter and more efficient dermatological care in rural Mongolia. Brit J Dermatol. 
2015;173(1):265-7. 
76. Eminovic N, Berghout RM, Bindels PJE, et al. A cost minimisation analysis in 
teledermatology: model-based approach. BMC Health Serv Res. 2010;10(1):251. 
77. Wootton R, Bahaadinbeigy K, Hailey D. Estimating travel reduction associated with 
the use of telemedicine by patients and healthcare professionals: proposal for 
quantitative synthesis in a systematic review. BMC Health Serv Res. 2011;11:185. 
78. Bashshur RL, Shannon G, Krupinski EA, et al. Sustaining and Realizing the Promise 
of Telemedicine. Telemed J E Health. 2013;19(5):339-45. 
 120 References 
79. Australasian Telehealth Society. Towards a National Strategy for Telehealth in 
Australia 2013-2018. 2013  [cited 2015 July 4]. Available from: 
http://www.who.int/goe/policies/countries/aus/en/ 
80. Coates DF, Bowling J, Teledermoscopy, In Telemedicine in Dermatology. Soyer HP, 
Wurm EMT, Binder M, Smith AC, Editors. 2011, Springer-Verlag Berlin Heidelberg: 
Dordrecht. p. 67-71. 
81. Australian College of Rural and Remote Medicine. Tele-Derm: a diagnosis from a 
dermatologist in 48 hours. 2015  [cited 2015 May 1]. Available from: 
https://www.acrrm.org.au/tele-medicine#one 
82. Medicare Australia. Telehealth. 2015  [cited 2015 July 4]. Available from: 
http://www.medicareaustralia.gov.au/provider/incentives/telehealth/ 
83. Chemmart Pharmacy. Spotcheck. 2015  [cited 2015 January 28]. Available from: 
http://www.chemmart.com.au/wellbeing/in-store-wellbeing-services/spotcheck 
84. Romero G, Cortina P, Vera E. Telemedicine and teledermatology (II): current state of 
research on dermatology teleconsultations. Actas Dermo-Sifiliográficas. 
2008;99(8):586-97. 
85. Whited JD. Teledermatology research review. Int J Dermatol. 2006;45(3):220-9. 
86. Whited JD. Summary of the status of teledermatology research. 2014  [cited 2015 
April 10]. Available from: http://www.americantelemed.org/docs/default-
source/special-interest-group-docs/2014-summary-of-the-status-of-teledermatology-
research.pdf 
87. Warshaw EM, Gravely AA, Nelson DB. Reliability of store and forward 
teledermatology for skin neoplasms. J Am Acad Dermatol. 2015;72(3):426-35. 
88. Wu X, Oliveria SA, Yagerman S, et al. Feasibility and efficacy of patient-initiated 
mobile teledermoscopy for short-term monitoring of clinically atypical nevi. JAMA 
Dermatol. 2015;151(5):489-96. 
89. Davies AR, Ware JJE. Involving consumers in quality of care assessment. Health Aff 
(Millwood). 1988;7(1):33-48. 
90. Kable AK, Pich J, Maslin-Prothero SE. A structured approach to documenting a 
search strategy for publication: A 12 step guideline for authors. Nurse Educ Today. 
2012;32(8):878-86. 
91. Law M, Stewart D, Pollock N, et al. Critical review form—Quantitative studies. 1998  
[cited 2015 April 1]. Available from: 
https://www.canchild.ca/en/canchildresources/educationalmaterials.asp#CriticalRevie
w 
92. Pak HS, Welch M, Poropatich R. Web-based teledermatology consult system: 
preliminary results from the first 100 cases. Stud Health Technol Inform. 
1999;64:179-84. 
93. Kvedar JC, Menn ER, Baradagunta S, et al. Teledermatology in a capitated delivery 
system using distributed information architecture: design and development. Telemed 
J. 1999;5(4):357-66. 
94. van den Akker TW, Reker CH, Knol A, et al. Teledermatology as a tool for 
communication between general practitioners and dermatologists. J Telemed 
Telecare. 2001;7(4):193-8. 
 References 121 
95. Williams TL, Esmail A, May CR, et al. Patient satisfaction with teledermatology is 
related to perceived quality of life. Br J Dermatol. 2001;145(6):911-7. 
96. Weinstock MA, Nguyen FQ, Risica PM. Patient and referring provider satisfaction 
with teledermatology. J Am Acad Dermatol. 2002;47(1):68-72. 
97. Whited JD, Hall RP, Foy ME, et al. Patient and clinician satisfaction with a store-and-
forward teledermatology consult system. Telemed J E Health. 2004;10(4):422-31. 
98. McKoy KC, DiGregorio S, Stira L. Asynchronous teledermatology in an urban 
primary care practice. Telemed J E Health. 2004;10 Suppl 2:S-70-80. 
99. Moreno-Ramirez D, Ferrandiz L, Bernal AP, et al. Teledermatology as a filtering 
system in pigmented lesion clinics. J Telemed Telecare. 2005;11(6):298-303. 
100. Eminović N, Witkamp L, de Keizer NF, et al. Patient perceptions about a novel form 
of patient-assisted teledermatology. Arch Dermatol. 2006;142(5):647-51. 
101. Bowns IR, Collins K, Walters SJ, et al. Telemedicine in dermatology: a randomised 
controlled trial. Health Technol Assess. 2006;10(43):1-39. 
102. Eminović N, de Keizer NF, Wyatt JC, et al. Teledermatologic consultation and 
reduction in referrals to dermatologists: a cluster randomized controlled trial. Arch 
Dermatol. 2009;145(5):558-64. 
103. Hsueh MT, Eastman K, McFarland LV, et al. Teledermatology patient satisfaction in 
the Pacific Northwest. Telemed J E Health. 2012;18(5):377-81. 
104. Kaliyadan F, Amin TT, Kuruvilla J, et al. Mobile teledermatology-patient satisfaction, 
diagnostic and management concordance, and factors affecting patient refusal to 
participate in Saudi Arabia. J Telemed Telecare. 2013;19(6):315-9. 
105. Ford JA, Pereira A. Does teledermatology reduces secondary care referrals and is it 
acceptable to patients and doctors?: a service evaluation. J Eval Clin Pract. 2015 
21(4):710-6. 
106. Marchetti MA, Fonseca M, Dusza SW, et al. Dermatoscopic imaging of skin lesions 
by high school students: a cross-sectional pilot study. Dermatol Pract Concept. 
2015;5(1):11-28. 
107. Demiris G, Speedie SM, Hicks LL. Assessment of patients' acceptance of and 
satisfaction with teledermatology. J Med Syst. 2004;28(6):575-9. 
108. Wu I-L, Chen J-L. An extension of Trust and TAM model with TPB in the initial 
adoption of on-line tax: An empirical study. Int J Hum-Comput St. 2005;62(6):784-
808. 
109. Holden RJ, Karsh BT. The Technology Acceptance Model: Its past and its future in 
health care. J Biomed Inform. 2010;43(1):159-72. 
110. Davis FD. Perceived Usefulness, Perceived Ease of Use, and User Acceptance of 
Information Technology. MIS Quarterly. 1989;13(3):319-40. 
111. Wade R. Home Telehealth User Compliance and the Technology Acceptance Model. 
J Patient Compliance. 2012;2(3):46-8. 
112. Orruno E, Gagnon MP, Asua J, et al. Evaluation of teledermatology adoption by 
health-care professionals using a modified Technology Acceptance Model. J Telemed 
Telecare 2011;17(6):303-7. 
113. Yarbrough AK, Smith TB. Technology Acceptance among Physicians: A New Take 
on TAM. Med Care Res Rev. 2007;64(6):650-72. 
 122 References 
114. Patrick YK. Chau PJH. Examining a Model of Information Technology Acceptance 
by Individual Professionals: An Exploratory Study. J Manage Inform Syst. 
2002;18(4):191-229. 
115. Taylor S, Todd PA. Understanding Information Technology Usage: A Test of 
Competing Models. Inform Syst Res. 1995;6(2):144-76. 
116. Lin C-H, Shih H-Y, Sher PJ. Integrating technology readiness into technology 
acceptance: The TRAM model. Psychol Marketing. 2007;24(7):641-57. 
117. Hsin Chang H. Task-technology fit and user acceptance of online auction. Int J Hum-
Comput St. 2010;68(1–2):69-89. 
118. Shih Chih Chen, Shing Han Li, Yi C. Recent Related Research in Technology 
Acceptance Model: A Literature Review Aust J Bus Manage Res. 2011;1(9):124-7. 
119. Agarwal R, Karahanna E. Time Flies When You're Having Fun: Cognitive 
Absorption and Beliefs about Information Technology Usage. MIS Quarterly. 
2000;24(4):665-94. 
120. Joo YJ, Lee HW, Ham Y. Integrating user interface and personal innovativeness into 
the TAM for mobile learning in Cyber University. J Comput High Educ. 
2014;26(2):143-58. 
121. Liu Y, Li H, Carlsson C. Factors driving the adoption of m-learning: An empirical 
study. Comput Educ. 2010;55(3):1211-9. 
122. Gefen D, Karahanna E, Straub DW. Trust and TAM in Online Shopping: An 
Integrated Model. MIS Quarterly. 2003;27(1):51-90. 
123. Venkatesh V, Davis FD. A Theoretical Extension of the Technology Acceptance 
Model: Four Longitudinal Field Studies. Management Science. 2000;46(2):186-204. 
124. Yang M-H, Lin B, Chandlrees N, et al. The effect of perceived ethical performance of 
shopping websites on consumer trust. J Comput Inform Syst. 2009;50(1):15-24. 
125. Kraai IH, Luttik MLA, de Jong RM, et al. Heart failure patients monitored with 
telemedicine: patient satisfaction, a review of the literature. J Card Fail. 
2011;17(8):684-90. 
126. Olsen CM, Green AC, Neale RE, et al. Cohort profile: The QSkin Sun and Health 
Study. Int J Epidemiol. 2012;41(4):929-i. 
127. Morze CJ, Olsen CM, Perry SL, et al. Good test-retest reproducibility for an 
instrument to capture self-reported melanoma risk factors. J Clin Epidemiol. 
2012;65(12):1329-36. 
128. Techneau. Assessing consumer trust and confidence. 2006 [cited 2014 March 16]. 
Available from: http://www.techneau.org/fileadmin/files/Publications/Publications 
/Deliverables/D6.1.1_report.pdf 
129. Marble N, Loescher LJ, Lim KH, et al. Use of technology for educating melanoma 
patients. J Cancer Educ. 2010;25(3):445-50. 
130. Lang TA, Secic M. How to Report Statistics in Medicine: Annotated Guidelines for 
Authors, Editors and Reviewers. 2nd edition ed. 2006, United States: American 
College of Physicians. 
131. Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for 
measurement properties of health status questionnaires. J Clin Epidemiol. 
2007;60(1):34-42. 
 References 123 
132. Saunders MNK. Web versus Mail: The Influence of Survey Distribution Mode on 
Employees' Response. Field Methods. 2012;24(1):56-73. 
133. Streiner DL, Norman GR. Health measurement scales: a practical guide to their 
development and use. 2008, New York, USA: Oxford University Press. 
134. Eysenbach G. Improving the Quality of Web Surveys: The Checklist for Reporting 
Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. 
135. Waltermaurer E. Questionnaire Design. Encyclopedia of Epidemiology. Thousand 
Oaks, CA: SAGE Publications. p. 880-3. 
136. Demiris G, Speedie S, Finkelstein S. A questionnaire for the assessment of patients' 
impressions of the risks and benefits of home telecare. J Telemed Telecare. 
2000;6(5):278-84. 
137. Bowling A. Research methods in health: investigating health and health services. 
2014, Maidenhead, Berkshire: Open University Press. 
138. Fekken GC. Reliability. 2000, New York, USA: American Psychological Association 
139. Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ. 
2011;2:53-5. 
140. Field AP. Discovering statistics using IBM SPSS statistics: and sex and drugs and 
rock 'n' roll. 2013, London, UK: SAGE Publications. 
141. Landis JR, Koch GG. The measurement of observer agreement for categorical data. 
Biometrics. 1977;33(1):159-74. 
142. SAS software. Prinicipal Components Analysis. 2015  [cited 2015 January 30]. 
Available from: http://support.sas.com/publishing/pubcat/chaps/55129.pdf 
143. Fabrigar LR, Wegener DT. Exploratory Factor Analysis. 2012, New York, USA: 
Oxford University Press. 
144. Hair JF. Multivariate data analysis. 2006, Upper Saddle River, USA: Pearson Prentice 
Hall. 
145. Tsai CH. Integrating Social Capital Theory, Social Cognitive Theory, and the 
Technology Acceptance Model to Explore a Behavioral Model of Telehealth Systems. 
Int J Environ Res Public Health. 2014;11(5):4905-25. 
146. Fayers PM, Machin D, Factor analysis in quality of life assessment in clinical trials. 
1988, Oxford, UK: Oxford University Press. 
147. Lei PW, Wu Q. Introduction to Structural Equation Modeling: Issues and Practical 
Considerations. Educ Meas Issues Prac. 2007;26(3):33-43. 
148. Tabachnick BG, Fidell LS. Using Multivariate Statistics. Volume 5. 2007, New York, 
USA: Allyn and Bacon. 
149. McPherson M, Elwood M, English DR, et al. Presentation and detection of invasive 
melanoma in a high-risk population. J Am Acad Dermatol. 2006;54(5):783-92. 
150. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for 
cutaneous melanoma. CA Cancer J Clin. 2004;54(3):131-49. 
151. Klaz I, Wohl Y, Nathansohn N, et al. Teledermatology: quality assessment by user 
satisfaction and clinical efficiency. Isr Med Assoc J. 2005;7(8):487-90. 
152. Ebner C, Wurm EM, Binder B, et al. Mobile teledermatology: a feasibility study of 58 
subjects using mobile phones. J Telemed Telecare. 2008;14(1):2-7. 
 124 References 
153. World Bank. Mobile Phone Access Reaches Three Quarters of Planet's Population. 
2012  [cited 2015 May 1]. Available from: http://www.worldbank.org/en/news/press-
release/2012/07/17/mobile-phone-access-reaches-three-quarters-planets-population 
154. Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. 
Telemed J E Health. 2009;15(3):231-40. 
155. Cimperman M, Brenčič MM, Trkman P, et al. Older Adults' perceptions of home 
telehealth services. Telemed J E Health. 2013;19(10):786-90. 
156. Butler DP, Lloyd-Lavery A, Archer CM, et al. Patient education on effective skin 
self-examination: which patient groups require special attention? J Plast Reconstr 
Aesthet Surg. 2011;64(12):1718-20. 
157. Tsao H, Olazagasti JM, Cordoro KM, et al. Early detection of melanoma: Reviewing 
the ABCDEs. J Am Acad Dermatol. 2015;72(4):717-23. 
158. Luttrell MJ, McClenahan P, Hofmann-Wellenhof R, et al. Laypersons' sensitivity for 
melanoma identification is higher with dermoscopy images than clinical photographs. 
Br J Dermatol. 2012;167(5):1037-41. 
159. Daniel CL, Armstrong GT, Keske RR, et al. Advancing Survivors' Knowledge (ASK) 
about skin cancer study: study protocol for a randomized controlled trial. Trials. 
2015;16:109. 
160. Zuo KJ, Guo D, Rao J. Mobile teledermatology: a promising future in clinical 
practice. J Cutan Med Surg. 2013;17(6):387-91. 
161. Spinks J, Janda M, Soyer HP, et al. Consumer preferences for teledermoscopy 
screening to detect melanoma early. J Telemed Telecare. 2015, May 29 [Epub ahead 
of print]. 
162. Mair F, Whitten P. Systematic review of studies of patient satisfaction with 
telemedicine. BMJ. 2000;320(7248):1517-20. 
163. DeVellis RF. Scale development: theory and applications. 2012, Thousand Oaks, 
California, USA: SAGE Publications. 
164. Yip MP, Chang AM, Chan J, et al. Development of the Telemedicine Satisfaction 
Questionnaire to evaluate patient satisfaction with telemedicine: a preliminary study. J 
Telemed Telecare. 2003;9(1):46-50. 
165. Bagozzi R. The Legacy of the Technology Acceptance Model and a Proposal for a 
Paradigm Shift. J Assoc Inform Syst. 2007;8(4):Article 12. 
166. Jackson CM, Chow S, Leitch RA. Toward an Understanding of the Behavioral 
Intention to Use an Information System. Decision Sciences. 1997;28(2):357-89. 
167. Chau PYK, Hu PJ-H. Investigating healthcare professionals’ decisions to accept 
telemedicine technology: an empirical test of competing theories. Inform Manage. 
2002;39(4):297-311. 
168. OECD. Education at a Glance 2014: Highlights. 2014  [cited 2015 July 5]. Available 
from: http://www.oecd-ilibrary.org/education/education-at-a-glance2014_eag_ 
highlights-2014-en 
169. Demiris G. Principles of survey development for telemedicine applications. J Telemed 
Telecare. 2006;12(3):111-5. 
 References 125 
170. Masino C, Lam TCM. Choice of Rating Scale Labels: Implication for Minimizing 
Patient Satisfaction Response Ceiling Effect in Telemedicine Surveys. Telemed J E 
Health. 2014;20(12):1150-5. 
171. Desai B, McKoy K, Kovarik C. Overview of international teledermatology. Pan Afr 
Med J. 2010;6:3. 
172. The International Foundation for Dermatology. Who we help. 2015  [cited 2015 July 
5]. Available from: http://www.ifd.org/about-ifd/who-we-help 
173. Coates SJ, Kvedar J, Granstein RD. Teledermatology: From historical perspective to 
emerging techniques of the modern era: Part II: Emerging technologies in 
teledermatology, limitations and future directions. J Am Acad Dermatol. 
2015;72(4):577-86. 
  

 Appendices 127 
Appendices 
APPENDIX A: PARTICIPANT INFORMATION SHEET 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What is this study about? 
This research study is being conducted as part of 
Caitlin Horsham’s research project. It investigates 
whether new technology can help with the early 
detection of melanoma. The new technology is called 
a mobile  “dermatoscope” (see picture on right). A 
dermatoscope is a device that can be attached to a 
smartphone to take magnified digital photographs of 
moles and spots on the skin. These digital images can 
be sent to dermatologists to determine whether the 
moles should be reviewed by a doctor.  
This research explores facilitators and barriers of 
people using mobile teledermoscopy for the early 
detection of skin cancer.  
Why Me? 
We’re looking for Queensland residents 
both male and female 18 years of age 
and older. 
 
Why are we researching teledermatology? 
Melanoma, the most serious type of skin cancer, is a major public health issue in Australia. 
Finding melanomas at an early stage is one way to improve survival rates for this cancer. One 
approach to detecting melanomas early is for people to examine their own skin for suspicious 
moles and skin spots so that they can alert their doctor and be examined promptly. Modern 
technology may improve such self-examinations. 
Participant Information Sheet 
Facilitators and barriers of   
mobile teledermoscopy 
 
What do I need to do? 
QUT researchers would ask you to: 
ALL PARTICPANTS 
1. Complete survey 1 (approx. 20 mins) online asking questions about how you feel about 
examining your skin, your skin cancer risk factors, your beliefs and attitudes about skin 
cancer, your skill and confidence level using a Smartphone and your potential acceptance of 
this new technology, both if you have or haven’t used it before.  
2. Two weeks later we will ask you to complete survey 2 (approx. 10 minutes) about further 
dermatoscope technology acceptance.  
SELECTED PARTICIPANTS (optional) 
3. Some selected participants will be offered to further participate in testing the dermatoscope 
after survey 1. These participants will be asked to test the functionality of the dermatoscope 
only. We will then ask you to provide additional feedback on this in survey 2. Please note, 
there will be no medical diagnosis or assessment of your moles and spots photographed. If 
you have any concerns about your skin, we recommend that you seek advice from your GP. 
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What will it cost me? 
 
There will be no costs to you. Upon completion of 
both surveys, you will go into the draw to win one 
of 2 $50 Coles/Myer gift vouchers.  
What are the possible benefits 
for me? 
The information obtained by this study may 
provide insight into whether the 
dermatoscope could be useful for consumers 
to detect melanoma. The information 
collected in this study may have the 
potential to help others in the future. 
What about privacy and 
confidentiality? 
All personal information obtained throughout the 
study will only be accessible in its identifiable 
form by the chief investigators or study 
coordinator. Any data collected as part of this 
project will be stored securely as per QUT’s 
Management of research data policy. No 
identifiable information will be used in publication 
of the results. This project will be carried out 
according to the National Statement on Ethical 
Conduct in Research in Human Research (2007) 
produced by the National Health and Medical 
Research Council of Australia. Participation in this 
study is voluntary.  
How can I find out more? 
If you have any questions you can 
contact the principle researchers and we 
will be happy to answer any queries 
that you may have.   
Caitlin Horsham 
Masters Research Student 
Queensland University of Technology 
Email: c.horsham@qut.edu.au 
 
Associate Professor Monika Janda  
Primary Supervisor  
Queensland University of Technology      
Ph: (07) 3138 3018                                    
Email: m.janda@qut.edu.au 
 
 
 
What are the risks? 
There are minimal risks associated with your 
participation in this study. In the event that you 
suffer distress or discomfort when self-
examining your skin or answering the 
questionnaires as a result of participating in this 
research project QUT Psychology and 
Counselling Clinic provides limited free 
counselling for research participants (07) 3138 
0999. 
 
What if I want to complain? 
QUT is committed to researcher integrity and 
the ethical conduct of research projects.  
However, if you do have any concerns or 
complaints about the ethical conduct of the 
project and would like to speak to someone 
who is not involved in the study, you may 
contact the QUT Research Ethics Unit on 07 
3138 5123 or email ethicscontact@qut.edu.au.  
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APPENDIX B: VIRTUAL SKIN CHECK STUDY: BASELINE QUESTIONNAIRE 
 
 
 
 
 
 
 
 
 
 
 
Facilitators	and	barriers	of	mobile	
teledermatology	 
 
 
 
 
 
 
 
 
 
 
   
 
Thank you very much for agreeing to participate in this study.  
Please answer the questions by marking an X for the answer that best 
applies to you. There are no right or wrong answers. Your opinion is 
important to us. 
 
 
 
 
 
 
Date completed: _______________ 
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Before you begin: 
Rather than using your real name, you will use an identifier so we can match your responses in the 
first and second survey. Your identifier is:   
(1) the first three letters of your mother’s maiden name, and  
(2) the day of your birth.  
 Example 1:  If your mother’s maiden name is Smith, and you were born on January 1st, your identifier 
would be SMI1. 
Example 2:  If your mother’s maiden name is Jones, and you were born on October 18th, your 
identifier would be JON18. 
 
My identifier is: __________________________________________ 
 
Section 1  
 
Skin cancer risk factors 
 
1. About how many separate SKIN CANCERS (but not moles or warts) have you ever had CUT 
OFF your skin?  
1 20+ skin cancers      
2 10-19 skin cancers  
3  2-9 skin cancers 
4 1 skin cancer 
5 None 
2. Have you made an attempt to get a suntan in the past 12 months?  
1 Yes 2 No 3 Don’t know/unsure  
 
3. When outdoors, how often do you do each of the following?  
 never  sometimes usually  always  
a. Wear a shirt with sleeves  1 2 3 4 
b. Wear sunglasses 1 2 3 4 
c. Stay in the shade  1 2 3 4 
d. Use sunscreen  1 2 3 4 
e. Limit your time in the sun during 
midday hours 1 2 3 4 
f. Wear a hat 1 2 3 4 
g. Stay under an umbrella 1 2 3 4 
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4. In general, compared to other people, would you say your health is? 
1 Excellent       2 Very good        3  Good        4 Fair        5 Poor  
 
 
5. Have any close blood relatives ever been told that they have MELANOMA? (Melanomas are the 
most serious form of skin cancer, are usually very dark, and are always removed by surgery) 
1Yes 2 No         3  Don’t know 
   
  
6. A sunburn is any amount of reddening of the skin after being in the sun. Overall, how many 
times did you get sunburnt in the past 12 months?  
1 Never        
2 Once 
3 2-5 times 
4 6 or more times 
5 Don’t know/unsure 
 
 
7. Compared to other Queenslanders, how likely do you think it is that you will get melanoma at 
some time in the future…  
1 Highly unlikely        
2 Somewhat unlikely 
3 About the same as other Queenslanders   
4 Somewhat more likely 
5 Highly likely 
6 Already been diagnosed 
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8. For each of the following statements please indicate whether you strongly agree, agree, 
disagree, strongly disagree, or are unsure with each statement. Please select only one option 
for each question.  
 Strongly Agree 
Agree Unsure Disagree Strongly 
Disagree 
a. It is important to check my skin 
for skin cancer even if I have no 
symptoms 
1 2 3 4 5 
b. I think checking my skin would 
make me anxious. 1 2 3 4 5 
c. Checking my skin regularly is a 
priority for me. 1 2 3 4 5 
d. I think I could find a suspicious 
spot on my skin if it was there. 1 2 3 4 5 
e. If I saw something suspicious on 
my skin, I’d go to the doctor 
straight away. 
1 2 3 4 5 
f. I am confident in my doctor’s 
ability to diagnose skin cancer. 1 2 3 4 5 
g. I have made plans on when to 
examine my own skin. 1 2 3 4 5 
h. I am confident that I can start 
examining my own skin again 
even if I have not looked at my 
skin in the past few months. 
1 2 3 4 5 
i. I am confident in that I can 
examine my skin for moles or 
spots using recommended 
procedures. 
1 2 3 4 5 
j. I can examine my own skin 
regularly, even if I have no one to 
help me. 
1 2 3 4 5 
k. If I regularly examine my skin, 
then I am helping to look after my 
own health. 
1 2 3 4 5 
l. I am confident that I can detect 
abnormalities in moles or spots I 
find. 
1 2 3 4 5 
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Attitudes towards Melanoma 
 
9. For each of the statements can you tell me how much you agree or disagree with each item? 
 
 
 
Section 2  
 
Colouring and skin type 
 
10. What was your natural hair colour at age 21?  
1 Red / auburn  2 Dark brown   3 Blonde    
4 Light brown  5 Black   6 Other ________________ 
 
11. What is your eye colour?  
1 Blue or grey  2 Green or hazel  3 Brown or black   
4 Other______________ 
 
12. What is your skin colour before tanning or on areas never exposed to the sun, such as 
the inside of your upper arm? Is it…  
1 Very fair  2 Fair 3 Medium 4 Olive or brown 
 
13. If you were exposed to strong sun for 30 minutes at the beginning of summer without a 
tan and without protection, would your skin…  
1 Not burn      2 Burn a little 3 Burn moderately 4 Burn badly 
 
14. After being exposed to the sun (for a long time) over several days, how deep a tan 
would you get?  
1 No tan 2 Tan slightly 3 Tan moderately  4 Tan deeply 
 
 Strongly 
Agree 
Agree Unsure Disagree Strongly 
Disagree 
a. The thought of melanoma 
scares me 1 2 3 4 5 
b. Treatment for melanoma is 
worse than the cancer itself 1 2 3 4 5 
c. I would not want to know if I 
have melanoma 1 2 3 4 5 
d. These days, many people with 
melanoma can expect to 
continue with normal activities 
and responsibilities 
1 2 3 4 5 
e. Going to the doctor as quickly 
as possible after noticing a 
symptom of melanoma could 
increase the chances of 
surviving 
1 2 3 4 5 
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15. Most people have some moles. Moles are small brown, black or pink, either raised or 
flat skin marking that do not change after sun exposure. How many moles do you think you 
have on your body (see picture below)? Either… 
1 None             2 A few                  3 Some          4 Many  
(0)                         (Less than 20)                 (20-50)                     (More than 50) 
 
                                      
 
 
 
 
 
 
 
 
Section 3  
 
Skin examination history 
 
16. In the past 12 months has a doctor deliberately checked the skin on your whole body 
for early signs of skin cancer? This usually involves removing your clothing so only your 
underwear remains. 
1 Yes 2 No 3 Unsure  
 
17. Have you or someone who is not a doctor, such as your spouse or partner, ever 
deliberately checked any part of your skin for early signs of skin cancer? 
1 Yes      
2 No  go to Q20 
3 Unsure  
 
18. In the past 12 months, have you or someone who is not a doctor, such as your spouse 
or partner, checked your skin for early signs of skin cancer? 
1 Yes 2 No 3 Unsure  
 
  
19. During your last skin check, did you have someone to help you see difficult to see 
areas, for example, your partner or relative?   
1 Yes 2 No   
 
20. How confident are you that you can check your skin correctly, with 1 being not at all 
confident and 10 highly confident? 
  
           1     2     3     4     5     6     7     8     9     10  
 
Not at all 
confident 
Highly 
confident 
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Section 4  
 
Mobile teledermoscopy 
 
Teledermoscopy is a new way of looking at moles or skin spots. Teledermoscopy uses a device called 
a dermatoscope (see picture below) to magnify moles and spots. This allows a dermatologist to get a 
better look at the shape, colour, and structure within the mole or spot. Mobile teledermoscopy is a 
process that uses a Smartphone to: 
a. attach to a custom dermatoscope that allows you to look at moles and skin spots;  
b. photograph moles or spots magnified with the dermatoscope camera;  
c. e-mail the photograph to a dermatologist, and  
d. receive feedback from the dermatologist about the mole or spot.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The idea is that you could identify a mole or skin spot that is worrisome to you, and then conduct 
steps first two steps above at home. You would then receive feedback about the mole or spot from a 
dermatologist. In this study, some participants will be asked to trial the functionality of the 
dermatoscope, however we are unable to provide a medical diagnosis of any lesions photographed. 
 
21. Have you ever used mobile teledermoscopy in the past? 
1 Yes      
2 No 
3 Unsure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consumer takes a 
photo of suspicious 
skin lesion at home 
using a smartphone 
and dermatoscope 
attachment 
 
 
 
 
 
 
 
Consumer emails 
the photo, lesion 
and patient history 
to dermatologist for 
diagnosis 
 
 
 
 
 
 
 
 
Remote 
dermatologist 
reviews and 
responds to the 
consumer via a 
website or mobile 
device 
 
 
 
 
 
 
 
The diagnosis 
would be sent 
directly back to 
your Smartphone 
email. 
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22. We are interested in your opinion for each of the following statements about mobile 
teledermoscopy, regardless of whether you have used it.  Please indicate whether you 
strongly agree, agree, disagree, strongly disagree, or are unsure with each statement. 
Remember to select one response for each statement. 
 Strongly 
Agree 
Agree Unsure Disagree Strongly 
Disagree 
a. I will use mobile teledermoscopy 
when it is offered to me 1 2 3 4 5 
b. The use of mobile teledermoscopy 
will improve the diagnosis of  spots 
and moles on my skin that look 
suspicious 
1 2 3 4 5 
c. It will be easy to perform mobile 
teledermoscopy 1 2 3 4 5 
d. Mobile teledermoscopy will be a 
standard way of health-care 
delivery in the future 
1 2 3 4 5 
e. Participating in mobile 
teledermoscopy will be in my best 
interests 
1 2 3 4 5 
f. I don’t like that there is no physical 
contact with a health professional 
using mobile teledermoscopy 
1 2 3 4 5 
g. Diagnosis of a suspicious mole or 
spot made through mobile 
teledermoscopy would be clear 
and easily understandable 
1 2 3 4 5 
h. The use of this technology does 
not threaten my privacy or 
confidentiality of my medical data 
1 2 3 4 5 
i. Mobile teledermoscopy will 
improve my skin self-examination 
performance 
1 2 3 4 5 
j. Mobile teledermoscopy will help 
me to examine my skin more 
thoroughly 
1 2 3 4 5 
k. My doctor will welcome the fact 
that I use mobile teledermoscopy 1 2 3 4 5 
l. Mobile teledermoscopy will help to 
diagnose skin cancer quicker 1 2 3 4 5 
m. I will find it easy to acquire the 
necessary skills to use mobile 
teledermoscopy 
1 2 3 4 5 
n. I would be satisfied with the 
diagnosis by mobile 
teledermatology without talking to 
the dermatologist in person 
 
1 2 3 4 5 
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Q. 22 cont. Strongly 
Agree 
Agree Unsure Disagree Strongly 
Disagree 
o. I will rely on the teledermatology 
process to supply accurate 
information about a mole or spot. 
1 2 3 4 5 
p. I will use mobile teledermoscopy if 
I receive adequate training  1 2 3 4 5 
q. Other health professionals 
(physicians, nurses, other 
specialists etc.) will welcome the 
fact that I use mobile 
teledermoscopy  
1 2 3 4 5 
r. In general, mobile teledermoscopy 
will be useful to improve diagnosis 
of skin cancer  
1 2 3 4 5 
s. I would use mobile teledermoscopy 
routinely when I do skin self-
examination in the future if it was 
available to me 
1 2 3 4 5 
t. A dermatologist cannot diagnose a 
skin cancer by mobile 
teledermoscopy as well as they 
can in person 
1 2 3 4 5 
u. I will use mobile teledermoscopy if 
I receive technical assistance when 
I need it  
1 2 3 4 5 
v. I would have complete trust in the 
dermatologist’s diagnosis based on 
a photo I emailed as part of mobile 
teledermoscopy 
1 2 3 4 5 
w. I will use mobile teledermoscopy 
only if it will save me time 1 2 3 4 5 
x. I will use mobile teledermoscopy 
only if it will save me money 1 2 3 4 5 
y. I will easily learn how to use mobile 
teledermoscopy 1 2 3 4 5 
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Section 5  
 
Your use of smartphones 
 
A Smartphone is a mobile telephone with built-in applications and Internet access. Smartphones 
provide text messaging, e-mail, Web browsing, still and video cameras, MP3 player and other 
features. Smartphones can run many applications (apps), turning the mobile phone into a mobile 
computer.  
If you have never used a Smartphone before, place a cross here  and go to SECTION 
6.  
 
23. Please indicate your skill level with the following Smartphone applications ranging from very 
unskilled to very skilled. If you do not use one of the options, or don’t know what it is please tick 
‘what’s this’ or ‘do not use’. (Mark one response for each item) 
 
 
 
 
 
 
 
 
 
 
 
 
 What’s 
this? 
Do not 
use 
 
Very 
unskilled 
Unskille
d 
Skilled Very 
Skilled 
a. Surfing the 
Internet/Web 1 2 3 4 5 6 
b. Sending SMS 
messages 1 2 3 4 5 6 
c. Reading SMS 
messages 1 2 3 4 5 6 
d. Sending email 1 2 3 4 5 6 
e. Reading email 1 2 3 4 5 6 
f. Opening attachments 1 2 3 4 5 6 
g. Uploading digital files 1 2 3 4 5 6 
h. Taking and managing 
photos 1 2 3 4 5 6 
i. Downloading 
applications 1 2 3 4 5 6 
j. Using applications 1 2 3 4 5 6 
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24. Please indicate the amount of time per WEEK during an average week that you spend 
using your Smartphone for the following purposes: (mark one response for each item)  
 
 Do not 
use 
Less 
than 1 
hr 
1-2 hrs 3-5 hrs 6-10 
hrs 
11 or 
more 
hrs 
a. Get information 1 2 3 4 5 6 
b. Play games 1 2 3 4 5 6 
c. Surf the Internet 1 2 3 4 5 6 
d. E-mail 1 2 3 4 5 6 
e. Word processing or 
other office-type 
programs 
1 2 3 4 5 6 
f. Listen to music 1 2 3 4 5 6 
g. Accessing other  
     applications 1 2 3 4 5 6 
 
Section 6: Final section  
 
Demographics  
 
25.  Gender?  
1 Male  2 Female 
 
26.  What is your age? 
 
27. What is the highest level of education you have completed?  
1 No high school or other qualification 
2 School or intermediate certificate    
3  Higher school or leaving certificate    
4 Trade/ apprenticeship    
5   Certificate/ diploma    
6 University degree         
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28. How would you describe your current work situation?  
1 Full-time worker  2 Part-time worker  3 Home duties  
4 Unemployed 5 Student  6 Retired   
7 Other (please specify) ______________________    
   
        
29. What is your present marital status?  
1 Married/living together       
2 Divorced/separated  
3 Widowed  
4 Single/never married     
5 Other (please specify) ___________________________________  
     
30. What country were you born in? 
         
1 Australia 
2 Other_________________________________________ 
 
31. If you were born in a country other than Australia, how old were you (age in years) when you 
moved permanently to Australia? 
 
Age in years 
 
32. How many YEARS of your life have you lived in the following three regions of AUSTRALIA: (to 
the nearest year) 
 
 
 
 
 
33. Do you have private health insurance?  
1 Yes   2 No 
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Thank you very much for taking part in Survey 1. 
 
You will receive survey 2 in two weeks time by email. 
 
Please provide your email address for survey 2 below. You will need to complete survey 2 to go in to 
the draw to win one of 2 x $50 gift vouchers. 
 
 
Email: ______________________________________________ 
 
 
 
END OF SURVEY 
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APPENDIX C: DERMATOSCOPE INSTRUCTIONS 
 
 
 
1. Tap the ‘Handyscope’ icon on your 
iPhone to open the application (see 
yellow box). 
2. Turn the dermatoscope on. The on/off 
switch is located directly next to the 
magnifying lens.  
 
 
 
3. The ‘Handyscope’ application will open in 
camera mode.  
4. Select a ‘worrisome mole’ or skin spot 
that you detected  
 
5. Place the magnifying lens on the 
dermatoscope directly over the mole or 
skin spot you wish to photograph. The 
magnifying lens should be touching your 
skin.    
6. Once you are confident that you have a 
clear image of your mole, tap the screen 
to take a photograph. 
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7. Tap ‘Save’ on the top right-hand side of 
the screen (see yellow box). Your image 
has been saved to Local Images. 
8. Once you have saved the image, you will 
be directed back the camera. 
 
 
 
 
 
 
 
 
 
 
9. To see your image, go to local images. To 
go to local images tap the icon  in 
the top left hand corner. 
10. You are now in local images, where you 
can see your saved photos. 
11. Tap on the red arrow next to the picture. 
 
 
 
 
 
 
12. Tap on ‘Localization’ (see red box) and 
specify your gender. Tap on the body area 
where you photographed the mole (you 
can zoom in on the body to help pinpoint a 
specific area and scroll across to reach 
other body areas). Tap ‘Done’ on the top 
left-hand side of the screen. 
 
13. Tap ‘Email Image’ (see blue box). Enter 
your email address if you wish to keep the 
photo. 
 
14. Tap ‘send’ in the top left hand corner. 
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APPENDIX D: DERMATOSCOPE SATISFACTION QUESTIONS 
 
 
 
 
2. Do you expect any difficulties when photographing your moles or skin spots?  (Please 
mark with an X all that apply) 
 
No difficulties 
1 
I expect difficulties taking a photo of a particular mole or skin spot 
4 
I  expect difficulties taking a clear  or close-up photo of a particular mole or skin 
spot 5 
I expect difficulties photographing a particular mole or skin spot because it is in a 
hard-to-see location or angle 6 
 
I  expect difficulties personalising the app functions (for e.g. entering my study ID, 
gender, birth date)    7 
I  expect difficulties sending the e-mail to the study dermatologist 
8 
Other, please describe: 
 
 
 
 
 
 
 
9 
 
 
3. Would you ask another person to help you photograph your 
moles or skin spots?   
No   
1 
 Yes 
2 
 
1. How confident are you that you could take satisfactory photographs of your moles or 
skin spots using the dermatoscope and email them to a dermatologist for evaluation? 
(Place an X above the number that best describes your confidence in relation to this 
question) 
 
 
 
 
 
 
         
 
  
1 
Not at all 
confident 
2 3 4 5 
Moderately 
confident 
6 7 
 
8 9 10 
Highly 
confident 
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4. For each of the following statements please indicate whether you strongly agree, agree, 
disagree, strongly disagree, or are unsure with each statement. Please select only one option 
for each question. 
 
 
 
 
 
 
 
 
 Strongly 
Agree
Agree Unsure Disagree Strongly 
Disagree
a. Taking photos with the 
dermatoscope attachment was 
easy 
1 2 3 4 5 
b. The procedures for taking 
photos were clearly explained 1 2 3 4 5 
c. Using the dermatoscope has 
motivated me to do skin 
examinations on myself more 
regularly 
 
1 
 
2 
 
3 
 
4 
 
5 
d. By taking pictures of my spots 
or moles, I would feel 
distressed, anxious or worried 
about these spots or moles 
1 3 4 5 2 
e. I intend to purchase a 
dermatoscope for myself in the 
future 
1 2 3 4 5 
f. Conducting a whole body skin 
examination with the 
dermatoscope would be easy 
1 2 3 4 5 
g. I will continue examining my 
skin in the future  1 2 3 4 
 
5 
h. I will continue examining my 
skin in the future using a 
dermatoscope 
1 2 3 4 5 
